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Host and pathogen genetics associated with
pneumococcal meningitis
John Andrew Lees
Meningitis is an infection of the meninges, a layer of tissue surrounding the brain. In cases
of pneumococcal meningitis (where the bacterium Streptococcus pneumoniae is the causat-
ive agent) this causes severe inflammation, requiring intensive care and rapid antibiotic
treatment. The contribution of variation in host and pathogen genetics to pneumococcal
meningitis is unknown. In this thesis I develop and apply statistical genetics techniques to
identify genomic variation associated with the various stages of pneumococcal meningitis,
including colonisation, invasion and severity.
I start by describing the development of a method to perform genome-wide association
studies (GWAS) in bacteria, which can find variation in bacterial genomes associated with
bacterial traits such as antibiotic resistance and virulence. I then applied this method to
longitudinal samples from asymptomatic carriage, and found lineages and specific variants
associated with altered duration of carriage. To assess meningitis versus carriage samples
I applied similar analysis techniques, and found that the bacterial genome is crucial in
determining invasive potential. As well as bacterial serotype, which I found to be the
main effect, I discovered many independent sequence variants associated with disease.
Separately, I analysed within host-diversity during the invasive phase of disease and found
it to be of less relevance to disease progression.
Finally, I analysed host genotype data from four independent studies using GWAS
and heritability estimates to determine the contribution of human sequence variation to
pneumococcal meningitis. Host sequence accounted for some variation in susceptibility
to and severity of meningitis. The work concludes with a combined analysis of pairs
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This thesis primarily concerns the application of a modern statistical genetics technique,
the genome wide association study (GWAS), to determine how genetic variability of both
host and pathogen contributes to invasive pneumococcal disease (particularly meningitis).
Chapter 2 describes the issues with applying this technique to bacterial genomes, and a
method I developed to overcome these difficulties. In chapters 3 and 4 I then applied this
new technique, and others, to describe genetics associated with carriage duration (a pre-
requisite for disease) and invasive disease respectively. Finally, in chapter 5, I performed a
similar analysis of the association between host genetics and invasive disease, ending by
jointly analysing both host and pathogen together in a genome-to-genome analysis.
These results are therefore tied together both through the disease studied, and the
technique used to analyse genotype to phenotype associations. I start with an introduction
to the disease: the clinical manifestations of bacterial meningitis, its cause and treatment are
mentioned, with specific reference to the Netherlands where most of the new data analysed
was obtained. As the focus is on pneumococcal meningitis I then give a background
of pneumococcal genomics and pathogenesis. Though the results start with analysis of
pathogen genomes, GWAS and its development is crucial throughout. This section of
introduction starts with a short history of this method in the context of human genetics
where it was first applied. The application to host susceptibility to infectious disease, while
analysed last in this thesis, is discussed at the end of this first introductory section. I then
go on to describe the application of GWAS to bacterial genomes.
1.1 Bacterial meningitis
Bacterial meningitis is a severe inflammation of the membranes surrounding the brain,
the meninges, which is a response to the presence of bacteria in the cerebrospinal fluid
(CSF) (Mook-Kanamori et al., 2011). This inflammation can compromise brain function,
requiring immediate admission to hospital (Weisfelt et al., 2006). Other forms of meningitis
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(viral, parasitic) are common, but are generally less severe than bacterial meningitis (Attia
et al., 1999; Ginsberg, 2004). I also note early on two other terms related to this infection:
bacteremia, which is bacteria in the blood, and invasive pneumococcal disease (IPD),
which is bacteria in any normally sterile site, with the most serious disease caused when in
the blood or CSF.
1.1.1 Diagnosis, epidemiology and treatment
Accurate diagnosis of meningitis is challenging (Attia et al., 1999; Brouwer, Tunkel & van
de Beek, 2010) and requires clinical experience based on patient presentation as biomarkers,
co-occurrences with other diseases and other routine patient data are uninformative (Khatib
et al., 2016). Some symptoms such as headache, neck-stiffness, fever and altered mental
state are usually required for a diagnosis of bacterial meningitis (van de Beek et al., 2006).
The ‘gold-standard’ for confirming bacteria as the causal agent is a positive culture
from the CSF (Attia et al., 1999; van de Beek et al., 2004). Following successful culture, a
range of microbiological techniques can be used to determine the organism (such as Gram
staining, PCR or MALDI-TOF). While highly specific, the sensitivity of this technique
relies on good antibiotic stewardship in the community, and a lumbar puncture (a sample
of the CSF) being taken before treatment commences (Attia et al., 1999; van de Beek et al.,
2006). In certain settings this may be impossible, and there is debate over situations where
it may be dangerous due to increasing intra-cranial pressure (Hasbun et al., 2001; Winkler
et al., 2002; Oliver et al., 2003).
It is also interesting to note the enormous effect of varying antibiotic use in the
community and early lumbar puncture on the sensitivity of obtaining positive cultures, as
this also affects the number of isolates which can be subjected to whole-genome sequencing
using present methods. In the Netherlands, for example, antibiotic use in the community
is well regulated and lumbar puncture is taken as standard upon admission to hospital
and before antibiotic treatment commences: positive culture is obtained in 80-96% of
suspected cases of bacterial meningitis (van de Beek et al., 2004; van de Beek et al., 2006)
– an ideal location to set up a genomic study. When treatment occurred before lumbar
puncture, positive culture rate lowered to 66-80% (Bohr et al., 1983; Nigrovic et al., 2008).
As practices, and many other factors, vary by country, so do positive culture rates: in Brazil
67% (Bryan et al., 1990); UK 19% (Ragunathan et al., 2000); Kenya 1.7% (Knoll et al.,
2009). In developing countries, where disease burden is highest, positive culture rates
range from 0.8-19.4% (Levine et al., 2009).
The variability over the conditions which need to be met for a positive diagnosis leads
to difficulty in obtaining accurate estimates for the prevalence of bacterial meningitis
(Brouwer, Tunkel & van de Beek, 2010; Jafri et al., 2013). In European adults, the focus of
this thesis, the best estimates for prevalence show that bacterial meningitis is now relatively
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rare (prevalence of 0.94 cases per 100 000 per year in 2013-14) (Bijlsma et al., 2016).
In adults, defined throughout as>16 years, meningitis is more common in immunodefi-
cient patients (Brouwer, Tunkel & van de Beek, 2010; Adriani et al., 2015). That is, people
with other conditions which lower the efficacy of the immune system making them more
prone to infectious diseases. For example HIV/AIDS, while rare in the Dutch population
(incidence 0.13% in 2013 (‘Monitoring Reports SHM’, 2013)), represents 1% of patients
diagnosed with bacterial meningitis (odds-ratio (OR) ∼ 7.5). Pre-disposition to infection
also occurs due to alcoholism, diabetes mellitus and splenectomy. For pneumococcal
meningitis incidence increases with age: individuals >65 years are most at risk (OR ∼ 6).
Once bacterial meningitis has been diagnosed, treatment is with broad-spectrum antibi-
otics administered two to three times a day (Tunkel & Scheld, 2002; Brouwer, Tunkel &
van de Beek, 2010). After confirmation of the bacterial species causing the infection the
antibiotic used may be changed to more effectively treat the infection, or in response to a
measured or expected resistance. Meningitis progresses rapidly, with 47% of cases having
<24 hours of symptoms, and all cases terminating within a week (Bijlsma et al., 2016).
The disease usually rapidly worsens during this time, so rapid diagnosis and treatment is
crucial for a favourable prognosis. In the Netherlands time from arrival to treatment is
a median of four hours, and this delay has a major impact on the outcome of treatment
(Aronin et al., 1998; Proulx et al., 2005).
The risks to the patient during the treatment is due to septic shock and acute inflamma-
tion of the meninges (Brandtzaeg, 1993). The former, more common in meningococcal
meningitis, is due to blood infection (bacteremia) causing damage to organs which in turn
leads to a dangerously lowered blood pressure (Pathan et al., 2003). This is the cause of
the blotchy rash diagnosed by the ‘tumbler test’, and can lead to limb loss (perhaps the
most common image of meningitis seen in the public sphere). Inflammation is caused by
the innate immune response to bacterial infection, largely due to the action of neutrophils
(Kolaczkowska & Kubes, 2013; Kruger et al., 2015). Even after death of the cell, the
remaining material from the bacterium continues to promote further inflammation.
Inflammation of tissue is effective at, and usually essential for, clearing bacterial
infection. However it is not good for the host if the tissue in question surrounds the brain.
The expansion of tissue at the top of the cranium puts physical pressure on the brain itself,
pushing it down towards the spinal column. The reduction of pressure of the CSF in the
spinal column caused by a lumbar puncture can therefore in some cases increase this effect,
so a CT or MRI scan of the head is first recommended in these circumstances to check for
shift in position of the brain before this procedure is carried out (van de Beek et al., 2006).
This pressure, if not relieved by treatment, leads to damage of the brain tissue, and death
(Pathan et al., 2003; van de Beek et al., 2004).
In some circumstances it is therefore appropriate to seek to suppress the host immune
system during treatment to limit the inflammation and damage to the brain it causes (de
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Gans et al., 2002; Brouwer, Heckenberg et al., 2010). In the Netherlands, the use of such
adjunctive therapy (dexamethasone) has been shown to reduce the rate of poor outcome
(OR 0.54; 95% CI 0.39-0.73) (Bijlsma et al., 2016), and in particular reduce the number of
patients who suffer long-term deafness or neurological effects after they have recovered
from the infection (van de Beek et al., 2010; Brouwer et al., 2013). Of course, suppressing
the action of the immune system when it is required to fight an acute infection may not be
a good idea, and the trade-off between decreasing inflammation and decreasing the severity
of infection must be considered. In immunocompromised patients such additional therapy
is therefore inappropriate, nor is its use outside of the conditions where the randomised
control trials of its efficacy took place (Molyneux et al., 2002; Mai et al., 2007).
These considerations also raise an interesting point about the strength of the host
response, which causes the same trade-off between effectively clearing infection without
causing extreme inflammation and damage to the meninges. If there is an intrinsic (most
likely genetic) basis for strong immune response in some patients this would likely make
them this group susceptible to contracting bacterial meningitis in the first place, but should
meningitis occur they may suffer from a worse disease outcome. The converse would be
true for naturally weaker immune responders.
The five-point Glasgow outcome score (GOS) is used to report the clinical outcome
of cases: 5 is full recovery, 4 recovery with moderate disability, 3 recovery with severe
disability, 2 persistent vegatative state, 1 is death (Jennett & Bond, 1975). Throughout,
anything other than 5 is referred to as an unfavourable outcome. Sadly, despite advances in
treatment and vaccination which have reduced incidence and disease severity, the serious
nature of bacterial meningitis persists. In a recent Dutch study Bijlsma et al. (2016)
estimated the case fatality rate in adults as 17% and unfavourable outcome in 38% of cases.
1.1.2 Causal organisms
Meningitis can be caused by CSF invasion from a wide range of bacterial species. In
European countries the bacteria which most frequently cause meningitis are Streptococcus
pneumoniae and Neisseria meningitidis, both of which are respiratory pathogens which
normally exist as commensals in the upper respiratory tract of humans (Brouwer, Tunkel
& van de Beek, 2010). In the past, serotype B Haemophilus influenzae caused the highest
proportion of bacterial meningitis cases, but nationwide roll-out of an effective vaccine in
a species for which serotype switching or replacement do not cause further disease have
all but eliminated haemophilus meningitis (Schuchat et al., 1997; McIntyre et al., 2012).
Recently an increase in Listeria monocytogenes, a food-borne pathogen, has been observed
(Koopmans et al., 2017) which may be due to changes in use of antibacterial agents in the
food-production chain (Kremer et al., 2017).
Vaccines have perturbed the populations of S. pneumoniae and N. meningitidis. In
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the case of S. pneumoniae, first the 7-valent pneumococcal conjugate vaccine (PCV) and
subsequently the 10- and 13-valent vaccines have immunised against the most invasive
serotypes of S. pneumoniae in children, reducing the amount of carriage of in the population,
and the amount of disease caused by these serotypes (Klugman, 2001; Knol et al., 2015).
However, due to serotype switching and replacement allowing for vaccine escape, whether
this vaccine has an overall effect on bacterial meningitis over longer time periods is yet
to be determined (McIntyre et al., 2012) (section 1.2.3). For N. meningitidis there are
now effective vaccines available against all invasive serogroups (A, B, C, W, X and Y)
(Rouphael & Stephens, 2012), and though the B vaccine is expensive and therefore still
has limited global coverage (Christensen et al., 2014), rates of meningococcal meningitis
have fallen (McIntyre et al., 2012).
The route of infection varies depending on the species of bacteria, though in the
majority of invasive cases the final stage is from blood to CSF (Mook-Kanamori et al.,
2011). These respiratory pathogens are carried asymptomatically in the nasopharynx by a
proportion of the population at any given time (Caugant et al., 1994; Hammitt et al., 2006).
In a small number of cases commensal nasopharyngeal bacteria may invade the blood
through a single cell bottleneck (bacteraemia) (Gerlini et al., 2014; Kono et al., 2016), then
cross the blood-brain barrier into the CSF where they cause meningitis (Weisfelt et al.,
2006). In some meningitis patients the CSF may be invaded directly due to CSF leakage or
otitis media (Adriani et al., 2015), in which case the progression of bacteria after carriage
is reversed: CSF to blood.
1.1.3 Immune response to pneumococcal meningitis
The host response to pneumococcal invasion mostly involves the innate immune system
(Janoff et al., 1999; Paterson & Mitchell, 2006). Initial defence is through anti-microbial
peptides (AMPs) such as lactoferrin and lysozyme which are secreted into mucosal surfaces
and are active against a broad range of infectious agents (Brogden, 2005; Andre´ et al.,
2015). Invading pneumococci are then detected by range of pattern recognition receptors
(including the Toll-like receptors) which are primarily activated in response to their outer
capsule but also other antigenic proteins such as pneumolysin (Paterson & Mitchell, 2006).
The two most important signalling molecules in this process are TNF-α and IL-1 (Jones
et al., 2005; Paterson & Orihuela, 2010), which are the first to be activated after infection
(Takashima et al., 1997; Quinton et al., 2007). These receptors regulate the inflammatory
response to infection (Koppe et al., 2012), causing recruitment of macrophages, which
engulf and destroy the pneumococci (Janoff et al., 1999), and neutrophils, which as well
as phagocytosis can release AMPs which cause inflammation and direct damage to the
bacteria (Craig et al., 2009; Hyams et al., 2010).
This immune response is aided by the complement pathway, a system of over thirty
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cascading proteins which aid the innate and adaptive immune responses (Walport, 2001a,
2001b). The pathway is activated in one of three ways (Serruto et al., 2010):
• Classical pathway – antibody recognition of of the bacteria, followed by binding of
complement C1 to the pathogen’s surface.
• Lectin pathway – recognises particular patterns of sugars on pathogen cell surfaces.
• Alternative pathway – constantly activated at low levels, positive feedback amplifies
the response over time. Factor H binds to host cell surfaces to suppress the activity
against self cells.
All three starting points end up with cleavage of C3 into C3a and C3b (Lambris et al.,
2008). C3a triggers a pro-inflammatory response and enhances recruitment of immune
cells to the region (through chemotaxis). C3b covalently bonds to the bacterial surfaces
causing three further effects: making them more susceptible to phagocytosis (known as
opsonisation); forming a C3→ C3a + C3b convertase on the cell surface, which amplifies
the response through a positive feedback loop; cleavage of C5 to C5a and C5b near the cell
surface. C5a fills a similar role to C3a and increases inflammation, whereas C5b causes
a cascade of proteins through C6-C9. This results in formation of the membrane attack
complex (MAC), which forms pores in the bacterial surface resulting in cell lysis and
death.
Due to the rapid progression of disease, and the acute nature of symptoms, the adaptive
immune system plays little role in fighting invasive infections (Paterson & Orihuela, 2010).
However, in carriage, antibodies (immunoglobulins) produced by the adaptive immune
system play a more important role. These antibodies increase opsonisation targeted
phagocytosis, neutralise toxins, and inhibit adhesion of pneumococci to host tissue surfaces
(Anttila et al., 1999; Janoff et al., 1999). In the nasopharynx the most abundant antibody
type is IgA (Kett et al., 1986). This antibody type can bind S. pneumoniae, and through
interaction with the complement pathway increases killing above the level of the innate
immune system alone (Janoff et al., 1999). IgG plays a similar role, and is the type of
antibody elicited by the pneumococcal vaccine against the capsule (McCool et al., 2002;
Balmer et al., 2003; Croucher et al., 2017).
S. pneumoniae and humans have co-evolved, hence the pathogen has methods to evade
each of the immune mechanisms discussed here (Lambris et al., 2008; Hyams et al., 2010).
I discuss the mechanisms S. pneumoniae uses to evade these responses in more detail in
section 1.2.2.
1.1.4 A nationwide Dutch cohort
The analysis presented in chapters 4 and 5 uses the MeninGene cohort: a prospective
cohort running from 2006 onwards in the Netherlands (Bijlsma et al., 2016). The study
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collects and combines data from cases of bacterial meningitis from across the Netherlands
using a number of means. Firstly, the national reference laboratory for bacterial meningitis
automatically receives blood and CSF isolates from about 85% of all culture-confirmed
cases, along with limited metadata. This metadata allows the identification of adult cases
along with the hospital the patient was treated at. The hospital is contacted, and the
attending physician is invited to seek patient consent to fill out a report on their case. If the
patient agrees to this, the physician also fills out more detailed information (treatment given,
clinical course, neurological findings at discharge) which is submitted to the MeninGene
database (http://www.meningitisamc.nl/en/inclusion-new-patient/meningene/). Bottles of
wine in bespoke MeninGene wooden cases are sent from an AMC office to physicians
each time they submit a patient, as an incentive to take part (fig. 1.1).
Figure 1.1: The incentive sent to physicians enrolling patients in the MeninGene study. Available in red or
white.
To ensure the study focuses on the normal route of infection, patients are excluded if
they have had neurosurgery or head trauma in the month prior to their meningitis, or if
they have a neurosurgical device present in their central nervous system (for example a
deep brain stimulation electrode). Patients who acquired bacterial meningitis nosicomially
(occurring during a hospital stay, or within a week after) rather than in the community are
also excluded. Around 200 cases not excluded for these reasons are added to the cohort
each year, mostly during the winter.
The aim of this collection is to identify host and bacterial genetic variants which
affect the susceptibility to and severity of bacterial meningitis. Consenting patients were
genotyped (using human tissue collected during the lumbar puncture) and positive bacterial
cultures whole-genome sequenced with the aim to link genetic variation to the extensive
clinical metadata collected for the cohort. In this thesis I am primarily concerned with
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pneumococcal meningitis: it was the largest and therefore most well powered part of the
collection. Before describing the necessary background to this analysis I first consider the
issues encountered when working with pneumococcal genomes.
1.2 Pneumococcal biology
In this section I first describe the basic biology of the pneumococcus, its pathogenesis and
how genetic studies have increased our understanding of its evolution.
S. pneumoniae is a Gram-positive bacterium, only found in human hosts. It is normally
a commensal in the nasopharynx, where it is challenged by host immune system (Paterson
& Orihuela, 2010), other bacteria such as H. influenzae (Pericone et al., 2000; Lysenko et
al., 2005) and Staphlyococcus aureus (Bogaert et al., 2004; Regev-Yochay et al., 2006)) and
itself (Dawid et al., 2007; Cobey & Lipsitch, 2012). The closest relative to S. pneumoniae
is Streptococcus mitis, a commensal with many, but not all, of the same virulence factors
and a much higher intra-species diversity (Denapaite et al., 2010).
Pneumococcal carriage in the nasopharynx is asymptomatic. Estimates of carriage
rates depend on the population, and the time of measurement (largely due to vaccination)
but are high enough to suggest that most people will be exposed to the pathogen during
their lifetime. Some examples of measured carriage rates in unvaccinated populations are:
66% in Kenyan children (Lipsitch et al., 2012); 68-84% in Karen infants on the Thailand-
Myanmar border, 17-30% in Karen adults (P. Turner et al., 2012). In the Netherlands
example estimates after vaccine introduction are: 69%-88% of children (Wyllie et al.,
2014; Wyllie et al., 2016); 3-15% of adults (Spijkerman et al., 2011; Bosch et al., 2016).
The duration of carriage ranges from a few days to many months (Abdullahi et al., 2012a;
P. Turner et al., 2012), and generally decreases with age (P. C. Hill et al., 2010). Outside
of the nasopharynx, S. pneumoniae infection can cause a variety of diseases. As well
as causing IPD (meningitis and bacteremia), the pneumococcus can cause less serious
diseases such as pneumonia and empyema (by entering the lungs), or sinusitis and otitis
media (by entering the inner ear).
1.2.1 Importance of capsular serotype
One of the most important distinguishing factors between members of the pneumococcal
species is their capsular type. The capsule is a polysaccharide structure which is bound to
the outer pneumococcal cell wall (with the exception of serotypes 3 and 37 (Dillard et al.,
1995; Llull et al., 1999)), and is important in most extra-cellular interactions. The capsule
is immunogenic (AlonsoDeVelasco et al., 1995), defends against the host immune system
(Hyams et al., 2010) and is likely required to survive in blood and so cause invasive disease
(Kadioglu et al., 2008).
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The different capsules are defined by their interaction with antisera (Lund & Henrichsen,
1978), though since the publication of the sequences of all known capsule loci by Bentley
et al. (2006) the genome has increasingly been used to define the serotype of an isolate.
This original publication consisted of 90 capsular types, however more are being discovered
(Kapatai et al., 2017) and the current count stands at 98. Other than serotypes 3 and 37 the
capsule locus consists of around 15 genes on the forward strand between dexB and aliA
(Yother, 2011). Nucleotide variation within these genes, and structural variation of the
locus leads to different antigenic serotypes.
The serotype is broadly correlated with the background genotype as the two are
vertically inherited (Croucher, Finkelstein et al., 2013; Chewapreecha, Harris et al., 2014).
However switching of serotype locus through recombination (horizontal inheritance) is
possible (Croucher, Harris, Fraser et al., 2011), though usually happens within a serogroup
(Croucher, Kagedan et al., 2015). Non-typable (NT) strains do not express capsule, either
due to a complete or partial deletion of the capsule locus (Chewapreecha, Harris et al.,
2014) or other surface proteins in its place (Salter et al., 2012; Park et al., 2012). They do
not generally cause invasive disease, but are observed to be frequent donors of DNA in
recombination events (Chewapreecha, Harris et al., 2014).
Serotypes have been shown to be associated with a number of important pneumococcal
phenotypes, most notably invasive potential (Brueggemann et al., 2003). The exact
mechanism is unknown, but capsular charge, thickness and expression seem to make a
difference (Y. Li, Weinberger et al., 2013; Manso et al., 2014). Capsule type has also
been shown to affect carriage duration (P. C. Hill et al., 2010; Abdullahi et al., 2012a;
P. Turner et al., 2012), recombination frequency (Croucher, Kagedan et al., 2015; Chaguza
et al., 2016), growth phenotype (Hathaway et al., 2012) and the ability to colonise the host
(Trzcin´ski et al., 2015).
Why over 90 different serotypes of pneumococci should be able to continue to coexist
over long times when some have much higher fitness than others is puzzling (Lipsitch et al.,
2009) – should the fitter serotypes not simply out-compete the less fit strains? Modelling
work by Cobey and Lipsitch (2012) has suggested that serotype specific immunity working
to stabilise competition, combined with acquired immunity to non-capsular antigens
(section 1.2.2) reduces differences between fitness, allowing the continued prevalence of
different serotypes and strains of S. pneumoniae.
1.2.2 Pneumococcal pathogenesis and immune evasion
As mentioned in section 1.2.1, the capsule is an important virulence factor, decreasing
binding of complement (C3b) and IgG to the cell surface (Musher, 1992; Abeyta et al.,
2003; Hyams et al., 2010). Its negative charge prevents phagocytosis (C. J. Lee et al.,
1991), and reduces susceptibility to neutrophil extracellular traps (Wartha et al., 2007).
25
Host and pathogen genetics associated with pneumococcal meningitis
The pneumococcal genome encodes a variety of other proteins which directly interact with
the host, mostly to enhance colonisation and avoid the host immune response (Kadioglu
et al., 2008). Though the role of these antigens in colonisation and disease is known,
whether sequence variation at these loci has an effect on pathogenesis in human disease
remains unclear. Some antigens such as pneumolysin (ply) are essential for transmission
and colonisation (Zafar et al., 2017; Rubins et al., 1998), whereas others such as pspA and
pspC enhance virulence (Ogunniyi et al., 2007) but are not required for disease. These
antigens can vary their sequence rapidly through recombination (Brooks-Walter et al.,
1999; Iannelli et al., 2002; Lipsitch & O’Hagan, 2007; Croucher, Harris, Fraser et al.,
2011) and are therefore highly variable. This mechanism may aid bacteria in evading
detection by the immune system (Lambris et al., 2008).
In fig. 1.2 I review the immune system’s response to pneumococcal infection (sec-
tion 1.1.3), and the mechanisms the bacteria use to evade destruction. One of the first
defences against pathogens is lactoferrin, encoded by the LTF gene. The core pneumococ-
cal protein PspA binds lactoferrin strongly, preventing killing by this mechanism (Shaper
et al., 2004; Andre´ et al., 2015). PspA has a further role in complement evasion, preventing
deposition of C3b on the pneumococcal surface, and by inhibiting the formation of C3
convertases (Tu et al., 1999; Hyams et al., 2010).
The pneumococcal protein PspC also interacts with the complement system. PspC
comes in two main forms, concordant with the genetic distances between their coding
sequences, either with a choline binding domain or an LPXTG motif instead anchors them
to the bacterial cell wall (Iannelli et al., 2002). PspC binds C3 using the choline binding
domain, inhibiting this immune pathway in a similar way to PspA (Q. Cheng et al., 2000).
On the bacterial cell surface, PspC can bind complement factor H (Janulczyk et al., 2000;
Dave et al., 2001). This downregulates the alternative complement pathway in the vicinity
of the cell, making the bacterial surface appear more like a host cell (Herbert et al., 2015).
To evade immunoglobulin, the pneumococcal genome encodes up to four proteases
which cleaves the heavy chain of human IgA (iga/zmpA, zmpB, zmpC, zmpD) of which two
(zmpA and zmpB) are core genes (Bek-Thomsen et al., 2012). This interaction inhibits the
action of these antibodies on S. pneumoniae, primarily in the mucous membranes (Poulsen
et al., 1996; Wani et al., 1996).
A number of other genes have been confidently implicated in pneumococcal virulence.
Dlt, which causes D-alanylation of teichoic acids in the cell wall (Deininger et al., 2007)
protects the cell against host AMPs (Kova´cs et al., 2006; Habets et al., 2012) and neutrophil
extracellular traps (Wartha et al., 2007). ply is confined to the cell cytoplasm due to lack
of a signal sequence, it is only released upon bacterial cell lysis. At low levels it can
cause apoptosis, activate complement, and is pro-inflammatory (Kadioglu et al., 2002).
Through inflammation this can increase shedding of S. pneumoniae during carriage, which
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pores in the membranes host cells, causing direct damage to the host tissues (Hirst et al.,
2004; Harvey et al., 2011). LytA, an autolysin, was thought to enhance virulence through
self-killing and release of pneumolysin (Berry & Paton, 2000), but has since been shown to
be independently associated with virulence in a mouse model (Balachandran et al., 2001).
Other known virulence factors include metabolic genes such as pflA (Yesilkaya et
al., 2009), adhesins allowing colonisation of host cell surfaces such as the Pht proteins
(Khan & Pichichero, 2012; Plumptre et al., 2013) and pclA (Paterson et al., 2008), and
the neuraminidases nanA/nanB which cleave sugars from host proteins contributing to
adherence and immune evasion (S. J. King et al., 2004; Manco et al., 2006). An imaging-
based localisation study has suggested that interaction between host factors pIgR and
PECAM-1 with pneumococcal adhesins PspC and RrgA is involved in brain invasion
during bacterial meningitis (Iovino et al., 2017).
Most of the studies confirming the effect of these proteins on virulence and the mech-
anism through which they do this have been by creating isogenic loss of function (LoF)
knock-out mutants, which completely lack the protein of interest, and investigating vari-
ance in their ability to cause disease in a mouse (Ogunniyi et al., 2007). While this reveals
interesting basic biology, and can be a useful approach for finding vaccine candidates
which are immunogenic and required for invasive disease, the relevance of these virulence
factors in clinical cases of disease (i.e. in humans) is currently unknown. More subtle
variation within these genes, and its overall importance compared to other virulence factors
is generally understudied, though some lab-based work has found capsular type to be more
important than antigenic variation (Abeyta et al., 2003; Weinberger et al., 2009; Hyams
et al., 2013) consistent with epidemiological studies (Weinberger et al., 2008; Weinberger,
Harboe et al., 2011). Woehrl et al. (2011) showed that C5 cleavage affects the outcome of
pneumococcal meningitis in a mouse model, but their sample size and statistical approach
was insufficient to show similar relevance in clinical cases.
Complete knock-out of a gene is not naturally (or only rarely) occurring variation in
the pneumococcal population due to the fitness cost it would incur. Rather than choosing
candidate proteins and showing they have an effect on disease in an animal model, an
alternative approach is to take a collection of clinical cases of disease and carriage and then
agnostically test all naturally observed variants for association with each niche. Animal
models can then lend further evidence to these results, and propose functional mechanisms.
I discuss the power of this approach and its potential application to pneumococcal virulence
in detail in sections 1.3 and 1.4.
Antibiotic resistance mechanisms
Since the introduction of antibiotics to treat S. pneumoniae infection, resistance has
arisen to each treatment, in some cases through multiple mechanisms. The most effective
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treatment in patients without allergies to penicillins are β -lactams, whose target is the
penicillin binding proteins (pbps). This disrupts cell-wall biosynthesis, leading to cell
death and lysis. Variation of these target proteins, while at a general cost to fitness, gives
rise to resistance to these antibiotics (Spratt, 1994b, 1994a).
Resistance to tetracycline and chloramphenicol are mediated through the tetM and
cat genes respectively, which are carried on the integrative conjugative element (ICE)
(Croucher et al., 2009). Erythromycin resistance can be gained through ermB which
methylates the target ribosomal site, or the mel/mef efflux pump; both of these mechanisms
are carried on transposable elements (Croucher, Harris, Fraser et al., 2011). Single base
changes in parC, parE and gyrA cause fluoroquinolone resistance (Pletz et al., 2006),
and single base changes in rpoB cause rifampicin resistance (Ferra´ndiz et al., 2005).
Trimethoprim resistance is through the mutation I100L in folA/dyr, though it has been
suggested other mutations in this gene can also contribute to resistance (Maskell et al.,
2001).
As expected, there is an association between the amount of use of antibiotics and the
levels of resistance in the population (Lipsitch, 2001; Samore et al., 2006). Similarly to
the existence of multiple serotypes, the continued existence of both antibiotic resistant
and sensitive pneumococci at a stable ratio over time is evolutionarily puzzling. In a
simple model, when treatment is being applied the resistant bacteria should out-compete
the sensitive, and when treatment is not being applied the sensitive bacteria should out-
compete the resistant. More complex models proposing linkage with carriage duration
modifying alleles (through altering carriage duration) or through including host structure
and treatment frequency have been proposed to address this conundrum (Lehtinen et al.,
2017; Cobey et al., 2017).
1.2.3 Population studies of S. pneumoniae
The first sequence of a pneumococcal genome was reported by Tettelin et al. (2001): the
virulent TIGR4 (serotype 4) strain. It was found to be a singular circular chromosome
of 2.16Mb, with a GC content of 39.7% encoding 2 236 genes. 84% of the genome was
found to be protein coding. The authors noted that the genome contained a relatively high
proportion of insertion sequence elements (5%), and the presence of a type I restriction-
modification system. Various specificity domains invertible from upstream in the genome
were found, which the authors hypothesised could allow rapid variation of the methylated
motif, inhibiting DNA transfer between clonal strains. Despite its early discovery, it
took another 13 years to fully describe the function and variation of this locus in the
pneumococcal population (see below and section 4.3.2).
The publication of the TIGR4 genome was shortly followed by the avirulent (non-
capsular) R6 strain (Hoskins et al., 2001). With more than one genome comparative
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genomics within the species could be performed, using breaks in synteny to find differences
in gene content or other variation between the sequences (Bentley & Parkhill, 2004). Lanie
et al. (2007) added the sequence of the serotype 2 D39 strain, and were able to find
different evolutionary rates in the three genomes, and further found that these mutations
affected the expression of regulatory, virulence and metabolic genes. Further analysis of
the sequence of a multidrug resistant clone using these techniques highlighted the role of
mobile elements in the evolution of S. pneumoniae (Croucher et al., 2009).
In parallel to single complete genomes and comparisons between them, other studies
based on the population genetics of the pneumococcus using a subset of the overall
genomic variation were taking place. Early population genetic studies used the sequences
of seven housekeeping genes to define a multi-locus sequence typing (MLST) scheme for
S. pneumoniae, where a single base change in any of these genes defines a new allele, and
any combination of alleles of the genes is a unique sequence type (Enright & Spratt, 1998).
An advantage to this scheme is that a recombination event is more correctly counted as
a single evolutionary change equivalent to a single base change, whereas counting the
number of base changes itself would overestimate the distance from recombination events
(Maiden et al., 1998). However, the designers of the scheme in S. pneumoniae later found
it to be somewhat flawed: one of the chosen genes (ddl) is in linkage disequilibrium (LD)
with the pbp2b gene, which is under diversifying selection due to its role in β -lactam
resistance, driving excess diversity in ddl through hitch-hiking of mutations (Enright &
Spratt, 1999).
Through the use of MLST schemes the genotype of S. pneumoniae could be defined
for large numbers (>100) of isolates, allowing association between background genotype
and traits such as serotype, resistance, virulence factors and recombination to be tested
(Hanage et al., 2005; Hanage et al., 2009). It was not until the availability of high
throughput sequencing that full length genomes of multiple isolates could be obtained,
unifying the two approaches of studying bacterial genomics.
The importance of recombination and mobile elements
Hiller et al. (2007) performed one of the first multi-whole genome studies of S. pneumoniae,
going beyond pairwise synteny comparisons between isolates. Using the whole genome
sequences of 17 S. pneumoniae isolates, they aligned all 3 170 clusters of orthologous
genes (COGs) and showed that there exists a ‘core’ of genes present in all isolates in a
population, but that the majority of genes are ‘accessory’ and are only present in a subset
of isolates. The mode frequency was presence in only one isolate (singleton genes). More
recent estimates using a larger sample size of 616 genomes found 1 194 core genes from a
total of 5 442 COGs (22%) (Croucher, Finkelstein et al., 2013).
The first large-scale study to fully unite techniques from both whole genome analysis
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and bacterial population genetics sequenced 240 isolates from the PMEN1 serotype 23F
multidrug resistant clone (variously referred to as Spain23F, ST81 and ATCC 700669).
Croucher, Harris, Fraser et al. (2011) were able to both find recombination events and
map them to specific regions of the genome. These recombinations were found most
frequently in antigens (pspA, pspC and psrP), prophage and a large ICE carrying drug-
resistance conferring genes. They also found that the capsule locus itself is frequently
involved in recombination events, leading to a switching of serotype; later work in a larger
population quantified the selective constraints on serotype switching, finding most switches
happen within a serogroup (Croucher, Kagedan et al., 2015). Overall, this showed that
pneumococcal variation can occur on much shorter timescales than previously thought,
allowing adaptation to environmental perturbations such as antibiotic use and vaccination.
The first high efficacy vaccine against S. pneumoniae was the seven-valent PCV, which
offered protection against the seven most common disease causing serotypes in the US
(Obaro et al., 1996; Klugman, 2001). Later vaccines have expanded this to ten and then
thirteen serotypes. The vaccination of children successfully reduced carriage rates of
these serotypes, and therefore disease. Since mass vaccination began the S. pneumoniae
population has started to escape the vaccine through two mechanisms. At a population
level, other serotypes not in the vaccine have less competition and are now found more
frequently in carriage (Weinberger, Malley & Lipsitch, 2011). At a genomic level serotype
switching to a non-vaccine type can directly aid vaccine escape (Croucher, Finkelstein
et al., 2013).
The frequency and role of recombination in pneumococcal evolution has continued
to be a theme in studies of population genetics. Subsequent work has quantified the
length of recombinant DNA fragments, and found them most likely to be a mechanism to
repair damaging mutations and guard against selfish mobile genetic elements rather than a
mechanism to exchange accessory genes (Croucher et al., 2012; Croucher et al., 2016). A
pneumococcal population can cease to be transformable due to a prophage inserting into
the comYC gene, interrupting its competence machinery (Croucher, Hanage et al., 2014).
The role of single nucleotide polymorphism (SNP) variation compared to recombin-
ation in evolution differs by lineage (Croucher, Mitchell et al., 2013). In one of the first
papers to move from analysis of a single lineage to a species-wide genomic analysis,
Chewapreecha, Harris et al. (2014) calculated the ratio of recombination to mutation events
r/m across the main lineages within the species: despite a similar number of mutations
per site per year, they found estimates to vary between 0.06-0.25 depending on serotype.
NT (unencapsulated) isolates had a significantly higher recombination rate than capsular
strains (r/m = 0.3-0.35), and were more frequently donors of recombinant DNA. This
suggested that NT serve as a reservoir for DNA, which is easily passed on without capsular
polysaccharides providing steric hindrance.
Prophage sequence, viral DNA inserted into the bacterial host genome in the lysogenic
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phase of replication, varies rapidly (Romero et al., 2009; Croucher, Coupland et al., 2014)
and reduces host cell fitness (DeBardeleben et al., 2014). While in other species prophage
can be found to carry ‘cargo’ genes which can advantage the host cell and partially offset
the fitness reduction of carrying the phage, this is uncommon in S. pneumoniae. Exceptions
are the phage MM1 which has been found to increase pneumococcal adherence (Loeffler
& Fischetti, 2006), and the phage-carried virulence genes pblB and vapE (Romero et al.,
2009).
The function of the inversions of the type I restriction-modification system, originally
noted in the first pneumococcal genome sequence, could now be explained by these studies
of population level variation. Despite the relatively rapid rate at which S. pneumoniae can
vary its genome, the rate of variation in prophage inserted into pneumococcal genomes
is much higher (Croucher, Coupland et al., 2014). The rapid phase variation of systems
such as this inverting variable restriction (ivr) locus is therefore required to defend the host
from foreign DNA. In parallel, in vitro work found that this phase variation also causes
genome-wide methylation and transcriptional changes, which have been suggested to have
knock-on effects on virulence (Manso et al., 2014; J. Li et al., 2016).
1.2.4 Within-host variation of S. pneumoniae
In the nasopharynx, evolution of S. pneumoniae is limited by a small effective population
size (Y. Li, Thompson et al., 2013), which limits efficient selection or purging of mutations
arising in the population . Combined with a single-cell bottleneck at transmission, likely
due to the airborne route of infection (Gerlini et al., 2014; Kono et al., 2016), this means
drift is the dominant evolutionary force within the host (Didelot et al., 2016).
Previously, it was thought that mutation rates in bacterial genomes were low, and
as such there would be no change within a single host (Ochman et al., 1999). Through
whole genome sequencing however, variation over the course of a single bacterial infection
was found to exist (Mwangi et al., 2007; E. E. Smith et al., 2006). Additionally, many
studies sequencing bacterial populations of various different species gave estimates of
mutation rates three orders of magnitude higher than previously expected (Bryant et al.,
2013; Morelli et al., 2010; Wilson et al., 2009). These new estimates of mutation rate were
also supported by evidence that DNA sequence variation can occur over the course of a
single infection (Eyre et al., 2013).
Such within-host variation has been shown to occur through a variety of mechanisms
such as recombination (Kennemann et al., 2011), gene loss (Ehrlich et al., 2010; Rau et al.,
2012) and variation in regulatory regions (J. Li et al., 2016; Manso et al., 2014; Marvig
et al., 2014). The rapid variation that occurs in these regions of the genome can increase
the population’s fitness as the bacteria adapt to the host environment (Barrick et al., 2009;
L. Yang et al., 2011), and potentially affect the course of disease (Young et al., 2012).
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Previous studies in single patients have shown variation between strains even during the
rapid clinical progression of bacterial meningitis (Croucher, Mitchell et al., 2013; Omer
et al., 2011).
In mixed infections the main mechanism through which S. pneumoniae compete
with each other is through the fitness effect of their capsule (Trzcin´ski et al., 2015). A
mechanism for intra-strain competition is the bacteroicins, encoded by a blp cassette
(Dawid et al., 2007), though pneumococcal genomes are diverse in which combination
of these bacteriocins they encode (Bogaardt et al., 2015). These produce peptides with
antibacteriocidal activity against other strains, and the cell may also contain immunity
proteins which protect against this (Moll et al., 1996). As there is a fitness defect from
producing these toxins and anti-toxins this can lead to a number of different interactions
affecting population dynamics (Miller et al., 2017). One example would be a ‘rock-paper-
scissors’ interaction: bacteriocin producing bacteria are fitter than those not producing;
those with the immunity protein are fitter than the bacteriocin producing bacteria; bacteria
with neither are fitter than the immunity protein producing.
1.3 Association mapping in humans
Before going on to describe how GWAS can be applied to the problems in pneumococcal
biology discussed in section 1.2, I first describe how this study design was first developed
in human genetics and its application to host genetics affecting pneumococcal meningitis.
It has long been a goal of genetics to map heritable traits to the genes which affect them.
Early attempts to map genetic regions to traits focused on simple Mendelian inheritance
within families. Mendelian traits are those which are caused by a single, fully penetrant,
allele. Dominant traits require just a single copy of the allele to mainfest the phenotype,
whereas recessive traits require both the maternal and paternal chromosomes to carry the
causal allele. The inheritance pattern within a family can determine whether a trait is
fully Mendelian, or if the alleles are likely to display incomplete penetrance (there is a
probability of an allele carrier having the trait, rather than certainty).
Given a family with a known pedigree where all members have been phenotyped for
a trait of interest, if a candidate allele is genotyped one can then calculate the logarithm
of odds (LOD) score which can be used to assess whether the allele co-segregates with
the trait (Morton, 1955). If it does, then the allele is either associated with the trait or
closely linked to an associated allele. How then, to choose the candidate allele? Some first
attempts were based on speculation and known biology, but an approach able to test all
genes was desired. By exploiting the linkage structure of the genome this became possible.
During meiosis, the maternal and paternal chromosomes undergo recombination, ex-
changing the order of alleles on each inherited chromosome. The recombination frequency
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varies along each chromosome and is more likely at certain positions. Sites with a small
physical distance between them are unlikely to have had a recombination event between
them, and are inherited as a single piece of DNA. When averaged over a population, this
results in high LD (which can be thought of as correlation between alleles at two different
sites) between nearby sites, an approximately exponential decay of LD moving away
from the site, and perfect linkage equilibrium (no correlation) between alleles on different
chromosomes (Reich et al., 2001).
Botstein et al. (1980) were the first to map linkage across the human genome, finding
linkage blocks which are inherited as a single unit and polymorphic loci which can be used
to determine which of these blocks an individual has. Complementary DNA probes which
genotype an allele can then determine the linkage block present. These ‘linkage’ studies
were the first attempts at searching the whole genome for association with a trait of interest,
and had a number of successes in rare diseases (Gusella et al., 1983; Siddique et al., 1991).
However, despite methodological improvements (Spielman et al., 1993), they suffered
from a number of fundamental issues in association mapping for common traits. Firstly,
they are designed to find associations between highly penetrant variants tending towards
the Mendelian case, so for less penetrant variants quickly loses power. This is well suited
for rare disease, but did not appear to be working for common diseases. A second, more
practical limitation is that it is difficult to collect entire families of affected cases and
genotype and phenotype every member of the pedigree – it would be much easier to
collected affected cases and unaffected controls opportunistically.
Testing every linkage block in the genome for co-segregation with a trait leads to many
thousands of tests, necessitating a heavy multiple testing correction burden (Lander &
Kruglyak, 1995). Risch and Merikangas (1996) showed that under this multiple testing
burden even a fairly penetrant common allele (OR = 2; minor allele frequency (MAF) =
13%) would require around 12 000 families to map the association. The lack of linkage
based associations was providing increasing evidence that common traits were affected
by multiple alleles with smaller individual effect sizes, this was good evidence that the
linkage study was not the right design for discovering complex disease genes. In other
animals linkage studies can still be a powerful approach, thanks to the ability to create and
design crosses rather than having to rely on observed natural pedigrees. For the study of
rare disease linkage studies can also be useful, as whole genome-sequencing has been able
to increase their association mapping specificity (Ott et al., 2015).
In the same paper, Risch and Merikangas (1996) calculated that a population study
would only need 640 samples to find the association. It had previously been proposed that
by sampling affected and unaffected individuals from a population, association between
an allele and the trait could be found by simple correlation. Population structure was
known to confound such studies, as alleles are present at different frequencies in different
populations due to their demographic history (for example, passing through a population
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bottleneck can cause alleles to be lost from the new population, and previously rare alleles
to become common). Therefore if there are uneven numbers of cases and controls from
different populations, allele frequency will appear to associate with case status. However,
sampling cases and controls from a single population can be used to address this issue
(Hirschhorn & Daly, 2005).
The real barrier to the proposal of performing population association studies of common
diseases was therefore the lack of knowledge about the human genome, and of human
genetic variation (Hirschhorn & Daly, 2005). The low throughput resequencing available
at the time was also an issue, and limited sample size and the number of markers tested.
‘Candidate gene’ studies had to guess a gene or region which may be associated with the
trait, and then performed an analysis of correlation between the trait and polymorphisms
in the gene. This initial guess was difficult to make, and not conducive to discovering
association of genes where little prior biological knowledge is available. Despite well-
known statistical guidelines for reporting associations (Lander & Kruglyak, 1995), many
candidate gene studies did not follow the correct multiple testing correction, leading to
very few results replicating in independent samples (Altshuler et al., 2008).
Such results have appeared between candidate genes and susceptibility to bacterial
meningitis (Khor et al., 2007; Woehrl et al., 2011), however I do not review them here.
Instead I quote a line from the review of Brouwer et al. (2009), whose meta-analysis was
unable to confirm any of the published results: ‘Results of the 44 case–control studies
were hampered by methodological flaws. First, and most importantly, sample sizes were
inadequate, preventing robust conclusions on the influence of the studied genetic variants
. . . control populations were heterogeneously selected and often not matched for age and
sex . . . quality control procedures for DNA extraction and genotyping were rarely done
. . . most studies that assessed multiple polymorphisms did not correct for multiple testing’.
It is perhaps surprising that over twenty years later similar mistakes are still being made,
and published (Stessman et al., 2017; Barrett et al., 2017).
1.3.1 Genome-wide association studies
A better design for genetic mapping with a common trait was therefore a population study
using all polymorphisms present in the population: this could test, in an unbiased manner,
every gene and region of the genome for association with the trait (Hirschhorn & Daly,
2005; Altshuler et al., 2008). The first steps towards this goal were the sequencing of
the human genome (Lander et al., 2001), and the genome-wide discovery of SNPs it
facilitated (Sachidanandam et al., 2001). These efforts led to an improved mapping of
linkage blocks in globally distributed populations, and the design of arrays which could
genotype hundreds of thousands of SNPs in a high-throughput manner, with the SNPs
chosen to capture variation across the entire genome through LD (International HapMap
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Consortium, 2005). Using whole-genome sequencing these population maps of variation
were later expanded in terms of variant frequency range, variant types, number and diversity
of samples (1000 Genomes Project Consortium et al., 2012).
Using these advances Klein et al. (2005) performed the first GWAS in 96 cases and 50
controls, mapping an association between age-related macular degeneration and the CFH
gene – narrowing the association to a region of a chromosome known from linkage based
studies to a single gene, and showing this method could be used to understand complex trait
genetics. The first large scale GWAS was the Welcome Trust Case-Control Consortium,
which was performed on seven common diseases, using 2 000 cases for each and a shared
set of 3 000 controls (Burton et al., 2007). The study was particularly successful in finding
genetic loci associated with autoimmune disorders, and also set out the methodology for
future studies.
I refer here to binary traits of interest (cases and controls), which can easily be gen-
eralised to multi-level or continuous traits. First, cases and controls are collected and
genotyped together on arrays. The arrays have green and red fluorescent probes which
bind to one of the two possible alleles (A and B, with B the effect/minor allele here) at
each SNP location, so by clustering based on intensity of each colour samples can be
called as AA, AB or BB. Crucially these SNPs were chosen to be roughly equally and
densely spaced across the genome, be common (MAF >5%) in the study population, and
‘tag’ nearby untyped variants through LD. This design later allowed for the incorporation
of population level variation to gain greater information at untyped sites using genotype
imputation.
After careful quality control (QC) of the genotype called on the samples, a test for
association is performed independently at every site. The test for association is, at its
simplest, a 3x2 contingency table between the genotypes and phenotypes with significance
tested using a χ2 test with two degrees of freedom (d.f.). Regression of the phenotype
against the genotype gives similar results, but can also include covariates (often age and
sex) or priors in the association. Most studies test for additive effects, where each extra copy
of the effect allele has an equal effect on the phenotype. Recessive effects can be modelled
by instead combining the AA and AB genotypes, and dominant effects by combining the
AB and BB genotypes. A p-value against the null hypothesis of no association is generated
at every site, and plotted on a log-scale against physical location on a ‘Manhattan plot’.
Association of a locus is usually declared when p < 5×10−8, which is a family-wise error
rate (FWER) of 0.05 with a Bonferroni correction for multiple testing using the number of
independent linkage blocks as the number of multiple tests. Figure 1.3 shows the overall
study design of a GWAS based on these methods, and the methods are described in more
detail when applied to the MeninGene cohort in chapter 5.
With the main technological limitations overcome, and the fact that a simple regression
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been a case of increasing the number of samples. The discovery power of GWAS is a
function of MAF, effect size and sample size – an increase in any of these increases power.
As MAF and effect size are determined by underlying biology and population history,
increasing the number of cases (and controls, though as the number of GWAS studies has
increased more samples have become available to use as shared controls) is how GWAS
study design has progressed from the first successes. Meta-analysis, where separate GWAS
studies are pooled in a combined analysis, both increases discovery power and makes
discoveries less likely to be artefacts due to technical noise in a single cohort (Altshuler
et al., 2008; A. Franke et al., 2010). Some studies, to minimise cost, genotype only their top
p-value markers in a second cohort using ‘MASSARRAY’. This uses mass spectrometry
to genotype a small number of specifically designed probes, so unlike running a whole
genotyping array this only allows validation at the chosen markers. Of course, evidence
from an orthogonal approach (functional analysis in an animal model for example) that
relates an associated locus/gene to the phenotype will also increase confidence that the
association is not an artefact of the specific cohort. A meta-analysis can be performed
using just the p-values, effect size and direction and sample size at each site (known
collectively as ‘summary statistics’) and does not require the full genotype of every sample.
By sharing this data at each incremental increase in sample size, GWAS consortia have
greatly increased the number of loci associated with a range of common diseases (Liu &
Anderson, 2014; de Lange & Barrett, 2015).
Due to LD between nearby variants, signals of association are not found to a single
SNP. Usually a set of between a few and hundreds of genotyped or imputed SNPs in the
region of the signal will be associated with the trait (albeit with different p-values), so
interpretation of the chain of causation from genetic variant to effect on phenotype is not
simple. However, with enough samples methods do exist to assign a probability of being
the causal variant (Spain & Barrett, 2015). In coding regions knowledge of the codon table
can predict the effect on proteins of genetic changes (McLaren et al., 2010), and analysis
of conversation of amino acids across species can predict the effect of amino acid changes
on protein function (Ng & Henikoff, 2003; Kircher et al., 2014) which can help fill in more
of the chain of causation. In some cases an associated locus may contain multiple causal
variants, in which case conditional analysis can be used to determine which variants are
independently associated.
GWAS in humans has gone from strength to strength, and as of June 2017 2 500 studies
have found over 40 000 significant associations (MacArthur et al., 2017).
Methodological advances
The issue of population structure driving association effects was initially dealt with by
sampling participants from a single country, and excluding individuals found to have
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divergent ancestry (which given their genotype can be determined). A. L. Price et al.
(2006) showed that performing principal component analysis (PCA) on study participants’
genotypes, and then including the leading principal components as fixed-effect covariates
in the association model could correct for this effect without as much power loss as
completely excluding samples. By instead including the kinship (relatedness) matrix as
random effects in a linear mixed model (LMM) type II error rate can be controlled when
combining samples of any ancestry, maximising sample size and discovery power (A. L.
Price, Zaitlen et al., 2010). Subsequent computational improvements and approximations
have made it possible to apply this to the millions of regressions needed when using
imputed variants (Lippert et al., 2011; Zhou & Stephens, 2012; Loh et al., 2015).
The availability of lower cost high throughput whole-genome sequencing has not
increased discovery power for common variants or enhanced the ability to fine-map
association signals. Money is best spent on obtaining many samples at the lower price-
point of genotyping arrays, rather than many sites. Whole-genome sequencing instead
increases the range of the allele frequency spectrum which can be tested for association
with a trait.
The design of GWAS genotyping arrays and tag-SNPs, when combined with improved
imputation panels and techniques, has been very successful in discovering loci down to
lower MAFs than originally thought possible (1%) (de Lange & Barrett, 2015; de Lange
et al., 2017). In the case of uncommon (0.1% <MAF <5%) variants, which are less well
tagged and are therefore poorly imputed (The Genome of the Netherlands Consortium,
2014), and rare variants (MAF <0.1%), which are not even present at a population level in
current reference panels, direct sequencing of these variants can help find new associations.
More complex rare variants, such as copy number variants (CNVs), long insertions or
deletions (INDELs) and structural variants, which were not included on genotyping arrays
can be tested using whole-genome sequencing. Very rare variants appearing in a single
sample (singletons) or two samples (doubletons) are the mode variant frequency in the
human genome (1000 Genomes Project Consortium et al., 2012). Without time for
them to become common in the population, strong selection may not arise against their
potential fitness defects. They may therefore play a role in determining complex trait
phenotypes. These variants are challenging to genotype from low coverage sequencing
data as population level variation cannot inform the genotype call, and they are difficult
to distinguish from sequencing errors (particularly at heterozygous sites). In the future,
cheaper high coverage whole genomes will help deal with some of these challenges.
While there is not enough information at a single site to perform a regression against
the phenotype, by grouping sets of these variants by their predicted functional effect
sufficient power to perform association tests can be reached (S. Lee et al., 2014). Rare
variants can be grouped for example by LoF of a gene or any element in an entire pathway,
or within a region around a gene or haplotype. The simplest association test of these
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variant sets is a burden test, which works best when the variants are causal and their effect
sizes are in the same direction. More complex tests relaxing these assumptions, such as
SKAT-O, are available (Wu et al., 2011; S. Lee et al., 2012). It therefore has been possible
to discover the role of rare variation in common auto-immune disorders such as type II
diabetes and inflammatory bowel disease using whole genome sequencing and newer
methods (Fuchsberger et al., 2016; Luo et al., 2017).
As well as expansion in terms of genotyping space, recent efforts have been made to ex-
pand the phenotype space. The compilation of large biobanks containing hundreds of thou-
sands of genotyped individuals each with thousands of phenotypic measurements (usually
through electronic health records) has inspired the creation of ‘PheWAS’ (phenome-wide
association study), in which the focus is instead on variants and the spectrum of diseases
and traits they are associated with (Denny et al., 2013; Bush et al., 2016). By association
of many diseases in the same set of individuals, the overlap in genetic architecture and
co-heritability between phenotypes can be assessed (Ge et al., 2017).
By exploiting the unidirectional causality of genetics on phenotype, the causality of
association between phenotypes can be determined using Mendelian randomisation (Davey
Smith & Hemani, 2014). Current efforts are being made to exploit the known hierarchical
relation between phenotypes to increase the power of PheWAS studies given their increased
multiple-testing burden, and also incorporate self-reported phenotype information (Cortes
et al., 2017).
1.3.2 Heritability
Heritability is a classical concept in quantitative genetics which represents the amount of
variation in a trait which can be ascribed to genetics (and is therefore inherited between
generations) versus other environmental factors (Lynch & Walsh, 1998). Fisher (1919) was
the first to reconcile Mendelian inheritance patterns, which are fully penetrant, with normal
variance about the mean observed in most human traits by proposing multiple inherited
genetic mechanisms each with their own variance components. Wright (1920) applied
this theory to guinea pig coat patterning, and so defined heritability H2 as the proportion
of variance in a phenotype σ2P which can be attributed to genetics σ
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The proportion of heritability which can be ascribed to additive variation σ2A as opposed to
dominant σ2D or epistatic σ
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If a trait is not heritable then one will not be able to find genetic variation associated
with it, but even significant evidence for small but non-zero heritability may have additive
genetic variants associated. Heritability does not however tell us about the distribution of
effect sizes of associated variants, nor is it constant between populations (Visscher et al.,
2008). Heritability is therefore an important parameter in estimating the power of GWAS,
and can also be used to describe the proportion of overall variance described by sets of
variants in the genome.
Before the availability of sequencing, known genetic relationships could be exploited
to determine H2. For example, monozygotic twins have an identical genetic sequence,
whereas dizygotic twins share only half of their sequence. However both cases share a
similar environment, so by comparing the correlation between phenotype of these two
cases with the overall phenotypic variance then H2 can be calculated (Lynch & Walsh,
1998).
The availability of genomic data has allowed calculation of the narrow-sense herit-
ability h2 directly from genetic variation detected in unrelated individuals. Taking the
significantly associated variants from GWAS and regressing them against the phenotype to
calculate the variance explained (R2) directly gives the heritability. However, these estim-
ates are systematically lower than estimates from twin studies across a range of human
traits, leading to the coining of the phrase ‘missing heritability’ (Manolio et al., 2009;
Eichler et al., 2010). Various reasons that heritability is being missed have been proposed
(untyped rare variants, structural variants, non-additive inheritance such as epistasis), but
the inclusion of weak effects which do not reach significance in GWAS has been shown to
be important (S. H. Lee et al., 2011).
To include all variants, a regression could be performed between all genotyped or
imputed sites and the phenotype to calculate the variance explained (so h2 = R2). However
the number of variants vastly exceeds the available number of samples, meaning this
regression cannot be directly performed. By instead assuming that effect sizes of genetic




m is the number of markers) a linear mixed model can be fitted by restricted maximum
likelihood to determine h2. In analogy with classic methods of heritability estimation, this
uses the kinship (amount of shared sequence) estimate from the sequence to determine
the relatedness of samples in the study. This is known as the ‘GCTA’ model (J. Yang,
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Lee et al., 2011) and has been successfully used to narrow the gap between heritability
estimates for human height from genomic and twin studies (J. Yang et al., 2010). This
technique has been shown to be robust to deviations from the model assumptions, with the
exception of varying LD between predictors (Speed et al., 2012), genotype certainty and
inclusion of predictors across the MAF spectrum. These issues which have been addressed
in recent advances by Speed et al. (2017). Including sets of predictors in this model, known
as ‘genomic partitioning’, has been shown to fulfil the desire to attribute part of the overall
h2 to selected pathways and/or regions of the genome (J. Yang, Manolio et al., 2011).
1.3.3 Host susceptibility to infectious disease
While GWAS has enjoyed great success at finding loci associated with auto-immune dis-
orders and anthropometric traits such as height and body-mass index, far fewer associations
with susceptibility to infectious disease have been found (Newport & Finan, 2011; Ko &
Urban, 2013). Twin-study and epidemiology based estimates of H2 have convincingly
shown that there is a genetic component to host susceptibility to a range of infectious
diseases (Jepson, 1998; Burgner et al., 2006), so why are associations hard to find?
Firstly, candidate gene studies ensnared the study of infectious disease association
studies for a number of years, without producing many reproducible findings (Abel &
Dessein, 1997, 1997; Brouwer et al., 2009). When GWAS became feasible, infectious
disease phenotypes began to be used. However, potential variability in exposure to the
pathogen being studied (in some cases making it difficult to find equally exposed controls),
difficulty of determining the exact pathogen causing a disease and lack of funding leading
to lack of samples have been suggested as reasons why associated loci have been hard to
find (Chapman & Hill, 2012).
An interesting debate continues over the genetic architecture of infectious disease sus-
ceptibility (A. Hill, 2012). In human history, susceptibility to infectious disease (especially
in childhood) would be associated with a serious fitness disadvantage, given the lack of
effective treatment. Given a sufficient effective population size these damaging variants
would therefore be purged from the population. However, autoimmune disease would have
had a small fitness cost, and recent changes in environment combined with population
bottlenecks allowing relatively rare alleles to become common may explain the relative
ease of finding these GWAS hits (Amos & Hoffman, 2010; Schraiber & Akey, 2015).
It has therefore been suggested that common variants which explain infectious disease
susceptibility may not exist, with variation in susceptibility caused by single variants
unique to each patient (monogenic cause) (Casanova, 2015).
Most likely, as in other complex traits, both modes of causation are possible in some
proportion. In bacterial infections, Zhang et al. (2009) performed a successful common
variant GWAS on leprosy susceptibility, and common variants in the ASAP1 gene and
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the human leukocyte antigen (HLA) have since been associated with susceptibility to
Mycobacterium tuberculosis infection (Curtis et al., 2015; Sveinbjornsson et al., 2016).
Similar results have been found for viral and parasitic infections (Fellay et al., 2007; Jallow
et al., 2009; Khor et al., 2011).
Host genetics of meningitis
Meningitis has been a relative success story for infectious disease GWAS. Davila et al.
(2010) performed one of the first successful studies on a bacterial infection, and found
variants in the CFH region to be associated with susceptibility to meningococcal meningitis
in 1 443 European children. In a similar manner to S. pneumoniae, N. meningitidis is
known to bind factor H with fHBP to inhibit activation of the alternative complement
pathway (McNeil et al., 2013). The minor alleles were found to be protective, so the
authors hypothesised that these less common forms of fH were more weakly bound by
fHBP, increasing the effectiveness of the host immune response.
Rautanen et al. (2016) performed a GWAS in 542 cases of pneumococcal bacteremia in
Kenyan children. They found variants on chromosome 17 in a long intergenic non-coding
RNA gene (AC011288.2) to be associated with doubled susceptibility to invasive disease.
The variants are specific to African populations so would not be found in a GWAS of a
European population. Expression of these gene was found only in neutrophils, a cell type
involved in the innate immune response to S. pneumoniae infection.
Finally, Davenport et al. (2016) assayed both genomic and transcriptomic variation in
384 British adults with sepsis. They found two classes of gene expression as response to
infection, activated depending on whether the patient was immunodeficient or not. They
were then able to map genetic variants which affected these transcriptional networks,
defining sepsis related eQTLs.
1.4 Association mapping in bacteria
The trend of scaling from a single genome to represent a bacterial species, to performing
comparative genomics between two genomes to analysis of populations of whole genomes
was seen not just in S. pneumoniae (section 1.2.3), but most pathogens deemed important
enough to undergo the first sequencing attempts. There has been increasing availability of
whole-genome sequence data from populations of bacteria along with phenotypes such as
antibiotic resistance, virulence and host specificity. A natural question is therefore which
pathogen variation, if any, contributes to these traits. The move to whole genomes of
populations occurred well after GWAS had been established in human genetics, yet the
first bacterial GWAS only started to appear years later. Falush and Bowden (2006) were
the first to formally address this disparity. There are three main issues which frustrate the
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simple study design so successful in the study of human complex traits: strong population
structure, greater variation of the pan-genome and low sample sizes.
1.4.1 The effect of population structure
The strong population structure of bacteria is both a technical limitation to be addressed
by the association model, and a fundamental limitation to the resolution of association
mapping. Humans are diploid eukaryotes which recombine during meiosis every gener-
ation. Over a population, this shuffling of alleles makes separate variants independent,
with the exception of nearby variants where LD is only partially broken by meiosis causes
some level of correlation. Bacteria are haploid prokaryotes, where between generations
the entire chromosome is clonally copied to the daughter cells, meaning all sites across the
entire genome are perfectly correlated. If a set of mutations are introduced de novo over
time, one of which is causal for the phenotype of interest, a naive association will find the
entire set of mutations to be associated with the phenotype (i.e. the causal mutation, and
the genetic background). While this is locally true around causal variants in the human
genome, the exponential LD decay still allows mapping the association to a single region.
However in bacteria LD extends across the entire genome and does not quickly decay over
the chromosome (P. E. Chen & Shapiro, 2015; Earle et al., 2016), so the set of associations
will also be genome-wide, preventing mapping of the causal association to a specific
region.
Another way to understand the issue of population structure is through the more
bacteria-centric idea of phylogeny (fig. 1.4). If a mutation which is causal for a phenotype
has arisen on an ancestral branch, the descendants will be more likely to have the phenotype
and the variant will be positively associated with the phenotype. However, any other
mutation on that branch (potentially thousands, depending on the branch length) will
appear equally associated. Again, these associations will not map to a single region of the
genome.
Such associations, variants correlated with a specific genetic background and the
phenotype, are known as ‘lineage’ associations. The best bacterial GWAS can reasonably
hope to achieve with such associations is to identify them as such (and not treat them
as potentially causal), and prioritise sets of associated variants for study by other means.
Alongside the formal use of GWAS, genomic epidemiology studies have investigated the
properties of clonal lineages with the phenotype of interest, using comparative genomics
to identify possible sets of genes or other variants which differ between phenotype positive
and negative clones (Shea et al., 2011; De Chiara et al., 2014; Cleary et al., 2016). Some
studies explicitly followed a GWAS of frequency differences between genes without
adjusting for population structure, and were lucky enough to find sets of only a handful of










































































































































































































































































































































































































































































































































Figure 1.4: Phylogenetic illustration of lineage and locus variants. Depicted is an example phylogeny, with
cases identified by red dots at the tips, and controls without dots. Variant presence is shown as coloured
arcs. a): The yellow variant is a causal lineage variant, and will be associated with the phenotype in a naive
analysis. However the green variant, present in the same clade, is not causal but will also appear associated
at the same level of significance. Indeed, any mutation that has occurred on the branch indicated by the arrow
will appear associated, hindering association mapping. b): The magenta variant has arisen independently
in three separate clades containing cases, giving more independence from genetic background and more
evidence for association with the phenotype. The association should have a higher p-value, and slightly
lower OR than the green and yellow variants due to the reduced penetrance observed.
However, it is possible for variants to be associated with a phenotype independent of
genetic background. These ‘locus’ variants can be mapped to a region of the genome,
and are currently the main focus of bacterial GWAS studies. This is not because they are
less important than lineage variants (both types of variant may explain any amount of the
heritability), but are easier to find and map.
The phylogeny picture described above also allows us to understand two mechanisms
by which locus associations may arise. Firstly, if a causal variant has happened more than
once, that is independently on multiple ancestral branches, it will remain associated with
the phenotype but now be uncorrelated with genetic background. These are homoplasic
variants, which are likely to occur when there is selection for the phenotype across the
species, for example with antibiotic use. Similarly, recombination between strains causes
horizontal inheritance of DNA which cannot be represented by a phylogeny (which only
represents vertical inheritance). Variants introduced by recombination are independent of
genetic background, and may be associated with the phenotype across the tree. In the LD
picture both these mechanisms break the correlation between variants and the rest of the
genome, though not in a simple way. I note that I have only explicitly considered ancestral
mutations so far. Mutations at the tips of the tree, if they have happened multiple times, are
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valid homoplasies. However, if they have only happened at a handful of tips, even if they
are causal, standard association will lack power to detect them regardless of population
structure.
The relative prevalence and importance of recombination and homoplasy varies by
the species and population of interest (as different selection pressures may have acted
on different populations over time). In highly diverse and recombinogenic species such
as S. pneumoniae and N. meningitidis, a phylogeny-based adjustment for population
structure is likely to be the wrong approach as this will cause the tree to be inaccurate
(Croucher, Page et al., 2015). However, the recombination makes genome-wide LD of
the population less prevalent and somewhat more like the human genome, so a suitable
regression approach may be used instead. In a clonal species such as M. tuberculosis, the
availability of an accurate phylogeny and the huge levels of LD make direct identification
of homoplasy more applicable than regression methods (Farhat et al., 2013; P. E. Chen &
Shapiro, 2015).
1.4.2 More variation and fewer samples
Most human genetic variation is due to small variants which can be detected by resequen-
cing and mapping to a reference from a single population (1000 Genomes Project Con-
sortium et al., 2015). Though some variation is lost by considering a single reference, the
contribution of pan-genomic variation is small (~1% of the overall sequence) (R. Li et al.,
2010). In bacteria short variants in core genes are undoubtedly important, but the presence
of an accessory genome not covered by simple SNP mapping, not to mention variation
within accessory genes, is a significant source of variation (McInerney et al., 2017).
A successful bacterial GWAS therefore needs to assess not only SNP and INDEL
variation, but also gene level variation. A simple way this can be achieved with modern
techniques (Page et al., 2015) is by associating the presence and absence of common
accessory COGs against the phenotype. This of course does not account for variation within
the accessory genes unless multiple alleles are clustered separately, however adjusting
this tradeoff of specificity and sensitivity in pan-genome estimation is difficult to tailor
specifically to GWAS.
An alignment-free method of variant detection is therefore ideal, as the computational
burden of multiple reference mappings, the bias of available references and the issue of
varying levels of missing calls across the genome makes alignment generally less suitable
than in human genomes. Genome assembly uses sequence words of length k, called k-mers,
to align sequence internally within a sample without requiring use of a reference (Zerbino
& Birney, 2008; Compeau et al., 2011). Further work has been able to co-assemble
multiple samples calling variation across the pan-genome in a reference free manner (Iqbal
et al., 2012), or call variation directly from k-mers in sequence reads (Gardner & Hall,
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2013). One of the first bacterial GWAS studies used k-mers as the variant to perform a
pan-genome-wide association study (Sheppard et al., 2013) (see section 1.4.3), and in
chapter 2 I will propose this as the unit of variation in bacterial GWAS.
The pan-genome and strong population structure makes it difficult to design genotyping
arrays of tag SNPs, especially as microbiologists do not have the luxury of an entire field
being able to focus on a single organism (albeit a fascinating and complex one). MLST
schemes can be used to define population structure with less sequencing effort, but do not
have sufficient precision to perform GWAS. Without the possibility of relatively cheap
genotyping arrays, bacterial sequencing has necessarily been whole-genome. The expense
of this sequencing, as well as the difficulty inherent in obtaining clinically relevant bacterial
samples has therefore limited sample sizes. Compounding this, the high level of variation
in bacteria despite their relatively short genome size increases the multiple testing burden,
necessitating large sample collections. Only recently were the first studies with thousands
of phenotyped genomes published (Shea et al., 2011; Chewapreecha, Harris et al., 2014),
with well powered GWAS studies following closely behind (Chewapreecha, Marttinen
et al., 2014).
1.4.3 Early successes
In perhaps the first bacterial GWAS, Bille et al. (2005) were able to develop a gene-based
microarray for N. meningitidis, and look for frequency differences between carriage and
invasive isolates deliberately chosen to cover the diversity of the species. Without explicitly
adjusting for population structure and only assaying a single form of variation they were
able to find a phage associated with hypervirulence (Bille et al., 2008).
By equally representing isolates from different genetic backgrounds, as defined by
MLST, in both cases and controls Bille et al. (2005) implicitly controlled for population
structure. If the representation of different genetic backgrounds was unequal in cases
and controls, in an identical way to human population structure this would confound the
results. A more direct method to inform sampling before sequencing is to take pairs
of phylogenetically close but phenotypically discordant isolates across the tree (Farhat
et al., 2014). While it would of course increase study power to simply sequence the entire
collection and adjust for population structure during analysis, the existing availability of
MLST of very large isolate collections can be used to perform this targeted approach at a
lower cost. Despite the limited resolution of MLST to determine genetic background, this
approach has been able to find functionally confirmed associations for L. monocytogenes
virulence (Maury et al., 2016) and M. tuberculosis transmissibility (Nebenzahl-Guimaraes
et al., 2016).
Sheppard et al. (2013) performed a ground-breaking bacterial GWAS, which was the
first to properly account for population structure and assay variation across the pan-genome
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using k-mers. The authors used k-mers of length 30 to test for association of genetic
variation in 29 Campylobacter jejuni and Campylobacter coli isolates with host specificity.
A Monte Carlo simulation of characters on the tree was used to define a null distribution
of the association test statistic when following the correlation structure of the phylogeny,
thus adjusting for population structure. K-mers which were significantly associated with
presence in isolates from cattle rather than isolates from birds were found to map to a
seven gene cluster, which included genes coding for vitamin B5 synthesis, a molecule
present in grains but not grasses. While an important leap forward methodologically, the
Monte Carlo simulation method was unfortunately not scalable to the large collections
of isolates needed for greater study power, and the reliance on a recombination removed
phylogeny is restrictive in many settings. The association found had a very large effect
size (OR 95% confidence interval (CI) 28−∞), hence the ability to find it using a small
number of samples.
It is worth noting that a similar issue with population structure exists with viral GWAS,
though in RNA viruses the high mutation rate and within-host diversity makes it a generally
weaker effect than in bacteria. Viral sequences are (almost always) shorter than bacterial
sequences, and though calling variation for association testing faces different challenges,
the eventual multiple testing burden is lower. By using principal components to adjust
for population structure, like in early human GWAS (A. L. Price et al., 2006), Bartha
et al. (2013) performed an association between HIV-1 amino acid changes and viral load.
Though they did not find any hits, this showed human genetics derived methods could
control type I error rate. This study was notable for being the first genome-to-genome
analysis of host and pathogen (section 5.3 covers this in more detail).
GWAS in S. pneumoniae
Given the high recombination rate and relatively high availability of samples, S. pneu-
moniae is a good candidate for bacterial GWAS. Chewapreecha, Marttinen et al. (2014)
therefore performed the first well powered bacterial GWAS, using 3 085 genomes from
pneumococcal carriage in an unvaccinated population to associate core SNPs called against
a single reference with resistance to β -lactams. With this many species-wide isolates
a phylogeny-independent method was required, and the authors opted to use the Co-
chran–Mantel–Haenszel (CMH) test to control for population structure. Using 188 discrete
population clusters defined by Bayesian analysis of population structure (BAPS) as groups,
this essentially performs a χ2 test for association within each clonal group, and then
meta-analyses the results from each cluster. This gave an overinflated test statistic, though
substantially lower inflation than the use of 35 less finely resolved clusters. Though both
have clearly been successful, the power and false positive rate of using discrete population
clusters through the CMH test or as binary covariates in a regression, versus the use of
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continuous covariates such as principal components remains unknown.
While they did not perform a formal meta-analysis, the results were validated in a
second population of 616 carriage isolates from children in Massachusetts (Croucher,
Finkelstein et al., 2013) finding 303 SNPs in the intersection of significant hits. Though
mosaic alleles of the pbp genes are known to cause resistance (section 1.2.2), the authors
aimed to identify the individual SNPs causal for resistance. However extensive and
complex LD across these regions stymied this inferential aim. The lowest OR of detected
hits in this study was around 2, a substantial improvement on previous smaller studies.
Aside from antibiotic resistance, only a single study has reported a GWAS for an
association between pneumococcal variation and a clinical outcome. Tunjungputri et al.
(2017) used an identical association model but tested COGs for association with 30-day
mortality in 349 cases of bacteremia, finding that the platelet binding protein pblB (Bensing
et al., 2001) was associated with increased mortality.
1.4.4 Phylogenetic methods
Having discussed the issues facing bacterial GWAS compared to human GWAS, and how
they were approached by early studies I will now cover the state-of-the-art methods and
analysis currently available for bacterial GWAS. As mentioned above these broadly fall
into two categories: phylogenetic methods and regression methods.
Phylogenetic methods offer precise control of type I error rate when accounting for
population structure, but rely on having a trusted phylogeny; not tainted by recombination
and with good branch supports. This is possible for small collections of isolates where
recombination can be removed (Croucher, Page et al., 2015; Didelot & Wilson, 2015;
Mostowy et al., 2017), but not feasible across a diverse species such as S. pneumoniae.
In some cases a posterior of trees can be used as input rather than a single representative,
which can partly account for poorly supported branch splits at the expense of a greater
computational burden. The total computational burden of these methods is generally high,
especially if they use Monte Carlo simulations, and they are therefore unlikely to scale to
millions of tests needed to assay variation across the entire pan-genome. Hence application
has mostly been limited to analysis of accessory COGs, or species/clades with limited
levels of SNP variation.
The history of these methods is rooted in assessing correlations between traits measured
across different species (Garland & Ives, 2000). Felsenstein (1985) first proposed the use
of independent contrasts, motivated by a Brownian motion model of trait evolution on
the tree, using the difference in phenotype between phylogenetic sister isolates and their
branch lengths to adjust for expected correlations between species (which has echoes of
the approach of Farhat et al. (2014)). A tool has been written to apply this instead to binary
traits using this form of approach (Brynildsrud et al., 2016). It associates COGs with
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phenotypes in a naive manner, then also uses pairwise comparisons (A. F. Read & Nee,
1995) on the phylogeny to estimate the number of times the trait has evolved independently.
However this model does not offer a way of combining the test of evolutionary convergence
with phenotypic association.
An alternative approach is to use a generalised least squares regression, but instead
of assuming independent and identically distributed error terms they use the phylogeny
to estimate covariances between error terms in the model (Pagel, 1997). Desjardins et al.
(2016) used this approach to test for correlated evolution between antibiotic resistance
and genetic variants in M. tuberculosis, which in conjunction with a naive association was
found to improve type II error rate without affecting type I rate in a handful of cases.
It is possible to simulate the null distribution of test statistics accounting phylogenetic
correlations using Monte Carlo simulations (Martins & Garland, 1991), which was the
method used by Sheppard et al. (2013) with the correlation between phenotype and genetic
variants at tips of the tree as the test statistic. A recently proposed extension specific
to bacterial GWAS also calculates test statistics which capture variants with correlated
evolution with the phenotype through changes at nodes, and integrating across branches
and therefore evolutionary history (Collins & Didelot, 2017).
1.4.5 Regression methods
In contrast to phylogenetic methods regression based methods are fast, do not require
an accurate phylogeny (and therefore may also be alignment-free) and are more in-sync
with the active development of human GWAS methods. They are therefore more scalable
with the large sample sizes needed for high powered GWAS studies, and the high number
of variants which must be tested across the pan-genome. However, compared to well-
calibrated phylogenetic methods these methods may have an elevated type I error rate.
Regression methods with similar control of the type I error rate have recently appeared,
but are generally restricted to the discovery of locus variants, and can only test association
at the tips of the tree rather than over the evolutionary history of the bacteria.
Following the approach of using principal components as fixed effects in a regression,
variants associated with phenotypes such as drug resistance and virulence have successfully
been found in a number of species other than those mentioned above (Laabei et al., 2014;
Alam et al., 2014; Salipante et al., 2015). This method is fast, and has been successfully
scaled to analysis of k-mer variants across the pan-genome (Weinert et al., 2015). The first
attempt to improve upon this method in terms of population structure control leveraged the
efficiency boosts in LMMs being used for trans-ethnic human GWAS studies. By applying
an efficient LMM, using the relationship between strains as random effects, to their top
variants from a naive association test, Earle et al. (2016) were able to find locus variants
affecting antibiotic resistance while controlling type I error from population structure.
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Within their model they were also able to identify potential lineage associations which
were associated with both the phenotype and the population structure components, albeit
with greatly reduced power.
Advances in expanding the variant space tested using regression methods have included
k-mers being assembled over a sample collection into unitigs – high confidence contigs
extracted from the de Bruijn graph without needing repeat resolution – thereby giving
larger haplotype-like variants to test (Jaillard et al., 2017). The inclusion of rare variants
by grouping LoF variants in genes has also been successful (Desjardins et al., 2016).
1.5 Conclusions
Since it became possible, GWAS has become the first step in the genetic analysis of complex
traits, taking an agnostic association approach across the entire genome to generate a
hypothesis for further work. By meta-analysis of data with other cohorts these associations
can be asserted with more confidence. With enough samples the association can be fine-
mapped, and in some cases the specific causal variant discovered. The focus of the field
of human genetics on this method has led to many methodological advances, which have
made this analysis more routine and more powerful.
The simple study design makes it relatively easy to collect large sample sizes, giving
high power for association mapping of polygenic traits. Compared to a lab-based or in
vivo assay, where a bottom-up approach of knocking out a gene and then testing for an
effect on phenotype may well be followed, GWAS has four potential advantages:
1. The top-down approach tests all regions of the genome simultaneously, and can find
associations which necessarily have any effect on phenotype without the need for
any prior biological hypothesis.
2. The variation tested occurs naturally in the study population, where more subtle
effects than a gene knock-out are likely important, and do not rely on a potentially
inaccurate animal model.
3. The phenotype tested can be anything quantifiable. This allows investigation of
important traits such as invasiveness or transmissibility which can’t be determined
in the lab.
4. Genetics has one way causation on phenotype, so in some cases successful associ-
ation mapping can be used to determine a causal link without worrying about other
epidemiological confounders. This can also be used to determine causal correlations
using Mendelian randomisation.
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These advantages, and the likely heritable and polygenic nature of bacterial meningitis
noted so far, therefore make it an ideal technique to discover more about genetic risk
factors for pneumococcal meningitis susceptibility and severity. Historically, studies have
been held back by only assessing candidate genes, and current studies have not had large
enough sample sizes or well-defined phenotypes in bacterial meningitis. The availability
of the MeninGene cohort addresses this by adding many more samples of culture-proven
pneumococcal meningitis, along with clinical outcomes.
The same benefits apply to traits in bacteria as well as humans, however issues of strong
population structure, pan-genomic variation and limited sample sizes make these studies
more difficult. Recent methods have successfully addressed a subset of these concerns, but
an approach which deals with all of these issues and is broadly applicable is still lacking.
Given the large sample sizes becoming available, a well-designed GWAS in bacteria is a
promising avenue for research. In the next chapter, I will start by developing and testing
a new method to perform bacterial GWAS in an efficient manner, which simultaneously
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2.1 Introduction
The goal of GWAS is to determine which genetic variants, anywhere in the genome, are
associated with a trait of interest. For a binary phenotype, DNA from unrelated cases
and controls are collected (ideally in the ratio 1:1 to maximise power). The simplicity
of sample collection and the power of the resulting test has made GWAS a compelling
study design in human genetics. In this I present work I undertook to apply this study to
populations of bacterial genomes.
I wished to overcome the following issues, which were yet to be simultaneously solved
by existing methods:
• Account for strong clonal population structure.
• A test which works for both complex and Mendelian-like traits.
• Test variation in the entire pan-genome.
• A computationally tractable method, implemented in a form others can use.
The first issue requires the development of an appropriate association test. The simplest
test between a variant and binary phenotype is a χ2 test based on the difference between
observed and expected counts in a 2x2 contingency table comparing the proportion of case
isolates an element is present in to the proportion of control isolates an element is present
in. This does not account for population structure described in section 2.3, leading to many
non-causal lineage associated variants reaching significance. Chewapreecha, Marttinen
et al. (2014) showed that performing this test separately in each discrete defined population
cluster, then combining the results (i.e. the CMH test) can mitigate this problem.
However, the definition of these clusters requires a core genome alignment and running
external software (BAPS). The former may not always be available, and the latter can be
computationally prohibitive to run. Additionally, when there are many population clusters
compared to the total number of samples, power may be reduced. I first investigated
the accuracy and computational requirements of a number of methods which represent
bacterial population structure, with the goal of finding one which is fast to run and does
not require a core genome alignment. Given such a definition of population structure, this
could then included as fixed effects in a logistic regression. This is similar to a χ2 test,
but allows covariates to be included in the model fit, in this case to account for clonal
population structure. I additionally gave consideration to the performance of this test when
a single highly penetrant variant causes the phenotype, as for many antibiotic resistance
determinants. This is closer to a Mendelian-like trait, as opposed to a complex trait which
is affected by many lower penetrance variants.
The issue of assaying variation in the bacterial pan-genome relates to what variant is
used as the predictor in these tests. Taking SNPs in the core genome, as in early human
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GWAS, will miss phenotypes caused by diverse forms of variation. This can include indels,
recombinations, variable promoter architecture, and differences in gene content as well
as capturing these variations in regions not present in all genomes. I compared calling
variation in terms of SNPs and COGs with k-mers – short words of DNA of length k,
that have the potential to capture all these forms of variation. In the present chapter only
common (≥ 1% MAF) variants are considered. The testing of rare variants (< 1%) is
underpowered in the sample sizes used here. The use of burden testing to approach this
issue is discussed and performed in section 4.4.
Finally, after coming up with a test framework to overcome these issues, I designed
the software package SEER to implement it. I used object oriented C++ code for speed
and maintainability, as well as access to efficient linear algebra and optimisation packages
(Sanderson, 2010; Sanderson & Curtin, 2016; D. E. King, 2009). I released SEER on github
(https://github.com/johnlees/seer), where user comments have contributed to continued
improvement and maintenance of the software.
The following sections describe how I dealt with each of these issues in turn. Section 2.6
then describes how the finished method was then applied to three datasets: on simulated
data to compare its performance to existing methods, and two real datasets. The first real
dataset tested whether known associations with antibiotic resistance can be recapitulated,
and the second attempted to find new associations with virulence.
2.2 K-mers as a generalised variant
K-mers have the potential to allow simultaneous discovery of both short genetic variants
and entire genes associated with a phenotype. Longer k-mers provide higher specificity but
less sensitivity than shorter k-mers (Ondov et al., 2016). Rather than arbitrarily selecting
a length prior to analysis or having to count k-mers at multiple lengths and combine the
results, I wished to count all k-mers at lengths over nine bases long (as below this mapping
specificity is poor).
Over all N samples, all k-mers over 9 bases long that occur in more than one sample
are counted. All non-informative k-mers are omitted from the output; a k-mer X is not
informative if any one base extension to the left (aX) or right (Xa) has exactly the same
frequency support vector as X. The frequency support vector has N entries, each being
the number of occurrences of k-mer X in each sample. Further filtering conditions are
explained in section 2.2.1 below.
I used three different methods to count informative k-mers from all samples in a study.
For very large studies, or for counting directly from reads rather than assemblies, I used an
implementation of distributed string mining (DSM) (Va¨lima¨ki & Puglisi, 2012; Seth et al.,
2014) which limits maximum memory usage per core, but requires a large cluster to run.
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DSM parallelises to as much as one sample per core, and either 16 or 64 master server
processes. DSM includes an optional entropy-filtering setting that filters the output k-mers
based on both number of samples present and frequency distribution. On 3 069 simulated
genomes this took 2 hrs 38 min on 16 cores, and used 1Gb RAM per core. The distributed
approach is applicable up to terabytes of short-read data (Seth et al., 2014), but requires a
cluster environment to run.
For data sets up to around 5 000 sample assemblies (gigabyte-scale data) we implemen-
ted a single core version, fsm-lite, which is easier to install and run. We based fsm-lite on
a succinct data structure library (Gog et al., 2014) to produce the same output as DSM. On
675 S. pyogenes genomes this took 3hrs 44min and used 22.3Gb RAM.
For comparison with older datasets, or where resources do not allow the storage of
the entire k-mer index in memory, I used DSK (Rizk et al., 2013) to count a single k-
mer length in each sample individually, then combined the results. I wrote the program
combineKmers using an associative array in C++ to combine the results from DSK in
memory. I concatenated results from k-mer lengths of 21, 31 and 41, as in Sheppard et al.
(2013). This could in future be scaled to larger genome numbers by instead using external
sorting to avoid storing the entire array in memory.
To get an idea of how much of the total genomic variance of the population each type
of variant (gene, SNP or word) captured, I compared the site frequency spectrum (SFS) of
informative k-mers with COGs and SNPs. Figure 2.1 shows this comparison for the 1 144
S. pneumoniae genomes described in chapter 4. The k-mer SFS is a similar distribution to
the SNP SFS, though there are in total two orders of magnitude more words. There are also
more fixed k-mers (> 99% allele frequency (AF)) – these are due to the core COGs seen in
the final row. Removing rare variants which are not tested for association, the k-mer SFS
remains representative of the two other variation types, and appears to be capturing both.
2.2.1 Filtering k-mers
Before testing for association, I filtered k-mers based on their frequency and unadjusted
p-value. This reduced false positives from testing underpowered k-mers and reduce
computational time. If not biologically plausible, k-mers with negative effect sizes are
filtered at this point.
K-mers are filtered if either they appear in < 1% or > 99% of samples, or are over 100
bases long when counted by DSM. I also first test if the p-value of association in a simple
χ2 test (with 1 d.f.) is less than 10−5, and remove it otherwise. In the case of a continuous
phenotype a two-sample t-test is used instead. The effect of these filters is discussed in
section 2.4.1.
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Figure 2.1: The SFS of 1 144 S. pneumoniae genomes. The x-axis is AF, the y-axis is the number of variants
with allele-frequencies in that bin. Each row uses different sites: the first row shows k-mer presence, the
second row SNPs as the sites (with respect to the ATCC 700669 reference), the third COGs. The first column
shows all sites, the second column only common sites with > 5% AF.
2.3 Accounting for population structure
Due to the clonal reproduction of bacteria, rather than eukaryotic sexual reproduction
resulting in recombination every generation, the genomes from a sampled population will
usually be highly related. This leads to extensive LD across the chromosome, and a simple
GWAS will therefore find many variants reaching significance due to their correlation with
causal variants. The relatedness between all the bacteria in the study must therefore be
quantified, and then appropriately used in the association model to control for this effect.
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In this section I detail ways in which the population structure may be quantified, then in
section 2.4 I explain how this is incorporated into an appropriate association test.
2.3.1 Phylogenetic simulation of genomes
To test the accuracy of population structure estimation, I simulated realistic data with a
known phylogenetic relationship. I then used a suite of methods that infer this phylogeny
from the resulting genome sequence assemblies or alignments, and evaluated them in terms
of accuracy, efficiency and ease of implementation. The use of simulated data under a
realistic model was desirable, as using a tree inferred from real read data as the true tree
would be circular, and would necessarily result in the model that was used to infer the tree
in the first place as being the most accurate.
I used artificial life framework (ALF) (Dalquen et al., 2012) to simulate evolution along
a given phylogenetic tree, using the 2 232 coding sequences in the ATCC 700669 genome
as the most recent common ancestor (MRCA). I used a phylogeny (fig. 2.2), originally
produced by Kremer et al. (2017) from a core genome alignment of 96 L. monocytogenes
genomes from patients with bacterial meningitis, possessing a number of qualities I wished
to be able to reproduce: two distinct lineages, several clonal groups within each lineage,
long branches and a polyphyletic cluster. I define N as the number of strains in the study
and M as the number of aligned sites.
To estimate rates in the generalised time reversible (GTR) matrix and the size dis-
tribution of insertions and deletions, I aligned S. pneumoniae strains R6 (AE007317),
19F (CP000921) and S. mitis B6 (FN568063.) using Progressive Cactus (Paten et al.,
2011). I used previously determined parameters for the rate of codon evolution (Kosiol
et al., 2007), relative rate of SNPs to indels in coding regions (J. Q. Chen et al., 2009),
rates of gene loss and horizontal gene transfer (Chewapreecha, Harris et al., 2014) when
running the simulation. In parallel, I used DAWG (Cartwright, 2005) to simulate evolution
of intergenic regions using the same GTR matrix parameters and previously estimated
intergenic SNP to indel rate (J. Q. Chen et al., 2009). I combined the resulting sequences
of coding and non-coding regions at tips of the phylogeny while accounting for gene loss
and transfer, and finally generated error prone Illumina reads from these sequences using
pIRS (Hu et al., 2012).
To generate input to phylogenetic inference algorithms, I created assemblies and
alignments from the simulated reads. I assembled the simulated reads into contigs with
velvet (Zerbino & Birney, 2008), then improved and annotated the resulting scaffolds
(Page et al., 2016). I generated alignments by mapping reads to the TIGR4 reference using
bwa-mem with default settings (H. Li, 2013), and called variants from these alignments
using samtools mpileup and bcftools call (H. Li, 2011). I used Roary (Page et al., 2015)
with a 95% BLAST ID cutoff to construct a pan-genome from the annotated assemblies,
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Figure 2.2: a) The phylogeny inferred by Kremer et al. (2017) used as the true tree in simulations. Tips
are coloured by BAPS cluster inferred from the core genome alignment. b) The UPGMA tree using k-mer
distances as used by SEER; tip colours are the original BAPS clusters shown in a).
from which a core gene alignment was extracted. I then created alignments by two further
methods. For a MLST alignment I selected seven genes at random from the core alignment
(present in all strains) which had not been involved in horizontal transfer events. For a
Progressive Cactus alignment, I ran the software on the assemblies using default settings,
and extracted regions aligned between all genomes from the hierarchical alignment file
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and concatenated them.
Using the nucleotide alignments described above as input, I ran the following phylo-
genetic inference methods:
• RAxML 7.8.6 (Stamatakis, 2014) with a GTR+gamma model (-m GTRGAMMA).
• RAxML 7.8.6 with a binary+gamma sites model (-m BINGAMMA).
• FastTree 2.1.9 (M. N. Price et al., 2009) using the GTR model (denoted slow) and
using the -pseudo and -fastest options (denoted fast).
• Parsnp 1.2 (Treangen et al., 2014) on all assemblies using the -c and -x options
(removing recombination with PhiPack).
I also created pairwise distance matrices using:
• Mash 1.0 (Ondov et al., 2016) (default settings) between assemblies.
• Andi 0.9.2 (Haubold et al., 2015) (default settings) between assemblies.
• Hamming distance between informative k-mers using a subsample of 1% of counted
k-mers from assemblies.
• Hamming distance between rows of the gene presence/absence matrix produced by
Roary (using 95% blast ID cutoff).
• Jukes-Cantor (JC) and logdet distances between sequences in the alignment, as
implemented in SeaView 4.0 (Gouy et al., 2010).
• Distances between core gene alleles (add a distance of zero for each core gene with
identical sequence, add a distance of one if non-identical), as used in the BIGSdb
genome comparator module (Jolley & Maiden, 2010).
• Normalised compression distance (NCD) (Vita´nyi et al., 2009), using PPMZ as the
compression tool (Alfonseca et al., 2005).
For all the above distance matrix methods I then constructed a neighbour joining (NJ)
tree, a BIONJ tree (Gascuel, 1997) using the R package ape, and an UPGMA tree using
the R package phangorn. In the comparison I retained the tree building method from these
three with the lowest Kendall-Colijn (KC) distance from the true tree.
To measure the differences in topology between the produced trees (either between the
true tree and an inferred tree, or between all different inferred trees) I used two measures.
As a sensitive measure of changes in topology I used the metric proposed by Kendall and
Colijn (2016) with λ = 0 (ignoring branch length differences). I compared the true tree
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against midpoint rooted random trees giving 286 (95% CI 276-293) as an upper limit on
poor topology inference.
For trees distant from the true tree by the KC metric it was useful to test whether
the tree was accurate overall and only a few clade structures were poorly resolved, or
whether the tree failed to capture important clusters at all. I therefore used a measure of
the clustering of the BAPS clusters from the true alignment on each inferred tree. For
each pair of isolates in a BAPS cluster, a one is added to the score if any children of their
most recent common ancestor is from a different cluster. I applied this to both the primary
BAPS cluster, which separates the two main lineages, and the secondary BAPS clusters
which define finer structure in the data. For the primary BAPS cluster a score of 0 was
achieved by the true tree, which maintained these clusters, and 2437 (95% CI 2401-2457)
for random trees. For the secondary BAPS clusters (excluding the ‘bin’ cluster) a score of
63 was achieved by the true tree, as one cluster is polyphyletic (removing this cluster gives
a score of 0 to the true tree), and 535 to random trees (95% CI 531-539).
Method KC BAPS 1 BAPS 2 CPU time Memory Overheads Parallelisability Accessory genome?
(0-286) (0-2437) (0-535)
RAxML + close 4.63 0 63 806.5 minutes 2.7 Gb Mapped alignment Pthreads No
reference alignment
RAxML 11.2 0 63 587 minutes 3 Gb Mapped alignment Pthreads No
+ alignment
Parsnp 14.0 0 63 42.5 minutes 2.6 Gb Assemblies Threads No
FastTree 16.0 0 63 189 minutes 10.6 Gb Mapped alignment Threads No
+ alignment (up to 4)
RAxML + core 18.6 0 63 29.2 minutes 0.15 Gb Core gene Pthreads No
gene alignment alignment
NJ + SNP 20.5 0 63 Negligible Negligible Mapped alignment No No
alignment
BIONJ + mash 51.7 0 63 0.75 minutes 10 Mb Assembly Embarrassingly Yes
distances
RAxML + MLST 62.6 0 63 1.4 minutes 19 Mb Assembly Pthreads No
alignment
BIONJ + andi 66.0 0 60 7.48 minutes 290 Mb Assembly Embarrassingly Yes
distances
RAxML + Cactus 67.2 0 63 9 600 minutes 37.4 Gb Assembly Threads No
alignment
RAxML + gene 77.3 0 57 4.28 minutes 20 Mb Core gene Threads Yes
presence/absence alignment
BIONJ + k-mer 89.6 0 63 37.3 minutes 180 Mb Assembly Threads Yes
distances
BIONJ + BIGSdb 149.8 0 22 0.48 minutes Negligible Assembly Embarrassingly No
UPGMA + NCD 210 0 627 1 040 minutes Negligible Assembly Embarrassingly Yes
Table 2.1: Accuracy and resource usage of phylogenetic reconstruction methods, ordered by KC metric score.
The method lists the best combinations of all alignment with phylogenetic method, and distance matrices
with phylogenetic methods. Three scores of accuracy of the phylogeny are shown; values in the header are
the range the values can take. Parallelisability shown is that built into the software, ‘embarrassingly’ is when
every value in a distance matrix is independent so can be parallelised up to N2 times.
Table 2.1 and fig. 2.3 show the results of my simulations. I used these simulations
to guide the population structure correction to use in SEER bearing in mind the criteria
laid out above, and also for efficiency/accuracy tradeoffs when constructing phylogenies
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Figure 2.3: Using the KC metric between all the inferred phylogenies in table 2.1 to create a pairwise
distance matrix, then an NJ tree from this matrix. This shows how the topologies from all methods are related
to each other (a tree-of-trees, or supertree). The true tree is in orange and was used to root the tree, and four
classes of method are labelled.
throughout the rest of this thesis.
Firstly I note that all methods except for the NCD were able to recapitulate the pop-
ulation clusters as defined by BAPS. Therefore for analyses which require identifying
clusters on the phylogeny, but not finer scale topology, quicker but less accurate methods
are sufficient. For construction of a maximum likelihood tree RAxML is currently the
most efficient software available. This was the most accurate method tested, and also the
most resource heavy. RAxML’s model fits the way the data was generated, and is expected
to be a good model of evolution. There was no significant difference in fit between the
inferred tree and the true tree (likelihood ratio test (LRT) = 2.34; p = 0.13). When applied
to an alignment with a reference genome more distant from the root, this method was still
the most accurate. Using a core genome alignment slightly reduces the accuracy, as the
number of sites M used in the inference was reduced compared to the pseudo-alignment
from mapping. Using an MLST alignment of seven genes reduces the accuracy greatly, as
only a small proportion of the genomic variants are now used the the inference.
I found parsnp and FastTree on a whole genome alignment to be the methods which,
while slightly less accurate than RAxML, were able to produce a good quality phylogeny
rapidly. This is useful for alignments with large N and M. Distance matrix and NJ methods
generally performed more poorly, but were still able to resolve large scale population
structure differences.
I now discuss in detail a method which fulfilled the criteria for SEER’s population
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structure correction: it accurately represented the BAPS clusters without needing a core-
genome alignment, used only the information already needed to perform and association
test on k-mers, could be efficiently implemented in C++ with the rest of SEER, and could
be used to provide covariates for a logistic or linear regression rather than using discrete
clusters or a phylogeny.
2.3.2 K-mer distance method producing covariates to control for pop-
ulation structure
Compared with modelling SNP variation, the use of k-mers as variable sequence elements
has been previously shown to accurately estimate bacterial population structure (Tasoulis
et al., 2014). As k-mers are going to be used as the input to the association test, it would
be convenient if they could also be used to control for population strucutre. I defined the
k-mer distance in table 2.1 as follows. First I take a random sample of between 0.1% and
1% of k-mers appearing in between 5-95% of isolates. I then construct a pairwise distance
matrix D, with each element being equal to a sum over all m sampled k-mers:
di j =∑
m
||kim− k jm|| (2.1)
where kim is 1 if the mth sampled k-mer is present in sample i, and 0 otherwise. Each
element di j is therefore an estimate of the number of non-shared k-mers between a pair
of samples i and j, and furthermore is proportional to the Jaccard distance between the
samples (Levandowsky & Winter, 1971). When I clustered samples using these distances,
I got the same results as clustering core alignment SNPs using hierBAPS (L. Cheng et al.,
2013) as shown in fig. 2.2b). These clusters have been used in previous bacterial GWAS
studies to correct for population structure (Chewapreecha, Marttinen et al., 2014). However,
this distance matrix has the clear advantage that no core gene alignment or SNP calling is
needed, so it can be directly applied to the the k-mer counting result.
In an analogous way to the standard method used in human genetics of using principal
components of the SNP matrix to correct for divergent ancestry (A. L. Price et al., 2006;
Chengsong & Jianming, 2009), I then wrote C++ code to perform metric multidimensional
scaling (MDS) on D, projecting these distances into a reduced number of dimensions.
The normalised eigenvectors of each dimension of this projection can then be used as
covariates in the regression model, where the number of dimensions used is a user-
adjustable parameter, and can be evaluated by the goodness-of-fit and the magnitude
of the eigenvalues. For the tree shown in fig. 2.2, one dimension was sufficient as a
population control (fig. 2.4a), whereas for the larger collection of 3 069 isolates 10-15
dimensions were needed to give tight control (fig. 2.4b). The small collection has much
of the variance explained by the first dimension/eigenvector, as there is a large separation
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between two main lineages. In the other collections there is a strain structure with multiple
lineages, so more dimensions must be included to capture this. Over all the studies I tested,
generally three dimensions appeared a good trade-off between sensitivity and specificity,
but I automatically provide a scree plot as output so users can choose an appropriate
























Figure 2.4: a) Stress against first thirty dimensions, calculated for the S. pneumoniae simulations in
section 2.6.1 (orange in panel b). Stress is defined as S2 = 1−R2, where the R2 statistic is calculated from a
regression between the upper triangle of entries in the distance matrix (i.e. pairwise between all samples)
and the Euclidean distance between samples in the reduced dimension space. b) Eigenvalues for the first
fifty dimensions of the 96 simulated S. pneumoniae isolates in black (section 2.3.1), 3 069 S. pneumoniae
isolates in orange (section 2.6.1), and 675 S. pyogenes isolates (section 2.6.3) in blue.
I noted above that the distance used to approximate bacterial population structure is
an estimate of the k-mer Jaccard distance. After the first version of SEER, the software
mash was developed. This instead uses the MinHash algorithm on k-mers to estimate the
Jaccard distance between sequences in a highly efficient manner (Ondov et al., 2016). As
shown in table 2.1 and fig. 2.3 this distance matrix is considerably more computationally
efficient than the subsampling proposed above, works from the same input data, and
produced a more accurate version of the tree topology in tests. Since version acc4bc1 I
have recommended the use of mash over the above calculation I implemented in SEER,
and provide scripts to run mash and MDS in a manner compatible with the rest of the
package.
2.4 Association testing
Using k-mers as a generalised variant and the above population structure definition I used
general linear models with fixed effects to test for association between genetic variation
and phenotypes. For each k-mer, I wrote code to fit a logistic curve to binary phenotype
data, and a linear model to continuous data. I took care to use time efficient optimisation
routines to allow testing of all k-mers. Bacteria can be subject to extremely strong selection
pressures, producing common variants with very large effect sizes, such as antibiotics
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inducing resistance-conferring variants. This can make the data perfectly separable, and
consequently the maximum likelihood estimate ceases to exist for the logistic model. Firth
regression has been used to obtain results in these cases (Heinze & Ploner, 2003).
In detail, the SEER association testing code does the following. For samples with







where absence and presence for each k-mer are coded as 0 and 1 respectively in column 2
of the design matrix X (column 1 is a vector of ones, giving an intercept term). Subsequent
columns j of X contain the eigenvectors of the MDS projection, any input categorical
covariates (automatically dummy encoded), and quantitative covariates (automatically nor-
malised). I used the Broyden–Fletcher–Goldfarb–Shanno (BFGS) algorithm to maximise




[yi · log(sig(Xβ )i)+(1− yi) · log(sig(1−Xβ )i)] (2.3)
where sig is the sigmoid function. If this fails to converge, n Newton-Raphson iterations
are applied to β :
β n+1 = β n+[−L ′′(β n)]−1 ·L ′(β n) (2.4)
from a starting point using the mean phenotype as the intercept, and the root-mean squared




β0, j>0 = 0.1
This is slower than using BFGS, but has a higher success rate.
If any entries for the observed counts in the contingency table were one or zero, or if
two counts were five or less then Firth logistic regression is used instead. This regression
is also used if after 1 000 Newton-Raphson iterations convergence is not reached, due to
the observed points being separable, or the standard error of the slope is greater than 3
(which empirically indicated almost separable data). Firth regression adds an adjustment
to log(L ):










using which I applied Newton-Raphson iterations as above.
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In the case of a continuous phenotype a linear model is fitted:
y = Xβ (2.6)
to find β , I used the BFGS algorithm to minimise the squared distance U(β ):
U(β ) = ||y−Xβ ||2 (2.7)
If this fails to converge then the solution is instead obtained by orthogonal decomposition
of the design matrix:
X = QR (2.8)
then back-solving for beta in:
Rβ = QT y (2.9)
For both the logistic and linear model the standard error on the slope β1 is calculated
by inverting the Fisher information matrix d2L /dβ 2 to obtain the variance-covariance
matrix. Inversions are performed using the Cholesky decomposition, or if this fails due to
the matrix being almost singular I used the Moore-Penrose pseudoinverse. In the initial
version of SEER, I used the Wald statistic to test the probability null hypothesis of no





which is the test statistic of a χ2 distribution with 1 d.f. This is equivalent to the positive
tail of a standard normal distribution, one minus the integral of which gives the p-value.
The Wald test loses power when large effect sizes are tested (Agresti, 2015); I observed
this when testing k-mers of a mosaic penA allele which are known to be causal for
cephalosporin resistance in Neisseria gonorrhoeae (Unemo & Shafer, 2014). A χ2 test
gave a p-value of 3.5×10−181 whereas a logistic regression using the Wald test gave a
p-value of 1.9×10−45, less significant than some non-causal k-mers. A better test is the
LRT: in this case, the LRT of the logistic model gave a p-value of 8.4×10−190, making
these k-mers the top hit.
Here, the LRT test statistic D is defined as





= 2 · [log{L (β1 = βfit)}− log{L (β1 = 0)}]
using eq. (2.3) as the likelihood. The distribution of D is χ2 with dfalt− dfnull. In this
case, two times the difference between the log-likelihood at the fitted value and the log-
likelihood of a fit where the k-mer presence/absence column is removed from the design
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matrix is tested using a χ2 distribution with one degree of freedom. Since version 038c4cd
of SEER the p-value for logistic regression is instead calculated using the LRT by default,
though the Wald test p-value is still reported for backwards compatibility.
2.4.1 Significance cut-off
For the basal cut-off for significance I used p < 0.05, with which I used the conservative
Bonferroni correction for multiple testing to give the threshold 1×10−8 based on every
position in the S. pneumoniae genome having three possible mutations (Ford et al., 2013),
and all this variation being uncorrelated. This is a strict cut-off level that prevents a large
number of false-positives due to the extensive amount of k-mers being tested, but does
not over-penalise by correcting directly on the basis of the number of k-mers counted. To
calculate an empirical significance testing cut-off for the p-value under multiple correlated
tests, I generated the distribution of p-values from 100 random permutations of phenotype.
For the 3 069 Maela genomes setting the FWER at 0.05 gave a cut-off of 1.4× 10−8,
supporting the above reasoning.
In general, the number of k-mers and the correlations between their frequency vectors
will vary depending on the species and specific samples in the study, so the p-value cut-off
should be chosen in this manner (either by considering possible variation given the genome
length, or by permutation testing) for individual studies. I have also included association
effect size and p-value of the MDS components in the output of SEER, to compare lineage
and variant effects on the phenotype variation.
The effect the initial χ2 filtering step can be seen by plotting the unadjusted and adjusted
p-values of the k-mers from the simulated data set described in section 2.6.1 against each
other (fig. 2.5). 430 k-mers of 12.7M passing frequency filtering have an unadjusted
p-value which fail to meet the χ2 significance threshold, but would be significant using
the adjusted test (and have a positive direction of effect). These k-mers were all short
words (10-21 bases; median 12) that appear multiple times per sample, and therefore
are of low specificity. When I tested the top p-value k-mer in this set it showed a strong
association of the presence/absence vector with three population structure covariates used
(p = 1.4×10−24; p = 1.2×10−46; p = 1.5×10−9 respectively). Using lasso regression,
the second population structure covariate has a higher effect in the model than the k-mer
frequency vector. Together, this suggested that these filtered k-mers are associated to a
lineage related to the phenotype, but are unlikely to be causal for the phenotype themselves.
To confirm this, I mapped these k-mers back to the reference sequence. None of these
k-mers map to the gene causal to the phenotype.
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Figure 2.5: The − log10 p-values from a χ2 test against the p-value from a logistic regression using the
first three MDS components as covariates. The points are from all the simulated k-mers passing frequency
filtering. The cut-offs used for each test are shown as red dashed lines. Top panel: marginal distribution
of χ2 p-values. Right panel: marginal distribution of logistic regression p-values. a) k-mers meeting the
threshold for significance (a cut-off of 1×10−8) in the logistic regression which map to the causal gene are
coloured in red. b) shading of each point is by MAF. Most of the k-mers with a high χ2 p-value and low
logistic regression p-value are at low frequency, as are those with equal p-values from each test.
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2.4.2 Downstream interpretation of significant k-mers
Significant k-mers can be interpreted directly through mapping to annotated genomes, or
by assembling them first. Assembly may be better at searching for gene clusters associ-
ated with phenotype as longer and more specific k-mers will be generated. I assembled
significant k-mers assembled using Velvet (Zerbino & Birney, 2008) choosing a smaller
sub-k-mer size which maximises longest contig length of the final assembly. K-mers in the
output which are substrings of other longer significant k-mers are removed.
I used BLAT (Kent, 2002) with a step size of 2 and minimum match size of 15 to
find inexact but close matches to a well annotated reference sequence. Small k-mers are
more likely than full reads to map equally well to multiple places in the reference genome,
so reporting both mappings increases the sensitivity. For the tested dataset an average
of 21% of k-mers significantly associated with antibiotic resistance report secondary
mappings. These k-mers are short (median 15bp), and therefore have low specificity and
high sensitivity as expected. I wrote a script which combines the p-values from SEER and
co-ordinates from mapping of the significant k-mers into a .plot file, which can be loaded
into visualisation software http://jameshadfield.github.io/phandango/ to create a Manhattan
plot.
When k-mers do not map to a reference genome, I wrote the C++ program map back
to help interpret these. This reads in all the tested assemblies from which the k-mers
were generated into memory, and threads are spawned which search for k-mers (and their
reverse complement) by exact string match. Using the mapped co-ordinates, annotations
of features in these regions can examined for overlap of function.
2.5 Development of SEER
I implemented SEER in C++ using the armadillo linear algebra library (Sanderson, 2010;
Sanderson & Curtin, 2016), and dlib optimisation library (D. E. King, 2009). When the
code was stable, I profiled its execution over a test dataset of 1 000 k-mers. Most of the
processing time was spent evaluating the exp() function, which is required O(N) times
per k-mer when calculating the likelihood function and its gradient during the logistic fit,
where N is number of samples. I was satisfied that this demonstrated an efficient usage of
CPU time, and further did not identify any memory leaks when profiling with valgrind.
For ease of deployment on non-cluster machines I also threaded each filtered k-mer’s
fitting routine; on four cores this achieved a 2.1 times speedup. While this could probably
be improved by increasing the number of k-mers handled by each thread, the algorithm is
embarrassingly parallel – in practise I split the k-mer file into 16 and ran an independent
process on each one. I also threaded the calculation of entries in the distance matrix D,
using mutex locks to ensure only one process wrote an entry to the matrix at a time. This
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was over 99% efficient.
On my simulation of 3 069 diverse 0.4Mb genomes described in section 2.6.1, 143M
k-mers were counted by DSM and 25M 31-mers by DSK. On the largest DSM set, using 16
cores and subsampling 0.3M k-mers (0.2% of the total), calculating population covariates
took 6hr 42min and 8.33GB RAM. This step is O(N2M) where M is number of k-mers,
but can be parallelised across up to N2 cores.
Processing all 143M informative k-mers as described took 69min 44s and 23MB RAM
on 16 cores. This step is O(NM) and can be parallelised across up to M cores.
After the initial release I added the following features, fixes and improvements in
response to user comments on github:
• Convergence errors and the type of regression used are added in a comment field for
each k-mer.
• Created a virtual machine with SEER installed, without the requirement for further
dependencies.
• Statically complied version (includes libraries in executable).
• Add scripts to map significant k-mers and create a Manhattan plot.
• An alternative implementation of the population structure correction, written in R.
• Tests of all features of SEER, and continuous integration of these through travis.
• Improved installation and usage instructions, including a self-contained tutorial.
2.6 Benchmarking SEER
I benchmarked the performance of SEER on three datasets. The first was a large simulated
set of S. pneumoniae genomes where I was able to define the associated element and
set its effect size manually – this allowed me to calculate the discovery power of SEER
for different sample sizes under different situations. The second dataset was 3 069 real
S. pneumoniae genomes with five antibiotic resistance phenotypes available which helped
me evaluate whether SEER could capture both gene and SNP mediated resistances (which
have large effect sizes, and are often homoplasic, so should be easy to find), and how SEER
compares to previous methods. Finally, I tested SEER on 675 S. pyogenes genomes from
invasive and non-invasive samples to see if SEER could discover any new associations
with a clinically relevant phenotype other than resistance.
70
Chapter 2. Bacterial genome-wide association studies
2.6.1 Simulated data
I used a framework similar to that described in section 2.3.1 to simulate genetic sequences.
To make running the simulation tractable for such a large population size, I took a random
subset of 450 genes from the S. pneumoniae ATCC 70066916 strain as the starting genome
for ALF (Dalquen et al., 2012). Using the same parameters as in section 2.3.1 I simulated
3 069 final genomes along the phylogeny observed in a Thai refugee camp (Chewapreecha,
Harris et al., 2014). pIRS (Hu et al., 2012) was again used to simulate error-prone reads
from genomes at the tips of the tree, which I then assembled by Velvet (Zerbino & Birney,
2008). DSM was used to count k-mers from these de novo assemblies. I counted 143M
informative k-mers from this simulated data, though on the real dataset of full length
genomes only 68M informative k-mers were counted.
I used a gamma plus invariant sites model as the distribution of rate heterogeneity
among sites. As I did not have estimates for the parameters of this distribution directly
from the data, I used the estimate given by ALF. The resulting gamma distribution must
have a longer tail than the real data, as some sites vary at high frequency. This created
many low-frequency k-mers. As the simulation is computationally very expensive to run,
I decided that rather than running it lots of times with different parameters until a k-mer
distribution identical to the observed data was reached it would be sufficient to use the
original result. The excess of low frequency k-mers would be filtered out in the common
variation associations I am testing. 24.7M k-mers passed frequency filtering from the
real data, whereas 12.7M passed from the simulated data – while this wasn’t quite the
linear scaling expected with genome length (which would predict around 7M k-mers) the
amount of common variation at the gene level was similar to real data. For the purpose I
used the simulations for, a gene driven association at different ORs, this result was still an
appropriate test.
I then simulated the phenotype based on the genetic sequence. I set the ratio of cases
to controls in the population (SR) at 50% to represent typical antibiotic resistance, and
designated a single variant (which could be either gene presence/absence or a SNP) as
causal. MAF in the population is set from the simulation of genomes, and OR can be
varied. The number of cases DE is then the solution to a quadratic equation (Newman,
2003), which is related to probability of a sample being a case by








I generated random subsamples of the population 100 times at a range of sample sizes
below the total, with case and control status assigned for each run using these formulae. I
defined power by the proportion of runs that had at least one k-mer in the gene significantly
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(c) Detecting k-mers near, in the correct gene, or con-
taining the causal variant for trimethoprim resistance.
Figure 2.6: Using simulations and subsamples of the population as described, power for detecting associ-
ations. All curves are logistic fits to the mean power over 100 subsamples.
Having knowledge of the true alignments, I then artificially associated an accessory
gene with a phenotype over a range of odds-ratios and evaluated power at different sample
sizes (fig. 2.6a). The expected pattern for this power calculation is seen, with higher odds-
ratio effects being easier to detect. Currently detected associations in bacteria have had
large effect sizes (OR > 28 host-specificity (Sheppard et al., 2013); OR > 3 beta-lactam
resistance (Chewapreecha, Marttinen et al., 2014)), and the required sample sizes predicted
are consistent with these discoveries.
The large k-mer diversity, along with the population stratification of gene loss, makes
the simulated estimate of the sample size required to reach the stated power conservative.
Convergent evolution along multiple branches of a phylogeny for a real population reacting
to selection pressures will reduce the required sample size (Farhat et al., 2013).
I also compared the performance when using k-mers counted at constant lengths by
DSK (Rizk et al., 2013) to perform the gene presence/absence association. Counting all
informative k-mers rather than a pre-defined k-mer length gave greater power to detect
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associations, with 80% power being reached at around 1 500 samples, compared with
2 000 samples required by 31-mers (fig. 2.6b). The slightly lower power at low sample
numbers is due to a stricter Bonferroni adjustment being applied to the larger number of
DSM k-mers over the DSK k-mers. This is exactly the expected advantage from including
shorter k-mers to increase sensitivity, but as k-mers are correlated with each other due to
evolving along the same phylogeny, using the same Bonferroni correction for multiple
testing does not decrease specificity.
The strong LD caused by the clonal reproduction of bacterial populations means that
non-causal k-mers may also appear to be associated. This is well documented in human
genetics; non-causal variants tag the causal variant increasing discovery power, but make it
more difficult to fine-map the true link between genotype and phenotype (Spain & Barrett,
2015). In simulations it is difficult to replicate the LD patterns observed in real populations,
as recombination maps for specific bacterial lineages are not yet known. To evaluate the
power of fine-mapping and associated locus to the single causal SNP I instead used the
real sequence data and the effect size of a known causal variant, and evaluated the physical
distance of significant k-mers from the variant site.
I tested the 68M k-mers from DSM for association with trimethoprim resistance: 2 639
k-mers reached significance, were mapped to a reference genome, and were found to cover
most of the genome with a peak at the causal variant (fig. 2.7). I placed mapped k-mers
near the correct physical location into three categories: those containing the causal variant
I100L (10 k-mers), those within the same gene (74 k-mers), or those within 2.5kb in either
direction (207 k-mers). Figure 2.6c shows the resulting power when random subsamples
of the population are taken. As expected, power is higher when not specifying that the
causal variant must be hit, as there are many more k-mers which are in LD with the SNP
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Figure 2.7: K-mers are mapped to the ATCC 700669 reference genome. Plotted coverage is the rolling
average over 100bp windows over the genome. The red dashed line at 1 533 003bp shows the location of the
causal variant, overlapping with the peak in coverage.
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2.6.2 Antibiotic resistance in pneumococcal carriage
I then applied SEER to the sequenced genomes from the study described in section 2.6.1
(Chewapreecha, Harris et al., 2014), using measured resistance to five different antibi-
otics as the phenotypes: chloramphenicol, erythromycin, β−lactams, tetracycline and
trimethoprim. Chloramphenicol resistance is conferred by the cat gene, and tetracycline
resistance is conferred by the tetM gene, both carried on the ICE ICESp23FST81 in the
S. pneumoniae ATCC 700669 chromosome (Croucher et al., 2009). For both of these drug
resistance phenotypes the ICE contained 99% of the significant k-mers, and the causal
genes rank highly within the clusters (table 2.2).
Antibiotic Resistant samples Number of significant k-mers
Total Mapped to reference Highest coverage annotation Causal element
Chloramphenicol 204 (7%) 1 526 1 526 1 508 – ICE 166 – cat
288 – ORF (UniParc B8ZK82)
206 – rep
166 – cat
Erythromycin 803 (26%) 1 154 112 10 – permease (UniParc B8ZKV5) 4 – mega element
8 – prfC 2 – mef
6 – gatA 2 – omega element
4 – ICE
β−lactams 1 563 (51%) 23 876 17 453 381 – ICE 47 – pbp2x
145 – prophage MM1 20 – pbp2b
50 – SPN23F15110 (UniParc B8ZLE7) 8 – pbp1a
49 – ICE orf16
Tetracycline 1 958 (64%) 962 962 962 – ICE 96 – tetM
136 – ICE orf16
121 – ICE orf15
96 – tetM
Trimethoprim 2 553 (83%) 2 639 210 21 – dyr 21 – dyr
Table 2.2: Results from SEER for antibiotic resistance binary outcome on a population of 3 069 S. pneumo-
niae genomes. Significant k-mers were first interpreted by mapping to the ATCC 700669 reference genome.
Up to the first four highest covered annotations are shown, and if the known mechanism is amongst these
it is highlighted in orange. The ICE is the top hit in three analyses, as it carries multiple drug-resistance
elements and is commonly found in multi-drug resistant strains (Croucher et al., 2009).
Resistance to erythromycin is also conferred by presence of a gene, but there are
multiple genes that can be causal for this resistance: ermB causes resistance by methylating
rRNA whereas mef /mel is an efflux pump system (Croucher, Harris, Fraser et al., 2011).
In this population, this phenotype was strongly associated with two large lineages, making
the task of disentangling association with a lineage versus a specific locus more difficult. I
mapped some of the significant k-mers to the mega and omega cassettes, which carry the
mel/mef and ermB resistance elements respectively.
I also mapped hits to other sites within the ICE, a permease directly upstream of
folP, prfC and gatA. Macrolide resistance cassettes frequently insert into the ICE in
S. pneumoniae, so it is in LD with the genes discussed above. In sulphamethoxazole
resistance folP is modified by small insertions, with which the adjacent permease is in LD
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with. Finally, prfC and gatA are both involved in translation, so could conceivably contain
compensatory mutations when ermB mediated resistance is present. Further evidence of
these compensatory mutations would be required to rule out the k-mers mapping to them
simply being false positives driven by population structure.
Some k-mers did not map to the reference, as they are due to lineage specific asso-
ciations with genetic elements not found in the reference strain. This highlighted both
the need to map to a close reference or draft assembly to interpret hits described in sec-
tion 2.4.2, as well as the importance of functional follow-up to validate potential hits from
GWAS methods such as SEER.
Multiple mechanisms of resistance to β−lactams are possible (Chewapreecha, Mart-
tinen et al., 2014). I considered just the most important (i.e. highest effect size) mutations,
which are SNPs in the penicillin binding proteins pbp2x, pbp2b and pbp1a. In this case
ranking annotations by highest coverage found these genes ranked top, but this was not
sufficient evidence for discovery as so many k-mers were significant – either due to other
mechanisms of resistance, physical linkage with causal variants or co-selection for res-
istance conferring mutations. Instead, I looked at the k-mers with the most significant
p-values: the top four hit loci were pbp2b (p = 10−132), pbp2x (p = 10−96), putative RNA
pseudouridylate synthase – UniParc B8ZPU5 (p = 10−92) and pbp1a (p = 10−89). The
non-pbp hit is a homologue of a gene in linkage disequilibrium with pbp2b, which would
suggest mismapping rather than causation of resistance.
Trimethoprim resistance in S. pneumoniae is conferred by the I100L mutation in the
folA/dyr gene (Maskell et al., 2001). The dpr and dyr genes, which are adjacent in the
genome, had the highest coverage of significant k-mers (fig. 2.8). To try and find the
specific variant causal for the phenotype (i.e fine-mapping) I used the BLAT mapping
of significant k-mers to a reference sequence, and called SNPs using bcftools (H. Li,
2011). I set quality scores for a read to be identical, as the Phred-scaled Holm-adjusted
p-values from association. I then filtered for high quality (QUAL > 100) SNPs, and then
annotated the predicted effect using SnpEff (Cingolani et al., 2012). I finally ranked
the effect of missense SNPs on protein function using SIFT, which uses whether sites
are conserved across the protein family to predict whether amino acid changes will alter
protein function (Ng & Henikoff, 2003). Following this fine-mapping procedure, I called
four high-confidence mutations that are predicted to be non-synonymous SNPs. One is the
causal SNP, and the others appear to be hitchhikers in LD with I100L. The SIFT ranking
places the known causal SNP top, showing that in this case fine-mapping is possible using
the output from SEER.
I compared the performance of SEER to two existing methods. Chewapreecha, Mart-
tinen et al. (2014) tested variants from a core-genome SNP mapping using plink (Purcell
et al., 2007); population clusters were used to perform a CMH test to control for population
structure. Sheppard et al. (2013) used fixed k-mer lengths of 21, 31 and 41 as counted
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Figure 2.8: Fine mapping the causal variant for trimethoprim resistance. The locus pictured contains 72
significant k-mers, the most of any gene cluster (fig. 2.7). Coverage over the locus is pictured at the bottom of
the figure. Shown above the genes are high quality missense SNPs, plotted using their p-value for affecting
protein function as predicted by SIFT. Scale bar is 200 base pairs.
by DSK (Rizk et al., 2013), with a Monte Carlo phylogeny-based population control. As
the second method is not scalable to this population size, I used the SEER population
control as calculated from all genomes in the population and a subsample of 100 samples
to calculate association statistics, which is roughly the number computationally accessible
by this method. In both cases, the same Bonferroni correction is used as for SEER.
Antibiotic Causal variant Significant sites Near correct site Notes
plink dsk plink
Tetracycline ICE, tetM 8 029 0 tetM – 124 ICE – 2240
Chloramphenicol ICE, cat 5 310 0 cat – 0 ICE – 1137
β−lactams pbp2x, pbp1a, pbp2b 858 0 pbp2x – 210 pbp1a – 113 pbp2b – 81
Trimethoprim dyr (I100L) 4 009 0 dyr – 47 dpr – 53 Causal SNP ranked 22nd
Erythromycin ermB, mef, mel, mefA 8 469 0 None Element not present in reference
Table 2.3: The power to find genetic associations with antibiotic resistance in the Maela study using existing
methods. For each of the five antibiotics, the true causal variant is listed, as are the number of hits passing
the significance threshold for each method (plink and DSK) and the number which map to the correct region.
Both SEER and association by core mapping of SNPs (using plink) identified res-
istances caused by presence of a gene, when it was present in the reference used for
mapping (table 2.3). Both produced their most significant p-values in the causal element,
though SEER appeared to have a lower false-positive rate. However, as demonstrated
by chloramphenicol resistance, if not enough SNP calls are made in the causal gene this
hinders fine-mapping. SNP-mediated resistance showed the same pattern since many other
SNPs were ranked above the causal variant. In the case of β−lactam resistance both
methods seem to perform equally well, likely due to the higher rate of recombination and
the creation of mosaic pbp genes.
Additionally, as for erythromycin resistance, when an element is not present in the
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reference it is not detectable in SNP-based association analysis. In such cases multiple
mappings against other reference genomes would have to be made, which is a tedious and
computationally costly procedure. Since the k-mer results from SEER are reference-free,
the computational cost of mapping reads to different reference genomes is minimised
as only the significant k-mers are mapped to all available references. Alternatively, the
significant k-mers can be mapped to all draft assemblies in the study, at least one of which
is guaranteed to contain the k-mer, to check if any annotations are overlapped.
The small sample, combined with fixed length 31-mer, approach did not lead to any
words reaching significance for chloramphenicol, tetracycline or trimethoprim as the effect
size of any k-mer is too small to be detected in the number of samples accessible by the
method. I found 19 307 hits for erythromycin, and 419 hits for β−lactams, at between
1-2% MAF which are all false positives that would likely have been excluded by a fully
robust population structure correction method such as the one the authors originally used.
2.6.3 Virulence of Streptococcus pyogenes
Most bacterial GWAS studies to date have searched for genotypic variants that contribute
towards or completely explain antibiotic resistance phenotypes. As a proof of principle
that SEER could be used for the discovery stage of sequence elements associated with
other clinically important phenotypes, I applied the tool to 675 S. pyogenes (group A
Streptococcus) genomes obtained from population diversity studies for genetic signatures
of invasive propensity.
347 isolates of S. pyogenes collected from Fiji (Steer et al., 2009) were sequenced
on the Illumina HiSeq platform, which I then combined with 328 existing sequences
from Kilifi, Kenya (Seale et al., 2016). I defined those isolated from blood, CSF or
bronchopulmonary aspirate as invasive (n = 185), and those isolated from throat, skin
or urine as non-invasive (n = 490). I then ran SEER to determine k-mers significantly
associated with invasion, followed by a BLAST of the k-mers with the nr/nt database to
determine a suitable reference for mapping purposes.
After this preliminary analysis, I found the top hit was the tetM gene from a conjugative
transposon (Tn916) carried by 23% of isolates (fig. 2.9a). These elements are known to
be variably present in the chromosome of S. pyogenes (Roberts & Mullany, 2009), and
the lack of co-segregation with population structure explained the power to discover the
association. However, as a different proportion of the isolates from each collection were
invasive (Fiji – 13%; Kilifi – 43%), the significant k-mers will also include elements
specific to the Kilifi dataset. Indeed, I found that this version of Tn916 was never present
in genomes collected from Fiji. To correct for this geographic bias, I repeated the SEER
analysis by including country of origin as a covariate in the regression. This analysis
removed tetM as being significantly associated with invasiveness, and highlighted the
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importance of such covariate considerations in performing association studies on large
bacterial populations.
Figure 2.9: Phandango view of S. pyogenes HKU488 reference genome (blue blocks at top genes on forward
and reverse strands, tetM highlighted in red) and Manhattan plot of start positions of significant k-mers:
a) associated with invasiveness when not adjusted for country of origin; b) and c) adjusted for country of
isolation.
After applying this correction, I identified two significant hits (fig. 2.9b,c). The first
corresponded to SNPs associating a specific allele of pepF (Oligoendopeptidase F; UniProt
P54124) with invasive isolates. This could indicate a recombination event, due to the
high SNP density and discordance with vertical evolution with respect to the inferred
phylogeny (Dubnau, 1999; Lefe´bure & Stanhope, 2007). The second hit represented
SNPs in the intergenic region upstream of both IgG-binding protein H (sph) and nrdI
(ribonucleotide reductase). In support of these findings, previous work in murine models
have found differential expression of sph during invasive disease (Raeder & Boyle, 1993,
1995; T. C. Smith et al., 2003b), but little to no expression outside of this niche (T. C.
Smith et al., 2003a). If these k-mers were found to affect expression of the IgG-binding
protein, this would be a plausible genetic mechanism affecting pathogenesis and invasive
propensity (Walker et al., 2014). The association of both of these variations would have
to be validated either in vitro or a within a replication cohort, and functional follow-up
such as RNA-seq may also help with determining the role of these genetic variants in
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S. pyogenes pathogenesis.
In contrast, when I applied existing association methods described above (plink and
DSK) to this S. pyogenes population dataset I found no sites significantly associated with
invasiveness. The CMH test (stratified by BAPS cluster) that uses SNPs called against
a reference sequence failed to identify the tetM gene and transposon as these elements
are not found in the reference sequence. Furthermore, the population structure of this
dataset is so diverse that 88 different BAPS clusters were found, which overcorrected for
population structure when using the DSK method, leaving too few samples within each
group to provide the power to discover associations.
2.7 Conclusions
SEER is a reference-independent, scalable pipeline capable of finding bacterial sequence
elements associated with a range of phenotypes while controlling for clonal population
structure. The sequence elements can be interpreted in terms of protein function using
sequence databases, and I have shown that even single causal variants can be fine-mapped
using the SEER output.
My use of all informative k-mers less than 100 bases long, a robust regression protocol
and the ability to analyse very large sample sizes showed improved sensitivity over existing
methods. This provides a generic approach capable of analysing the rapidly increasing
number of bacterial whole genome sequences linked with a range of different phenotypes.
The output can readily be used in a meta-analysis of sequence elements to facilitate the
combination of new studies with published data, increasing both discovery power and
confirming the significance of results.
As with all association methods, the approach is limited by the amount of recombination
and convergent evolution that occurs in the observed population, since the discovery of
causal sequence elements is principally constrained by the extent of LD. However, by
introducing improved computational scalability and statistical sensitivity SEER improved
on previous GWAS methods for answering important biologically and medically relevant
questions.
In subsequent chapters I will start by using the GWAS techniques developed here to
assess the contribution of bacterial variation to various stages of pneumococcal infection.
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3.1 Introduction
In chapter 2 I developed a method and piece of software to perform GWAS on bacterial
populations. The main test of SEER was finding known antibiotic resistance determinants.
These are one of the easiest GWASs to perform in bacteria, as the effect size of these
variants is so high (close to fully penetrant, hence the need to use Firth regression in some
cases) and the selection pressure over time has led to the causal variants being homoplasic
and broadly spread evenly across the population. In this chapter I test the method on a
phenotype likely to be polygenic in origin, with causal variants that are both population
stratified (lineage effects) and independent of population structure (locus effects) (Earle
et al., 2016).
S. pneumoniae spends most of the transmission cycle in the nasopharynx, and so
understanding and predicting the amount of time spent in this niche is critical for under-
standing this bacterium’s epidemiology, and therefore controlling transmission (Abdullahi
et al., 2012a; Melegaro et al., 2007). The nasopharynx is a complex niche in which
each pneumococcal genotype must tackle a wide range of factors including host immune
defence (McCool et al., 2002), other bacterial species (Pericone et al., 2000), and other
pneumococcal lineages (Auranen et al., 2010; Cobey & Lipsitch, 2012) in order to main-
tain the genotype’s population. The average nasopharyngeal duration period is therefore
affected by a large number of factors, which may, themselves, interact.
A major potential advantage of GWAS in bacteria is the ability to test association
with less well defined phenotypes, for example transmissibility (Nebenzahl-Guimaraes
et al., 2016), or phenotypes which would be difficult to test in a lab. Here I assess genetic
variation associated with pneumococcal carriage duration. Traditionally this would be
difficult to assess due to the complexity of the nasopharyngeal niche, and the length of
time experiments would need to be run for.
One factor that is known to strongly associate with carriage duration is serotype: as cap-
sular polysaccharides are important in bacterial physiology and determining host immune
response, different serotypes have different clearance and acquisition rates (Abdullahi
et al., 2012a; P. C. Hill et al., 2010; Ho¨gberg et al., 2007; Melegaro et al., 2007; P. Turner
et al., 2012). Additionally, a range of other proteins have been identified as critical to
the colonisation process (Kadioglu et al., 2008), some of which exhibit similar levels of
diversity to the capsule polysaccharide synthesis locus (Iannelli et al., 2002; Jedrzejas
et al., 2001). However, the overall and relative contributions of these sequence variations
to carriage rate have not yet been characterised. In addition variation of pathogen protein
sequence, accessory genes and interaction effects between genetic elements may also have
as yet unknown effects on carriage duration.
Changes in average carriage duration have been shown to be linked with recombination
rate (Chaguza et al., 2016), which has been found to correlate with antibiotic resistance
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(Hanage et al., 2009) and invasive potential (Chaguza et al., 2016). The carriage duration
by different serotypes is widely used in models of pneumococcal epidemiology, and
consequently is important in evaluating the efficacy of the PCV (Melegaro et al., 2007;
Weinberger, Harboe et al., 2011). Additionally, modelling work has proposed that if
alleles exist which alter carriage duration, these explain the long standing puzzle of how
antibiotic-resistant and sensitive strains stably coexist in the population (Lehtinen et al.,
2017). Measurement of carriage duration and the analysis of its variance beyond the
resolution of serotype will have important consequences for these models.
I sought to determine the overall importance of the pathogen genotype in carriage
duration in a human population, and to identify and quantify the elements of the genome
responsible for the variation in carriage duration using GWAS. By combining epidemi-
ological modelling of longitudinal swab data with and genome wide association study
methods on the connected sequences, I made heritability estimates for carriage duration.
I further partitioned the heritability into contributions from lineage and locus effects to
quantify the variation caused by each individual factor.
3.2 Ascertainment of carriage episode duration using epi-
demiological modelling
I first estimated carriage duration from longitudinal swab data available for the study
population. For 598 unvaccinated children up to 24 swabs taken over a two year period
were available. The study population was a subset of infants from the Maela longitudinal
birth cohort (C. Turner et al., 2013), and was split into two cohorts. In the ‘routine’
cohort, 364 infants were swabbed monthly from birth, 24 times in total. All swabs had
been cultured and serotyped using the latex sweep method (P. Turner et al., 2013). In the
‘immunology’ cohort 234 infants were swabbed on the same time schedule, but cultured
and serotyped following the World Health Organisation (WHO) method (P. Turner et al.,
2012). NT pneumococci had been confirmed by bile solubility, optochin susceptibility and
Omniserum Quellung negative.
I only considered swabs from infants in the study, as mothers did not have sufficient
sampling resolution relative to their average length of carriage to determine carriage
duration. Furthermore, the immune response of mothers to bacterial pathogens is different
to children (Maro´di, 2006), leading to shorter carriage durations (Gritzfeld et al., 2014).
To estimate carriage duration from the longitudinal swab data I constructed a set of
hidden Markov models (HMMs) with hidden states corresponding to whether a child was
carrying a serotype at a given time point, and observed states corresponding to whether a
positive swab was observed for this serotype at this time point. The most general model
for the swab data would be a vector with an entry of 0 or 1 for every possible serotype (of
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56 observed in the population), corresponding to whether each serotype was observed in
the swab at each time point. However, the number of parameters to estimate in this model
(with over 6 million states) is much larger than the number of data points (around 14000),
and in particular some serotypes have very few positive observations. Instead, I modelled
each serotype separately.
The models fitted, and their permitted transitions and emissions are shown in fig. 3.2.
In model one, observation i emits state 2 if positively swabbed for the serotype, and state
1 otherwise. The unobserved states correspond to the child ‘carrying’ and being ‘clear’
of the serotype respectively. I assumed swabs have a specificity of one, so do not show
positive culture when the child is clear of the carried serotype; I therefore set the coefficient
for the chance of observing positive culture when no bacteria are present to zero (e21 = 0
in the emission matrix). Model two added a third state of ‘multiple carriage’ which is
occupied when the serotype and at least one other are being carried. Both models were
compared with a version which allows the parameters to covary with whether the child has
carried pneumococcus previously. In model three I accounted for this explicitly by having
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Figure 3.2: HMMs of swab time series, and their goodness-of-fit. I fitted three different models to the
processed time-series data with states, allowed transitions and emissions as shown. I refitted each model
allowing the transitions probabilities to covary with the age of the child and whether the child had carried
pneumococcus previously. For the converged model the Akaike information criterion (AIC) is shown for the
original fit, and when including these covariates (AICcovar).
I modelled the time series of swab data using a continuous-time HMM, as implemented
in the R package msm (Jackson, 2011). Unobserved (true) states correspond to whether the
child is carrying bacteria in their nasopharynx, and observed (emitted) states correspond to
whether a positive swab was seen at each point. Transition probabilities between each state
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Q and the emission probabilities E were jointly estimated by maximum likelihood using
the BOBYQA algorithm. To get a good fit of the HMM, I normalised observation times for
each sample. Defining infant birth as t = 0, subsequent sampling times ti were measured
in days, and normalised to have a variance of one. I then constructed the most likely
path through the unobserved states for each child using the Viterbi algorithm (Forney,
1973) with the observed data and estimated model parameters. Assuming that continuous
occupation of the carried state corresponded to a single carriage episode, I calculated the
duration for each such episode from the inferred true states.
I applied all three models to 19F carriage episodes, as these had the most data available,
and calculated the AIC (Akaike, 1974) for each model that converged. Only the simplest
model (model one) converged, as judged by having a positive-definite Hessian and a
converged BOBYQA run. The more complex models had lower log-likelihoods: as
extensions of the simpler model they should have higher log-likelihoods, so this result
was not consistent with model convergence. I tried fitting models two and three using a
fixed false positive values slightly greater than zero: this lead to better log-likelihoods,
but the models still didn’t converge. This failure of the more complex models is probably
because most children in the study immediately enter the carrying state, and episodes of
dual carriage (when split up by serotype) are rare. Therefore there were not enough events
between these carriage states to estimate to the transition and emission intensities, without
sensitivity to initial conditions during the fitting.
I then fitted the best performing model in this test for all serotypes separately. Latex
sweeps could not differentiate 6A and 6C serotypes, so I treated these as a single serotype
(in WHO serotyping PCR was used to differentiate these serotypes, but I still combined
them for consistency across the two cohorts). 15B and 15C serotypes spontaneously
interconvert, so were combined. I also removed two duplicated swabs (08B09098 from the
immunology cohort; 09B02164 from the routine observation cohort). The models for 19F,
23F, 6A/C, 6B, 14 and NT converged, but other serotypes did not have enough observations
to successfully fit the parameters of the model. For these less prevalent serotypes I used the
transition and emission parameters from the 19F model fitted with the correct observations
when reconstructing the most likely route taken through the hidden states. I manually
inspected the results to ensure this did not cause systematic overestimation when compared
with previous studies.
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I found that the fit for NT swabs produced results which overestimated carriage duration
when compared to previously reported estimates. The best fit to the model overestimated
the e21 parameter, which measures the false negative rate of swabbing, in favour of reduced
transition intensities. I therefore fitted the model again, fixing this rate at 0.12. I based this
figure on non-typable S. pneumoniae abundance as defined by 16S survey sequencing. At
1% proportional abundance in the sample, 12% came out as culture negative (table 3.1).
Abundance Culture positive Number
>1% Cultured 361
>1% Not cultured 44
<1% Cultured 56
<1% Not cultured 54
Table 3.1: Success of culturing unencapsulated S. pneumoniae. Based on having >1% abundance of 16S
reads showing the bacteria as being present, 44/361 true positive swabs were not successfully cultured.
3.2.1 Combining epidemiological data with genomic data
From all the swab data, I estimated that there were a total of 4 382 carriage episodes (7.3
per child), of which 2 254 had a complete set of AMR data available (fig. 3.3). After
removing ten outlier observations (fig. A.3) from swabs taken accidentally during disease,
I was able to match 2 157 sequenced genomes with a carriage duration.
As I aimed to fit a multiple linear regression model to the carriage duration y against
binary lineage associated predictors, I first ensured the data was appropriate for this model.
The phenotype distribution was positively skewed, with an approximately exponential
distribution. Residuals were therefore non-normally distributed, potentially reducing power
(McCulloch, 2003). In the regression setting, a monotonic function can be applied to
transform the response variable to avoid this problem. I first took the natural logarithm of
the carriage duration
yˆ = ln(y)
which led to the residuals being much closer to being normally distributed (figs. 3.3
and A.2). I applied the same transformation to child age, when it was used as a covariate
in association. For association with a LMM I instead took a monotonic transform of the
carriage duration using warped-lmm (Fusi et al., 2014) to maximise the study’s power to
discover associations and estimate heritability (figs. A.1 and A.2). This used a sum over
three nonlinear step functions, plus a linear term, to transform the residuals into Gaussians
(Snelson et al., 2004).
For each isolate with an inferred carriage duration I extracted SNPs from the previously
generated alignment against the ATCC 700669 genome (Chewapreecha, Marttinen et al.,
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Figure 3.3: Distribution of carriage duration, and effect of monotonic transformation. Panel a) shows a
histogram of the inferred carriage duration, b) shows this result after the natural logarithm is taken, and c)
after the warping function is applied.
2014). Consequences of SNPs were annotated with VEP, using a manually prepared
reference (McLaren et al., 2010). I generated a phylogenetic tree from this alignment using
FastTree under the GTR+gamma model (M. N. Price et al., 2009). The carriage duration
was mapped on to this phylogeny using phytools (Revell, 2013). I then filtered the sites
in the alignment to remove any where the major allele was an ‘N’, any sites with a minor
allele frequency lower than 1%, and any sites where over 5% of calls were missing. This
left 115 210 sites for association testing and narrow-sense heritability estimation. I also
used the 68M non-redundant k-mers with lengths 9-100 from the de novo assemblies of
the genomes counted in section 2.2. I filtered out low frequency variants by removing any
k-mers with a minor allele frequency below 2%, leaving 17M for association testing.
3.3 Overall heritability of carriage duration is high
To recap section 1.3.2, the variation in carriage duration σ2P is partly caused by variance
in pneumococcal genetics, and variance in other potentially unknown factors such as
host age and host genetics. It is common to write this sum as two components: genetic
effects σ2G and environmental effects σ
2
E. The proportion of the overall variation which
can be explained by the genetics of the bacterium is known as the broad-sense heritability
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. Variants which are directly associated with carriage duration independently
of other variants (non-epistatic effects) contribute to the narrow-sense heritability h2, which
is smaller than the overall broad-sense heritability (Visscher et al., 2008).
H2 can be estimated by linear regression on the phenotype of donor-recipient pairs
which nearly share their genetics (Fraser et al., 2014). However in this dataset previous
work was only able to confidently identify five transmission events, which was not enough
to apply this method. Alternatively, analysis of variance of the phenotype between patho-
gens with similar genetics can be used to estimate heritability (T. J. C. Anderson et al.,
2010). By applying this to phylogenetically similar bacteria (fig. 3.4), I estimated broad
sense heritability H2 with the ANOVA-CPP method in the patherit R package (Mitov
& Stadler, 2016), using a patristic distance cutoff of 0.04 (fig. A.4). This estimated that
H2 = 0.634 (95% CI 0.592-0.686), implying that the genetics of S. pneumoniae is an
important factor in determining carriage duration in this population. If environmental
conditions are associated with streptococcal genotype between populations (such as host
vaccination status) the heritability estimate may differ.
A lower bound on h2 can be calculated by fitting a LMM through maximum likelihood
to common SNPs (h2SNP) (S. H. Lee et al., 2011; Manolio et al., 2009). I used the ‘GCTA’
model implemented in warped-lmm (Fusi et al., 2014) to estimate h2SNP for carriage
duration data, using the filtered SNPs and including child age and previous carriage as
covariates. This yielded an estimate of 0.445, consistent with the estimate for H2. I
also estimated h2SNP using LDAK (Speed et al., 2012) with default settings, which gave an
estimate of 0.437 (<1% difference from the warped-lmm estimate).
3.4 Lineage effects on carriage duration
After calculating the overall heritability, I wished to determine the amount that the specific
variation in the pathogen genome contributes to changing carriage duration. However the
strong LD present across the entire genome of S. pneumoniae, makes it difficult to pinpoint
variants associated with carriage duration and not just present in the background of longer
or shorter carried lineages (P. E. Chen & Shapiro, 2015). Serotype and antibiogram are
correlated with the overall genome sequence (Brueggemann et al., 2003; Chewapreecha,
Harris et al., 2014; Enright & Spratt, 1998), so if these factors are associated with carriage
duration, large sets of variants which define long-carried and short-carried lineages will be
correlated with carriage duration in a naive association test (P. E. Chen & Shapiro, 2015;
T. D. Read & Massey, 2014).
I use the distinction between variants which evolve convergently and affect a phenotype
independently of lineage – termed locus effects – to those which are collinear with a
genotype which is associated with the phenotype, termed lineage effects (Earle et al., 2016).
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Figure 3.4: Mapping of carriage duration onto phylogeny. Using the carriage duration as a continuous trait,
the ancestral state at every node of the rooted phylogeny was reconstructed. Red branches are carriage for a
short time, blue for a long time. Clusters identified in previous analysis have been labelled.
Locus effects may be associated with a change in carriage duration due to convergent
evolution (which may occur through recombination between lineages). In such regions,
the causal loci and corresponding phenotypic effects are easier to identify (Power et al.,
2016). The fixed effect model of SEER (chapter 2) or LMMs can be used to find these
variants which are associated with a bacterial phenotype independent of lineage; discovery
of homoplasic and polygenic variation associated with the phenotype across the entire tree
is well powered (Earle et al., 2016).
While the high heritability suggests many pathogen variants do affect carriage duration,
it does not give information on how many of these will be locus or lineage effects. I
mapped carriage duration onto the phylogeny, reconstructing the ancestral state at each
node. Consistent with the high heritability of carriage duration I found that carriage length
was clearly stratified by lineage (fig. 3.4): I calculated Pagel’s lambda as 0.56 (p < 10−10)
(Pagel, 1997). λ = 0 corresponds to a star-like tree, whereas λ = 1 is Brownian-motion
evolution of the trait. I also modelled the evolution of carriage duration along the tree using
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an Ornstein-Uhlenbeck model as implemented in patherit, and compared the likelihood
of the full fit to that with no genetic effect on the trait (σ2G = 0) using a LRT with one
degree of freedom. This also suggested that lineage genetics were significantly correlated
with the trait (LRT = 952; p < 10−10)
3.4.1 Serotype and drug resistance explain part of the narrow-sense
heritability
I first tested for the association of serotype with carriage duration using lasso regression
and with a LMM. Serotype is correlated with sequence type (Croucher, Harris, Fraser et al.,
2011) and has previously been associated with differences in carriage duration (Abdullahi
et al., 2012a; P. Turner et al., 2012). I also included resistance to six antibiotics, the causal
element to some of which are known to be associated with specific lineages (section 2.6.2) .
These are therefore possible lineage effects which would be unlikely to be found associated
under a model which adjusts for population structure.
Not all serotypes and resistances may have an effect on carriage duration, or there
may not be enough carriage episodes observed to reach significance. As including extra
predictors in a linear regression always increases the variance explained, I first performed
variable selection using lasso regression (Efron et al., 2004) to obtain a more reliable
estimate of the amount of variation explained. Where a resistance and serotype are
correlated and both associated with a change in carriage duration, this will produce a robust
selection of the predictors (Hebiri & Lederer, 2012).
I encoded all 56 observed serotypes (including NT) and phenotypic resistance to the
six antibiotics (chloramphenicol, β -lactams, clindamycin, erythromycin, trimethoprim
and tetracycline) as dummy variables. I used serotype 6A/C as the reference level, as this
had a mean carriage duration close to the grand mean in previous analysis. Orthogonal
polynomial coding was used for the latter four antibiotics, where resistance could be
intermediate or full. I then regressed this design matrix X against the transformed carriage
duration yˆ. I removed three observations with low carriage lengths due to a delayed initial
swab, and seven observations with leverages of one (fig. A.3).
I performed variable selection using lasso regression (Efron et al., 2004), implemented
in the R package glmnet (Friedman et al., 2010). I used leave-one-out cross-validation
to choose a value for the `1 penalty; the value one standard error above the minimum
cross-validated error (Tibshirani et al., 2001) was selected (λ = 0.033; fig. A.5). The 20
predictors with non-zero coefficients in the model at this value of λ were used in a linear
regression to calculate the multiple R2, which corresponds to the proportion of variance
explained by these predictors.
I also estimated the variance components from serotype and resistance using genomic
partitioning (J. Yang, Manolio et al., 2011), as implemented in LDAK. This estimates h2
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from a subset of the overall genetic loci, allowing for the heritability associated with a
particular region of the genome to be tested. I used SNPs in the capsule locus to calculate
a kinship matrix approximating the contribution from serotype variation. For antibiotic
resistance I used SNPs in the pbp genes, dyr gene and ICE transposon to calculate a kinship
matrix. Restricted maximum likelihood was used to estimate the variance explained by
each of these components.
The selected predictors and their effect on carriage duration are shown in table 3.2.
The total variance explained by these lineage factors was 0.19, 0.178 for serotype alone
and 0.092 for resistance alone. When I used genomic partitioning of variance components
these were instead estimated to be 0.253, 0.135 and 0.113, respectively. I applied the
covariance test (Lockhart et al., 2014) to determine which lineage effects were significantly
associated with carriage duration and found that 19F, erythromycin resistance, 23F, 6B
caused significant (α < 0.05) increase in carriage duration and being non-typable caused a
significant decrease.
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Table 3.2: Coefficients from lasso regression model of carriage duration. The mean (intercept) corresponds
to a sensitive 6A/C carriage episode, and different serotypes and resistances are perturbations about this
mean. Positive effects are expected to have a greater magnitude, due to the positive skew of carriage duration.
Rows in bold were significant predictors in the covariance test.
3.4.2 Independent effects of serotype and genetic background
Previous studies have used isogenic strains to look for effects of serotype of colonisation
and carriage duration independent of genetic background. Resistance to killing (Weinberger
et al., 2009), growth phenotype (Hathaway et al., 2012) and resistance to complement
(Melin et al., 2010) have all been shown to affect carriage through serotype rather than
genetic background. Conversely, some bacterial genetic variation has been shown to be
able to affect colonisation independent of serotype (Nadeem Khan et al., 2014).
I therefore wished to test whether the detected effect of serotype and resistance on
carriage duration was entirely mediated through their covariance with lineage, or whether
they are independently associated with carriage duration. I first looked for differences
in duration over three recent capsule gain/loss events; if there is an effect of serotype
independent of genetic background, these would be predicted have the largest difference
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between serotypes while controlling for the relatedness of isolates. Capsule switch events
had been previously identified by first reconstructing of the ancestral state of the serotype
at each node through maximum parsimony (Chewapreecha, Harris et al., 2014). For
each node involving loss or gain of the capsule, those with at least one child being a tip
were selected to find recent switches (all were capsule gain). The carriage duration of all
unencapsulated children (in the phylogenetic sense) of the identified node were used as
the null distribution to calculate an empirical p-value for the switched isolate. P-values
were combined using Fisher’s method (Rosenthal, 1978). No significant difference in
duration was seen between isolates with or without capsule within the same lineage (p =
0.39; fig. 3.5).
However, as these events were limited in number, assumed genetic independence within
the clade and occurred only in part of the population, I also performed the same regression
as above while also including lineage (defined by discrete population clusters) as a predictor.
This therefore allows serotypes which appear in different population clusters to distinguish
whether lineage or serotype had a greater effect on carriage duration. The covariance test
found that 19F, erythromycin resistance and being non-typable had significant effects on
the model (in that order). As these terms enter the model before any lineage specific effect,
this suggested these serotypes and resistances are associated with variation in carriage
duration independent of background genotype
This lasso-based analysis may be vulnerable to confounding from unmeasured variables
which may be associated with the explanatory variables (serotype and resistance). To fully
account for the effect of the bacterial genome rather than relying on discrete clusters as
covariates in the regression, I then performed regression of these lineage effects under a
LMM where the relatedness between strains was instead included as a random effect. The
predictors had the same order of significance, but only serotype 19F reached genome-wide
significance (p = 3.8×10−7).
Together, this suggested that the main lineage effect on carriage duration is the serotype,
but only some serotypes (19F) have an association independent of genetic background. I
also found that erythromycin resistance may be significantly associated with an increased
carriage duration. While being a relatively uncommon treatment in this setting (3% of
treatments captured), I did not find that other antibiotics were associated. This may
be because erythromycin resistance would be expected to cause an almost four order
magnitude increase in minimum inhibitory concentration (MIC), whereas other resistance
acquisitions have a much smaller effect.
3.4.3 Average carriage duration by serotype
Additionally, I calculated the mean sojourn times (average length of time children are
expected to remain in the carrying state of the model with the given serotype) and mean
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Figure 3.5: Change in carriage duration associated with capsule switching events. For each of the three
events analysed the subtree containing the switch is shown on the left. For each isolate within the subtree,
carriage duration (on a roughly exponential scale), warped carriage duration (on a roughly linear scale) and
serotype are shown as coloured bars aligned with the tip.
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number of carriage episodes from the fit to the HMM for commonly carried serotypes
(table 3.3), which gave results similar to the regression performed above. These estimates
are comparable to the previous analysis on a subset of these samples. The majority of
carriage episodes were due to five of the seven paediatric serotypes (Shapiro & Austrian,
1994), or non-typeable isolates. The results show 19F, 23F and 14 were carried the longest,
6A/C and 6B for intermediate lengths, and NT the shortest.







Table 3.3: Mean length of carriage, and expected number of carriage episodes within the first two years of
life. Only serotypes with enough data for the HMM fit to converge are shown. Starred observations have a
standard error which is larger than the estimated value, indicating low confidence in the estimate.
The overall picture of the first two years of infant carriage is one containing one or
two long (over 90 day) carriage episodes of a common serotype (6A/C, 6B, 14, 19F, 23F)
and around two short (under a month) carriage episodes of non-typable S. pneumoniae.
Colonisation by other serotypes seem to cause slightly shorter carriage episodes, though the
relative rarity of these events naturally limits the confidence in this inference. That some
serotypes are rarer and carried for shorter time periods may be evidence of competitive
exclusion (Hardin, 1960; Trzcin´ski et al., 2015), as fitter serotypes quickly replace less fit
serotypes thus leading to reduced carriage duration. The calculated mean carriage duration
of NT pneumococci is similar to the minimum resolution I was able to measure by the
study design, which suggests carriage episodes may actually be shorter than one month.
Unfortunately the only existing study with higher resolution did not check for colonisation
by NT pneumococci (Abdullahi et al., 2012a).
These estimates are similar to previous longitudinal studies in different populations
(P. C. Hill et al., 2010; Ho¨gberg et al., 2007; Melegaro et al., 2007), though against
the Kilifi study these estimates are systematically larger. This may be due to the lower
resolution swabbing we performed, or may be because the previous study was unable to
resolve multiple carriage (11% of positive swabs). While the heritability estimates are
specific to this population due to differences in host, vaccine deployment and transmission
dynamics, the similarity of the estimates of serotype effect to those from different study
populations suggests our results may be somewhat generalisable.
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3.5 Additional loci identified by genome-wide association
To search for locus effects I used the linear mixed model implemented in fast-lmm
(Lippert et al., 2011) to associate genetic elements with carriage duration, independent of
overall lineage effects. I used the warped phenotype as the response, the kinship matrix
(calculated from SNPs) as random effects, and variant presence, child age and previous
carriage as fixed effects. For SNPs I used a Bonferroni correction with α < 0.05 and
an N of 92 487 phylogenetically independent sites to derive a genome-wide significance
cutoff of p < 5.4×10−7, and a suggestive significance cutoff (Lander & Kruglyak, 1995;
Stranger et al., 2011) of p = 1.1× 10−4. I tested pairwise LD between the significant
SNPs by calculating the R2 between them. I removed those with R2 > 0.2, assuming these
represented the same underlying signal, to define the significant loci. For k-mers I counted
5 254 876 phylogenetically independent sites, giving a genome wide significance cutoff
of 9.5×10−9. I used blastn with default settings to map the significant k-mers to seven
reference genomes (ATCC 700669, INV104B, OXC141, SPNA45, Taiwan19F, TIGR4 and
NT 110 58), and the possible Tn916 sequences (Croucher, Harris, Fraser et al., 2011).
The results for SNPs are shown in fig. 3.6 and table 3.4, with 14 loci reaching suggestive
significance and two reaching genome-wide significance (top hit β = 0.17; p= 2.1×10−7;
MAF = 1%). I also found that 424 k-mers reached genome-wide significance (top hit
β = 0.11; p = 2.1×10−12; MAF = 2%), which I filtered to 321 k-mers over 20 bases long
to remove low specificity sequences (fig. A.7). To determine their function, I mapped these
k-mers to the coordinates of reference sequences.
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Co-ordinate Nearest annotation Effect size P-value Significance level
6753 trcF -0.12 6.2×10−5 Suggestive
254312 pepS -0.11 6.4×10−5 Suggestive
303239 IS630-Spn1 transposase 0.078 9.2×10−5 Suggestive
333632 pbp1a 0.079 2.5×10−5 Suggestive
971849 SPRITE repeat region 0.078 9.4×10−5 Suggestive




1308604 aroA -0.27 3.8×10−5 Suggestive
1472933 Upstream of fms -0.23 5.3×10−5 Suggestive
1473700 putative glutathione S-
transferase
-0.16 8.8×10−5 Suggestive
1515497 hypothetical phage pro-
tein
-0.099 5.2×10−5 Suggestive
1516293 putative phage Holliday
junction resolvase
-0.10 5.1×10−6 Suggestive
1516350 putative phage Holliday
junction resolvase
-0.12 2.1×10−7 Genome-wide sig-
nificant
1517063 phage protein -0.11 3.3×10−7 Genome-wide sig-
nificant




Table 3.4: SNP locus effects at genome-wide and suggestive significance. Co-ordinates are with respect to
the ATCC 700669 reference genome, and are for the lead SNP in each locus after LD-pruning. Effect sizes
are for the warped phenotype.
3.5.1 Prophage sequences associated with reduced carriage duration
The only genome-wide significant SNP hits are synonymous changes in the replication
module of the prophage in the ATCC 700669 genome (MAF = 1%), a highly variable
component of the pneumococcal genome (Croucher, Coupland et al., 2014) (fig. 3.7). The
LD structure suggested there were two separate significant signals found in this region. I
therefore performed another GWAS conditioning on the top hit (using it as a fixed effect
in the regression at other sites, and removing it from kinship estimation) to test if there
was a second independent signal, but found that the second hit in this region was no longer
significant (position 1526024; p = 2.2×10−4). The current data is therefore consistent
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with only a single significant hit to prophage.
The most significant k-mer hits were also located in phage sequence (MAF 2%) and
were associated with a reduced duration of carriage. As these mobile genetic elements
are less weakly population stratified than other regions of the genome, they are easier
to find as locus effects. The LD in this region is less than in the rest of the genome, as
prophage sequence is highly variable within S. pneumoniae lineages (Croucher, Coupland
et al., 2014). Multiple independent phage variants may therefore affect carriage duration,
which will increase their significance using a LMM. Indeed, the significant results from the
LMM (top SNP p = 2.1×10−7; top k-mer p = 2.1×10−12) are not significant (top SNP
p = 5.1× 10−6; top k-mer p = 5.7× 10−8) under a model of association using a linear
regression with the first 30 principal components as fixed effects to control for population
structure rather than random effects, and are strongly associated with the population
structure components of the model (highest association p = 5.2× 10−75 with principal
component 2).
I first postulated that presence of any phage in the genome may cause a reduction in
carriage duration. I identified the presence of phage by performing a blastn of the de
novo assemblies against a reference database of phage sequence (Croucher et al., 2016).
If the length of the top hit was over 5000 I defined the isolate as having phage present
(fig. A.6). I then used the presence of phage as a trait under the same linear mixed model,
however I found no evidence of association when correcting for population structure (p =
0.35). These results are therefore evidence that infection with a specific phage sequence is
associated with a slight decrease in carriage duration. A similar result has previously been
found in a genome-wide screen in N. meningitidis, where a specific phage sequence was
found to affect the virulence and epidemiology of strains (Bille et al., 2005; Bille et al.,
2008). Additionally, previous in vivo tests have shown phage elements to cause a fitness
decrease of S. pneumoniae during carriage (DeBardeleben et al., 2014).
The genetic polymorphisms in the prophage associated with changes in carriage dur-
ation, found in 2% of viral sequences, were within coding sequences inside the phage
replication module (Romero et al., 2009). It is unlikely the specific variants of these
proteins cause a significant difference in phenotype, because they are only highly ex-
pressed after the prophage is activated, and cell lysis usually happens shortly afterwards.
One explanation for these results is that some subpopulations of prophage do not cause
a significant decrease in their host bacterium’s carriage duration, which could be due
to beneficial ‘cargo’ genes. However previous surveys of pneumococcal prophage have
found little evidence of these elements carrying such sequences (Croucher, Coupland et al.,
2014; Romero et al., 2009). One phage protein that has been found to alter the bacterial
phenotype is PblB, a phage structural protein that can also mediate bacterial adhesion to
platelets (Loeffler & Fischetti, 2006). However, pblB is within the morphology module
(Romero et al., 2009) and as an adhesin might if anything be expected to increase carriage
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Figure 3.7: Manhattan plots of phage-associated SNPs associated with carriage duration. As in fig. 3.6,
but enlarging the phage region found to be significant. SNPs are coloured by their LD with the lead SNP
(the highest P-value in the region plotted), and are crosses if they are predicted to cause a change in coding
sequence. Panel a) shows LD in relation to the lead SNP at position 1516350. Panel b) plots genes in the
region, with the start and end of the phage genes labelled. Panel c) shows LD in relation to the second SNP
signal at position 1517063.
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duration, and was not detected in the association analysis. Hence the detected association
is unlikely to represent expression of viral machinery or cargo genes in the host cell while
the prophage is dormant.
Alternatively, the association with only a subset of prophage may have been a con-
sequence of the study sampling design. Using a monthly swabbing approach, it was only
possible to infer changes in the carriage duration of genotypes that colonise hosts for
relative long periods. Therefore any prophage variant that enhances a virus’ ability to
infect long carriage duration pneumococci may have an increased association with the
variation in the observed phenotype. As phage commonly exhibit high levels of strain
specificity (Duplessis & Moineau, 2001), this is a plausible mechanism, although the role
of the replication module in such host preference is unclear.
An additional mechanism by which prophage can affect host phenotype is by inserting
into, and thereby disrupting, functional genes. Pneumococcal prophage frequently insert
into comYC, thereby preventing the host cell undergoing transformation (Croucher, Harris,
Fraser et al., 2011; Croucher, Hanage et al., 2014). Using previous categorisation of
the comYC gene in this collection into intact versus interrupted or missing (Croucher
et al., 2016), I found that having an intact comYC gene (23% of isolates) was significantly
associated with an increased carriage duration (β = 0.29; p = 1.4× 10−44). The effect
size is similar to the associated phage k-mers, but has at a higher allele frequency (hence
the increased significance of the result). An interpretation consistent with these findings
would be that the effect of phage k-mers is actually through interrupting comYC. The
k-mers themselves were spread out to lower frequencies due to their sequence variability,
and none of the references I used allowed mapping to find the comYC interruption directly.
3.5.2 Other loci associated with altered carriage duration
Signals at the suggestive level included pbp1a and pbp2b, which suggested as above that
penicillin resistance may slightly increase carriage duration, but there are not enough
samples in this analysis to confirm or refute this. Other signals near genes at a suggest-
ive level included SNPs in trcF (transcription coupled DNA repair), padR (repressor of
phenolic acid stress response), pepS (aminopeptidase), aroA (aromatic amino acid syn-
thesis), fms (peptide deformylase) and a thioesterase superfamily protein. K-mers from
erythromycin resistance genes (ermB, mel, mef ) were expected to reach significance from
the above analysis, but did not: however I showed in section 2.6.2 that the power to detect
these elements in a larger sample set taken from the same population is limited due to the
multiple resistance mechanisms and stratification of resistance with lineage.
The test statistic from fast-lmm roughly followed the null-hypothesis, with the excep-
tion of the significant phage k-mers (fig. A.8). However there is limited power to detect
effects associated with both the lineage and phenotype. This effect has been previously
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noted, and while LMMs have improved power for detecting locus specific effects they
lose power when detecting associated variants which segregate with background genotype
(Earle et al., 2016). To search for candidate regions which may be independently associated
with both a lineage and increased carriage duration, I ran an association test with SEER
(chapter 2) using a set number of fixed effects as the population structure correction. In
this case I used the patristic distances from the phylogenetic tree as the kinship matrix,
which I then projected into 30 dimensions using metric multidimensional scaling to obtain
covariates. This may be expected to have higher power than an LMM for true associated
variants on ancestral branches as some association with population structure is permit-
ted, but will also increase the number of false positives (variants co-occurring on these
branches which do not directly affect the carriage duration themselves). To reduce the
number of false positives I used a strict threshold of p < 10−14. I separately tested SNPs
for their association with those principal components which were themselves significantly
associated with carriage duration, and therefore may be driving the lineage associations
using the model of Earle et al. (2016).
The most highly associated SNPs were in all three pbp regions associated with β -
lactam resistance, the capsule locus, recA (DNA repair and homologous recombination),
bgaA (beta-galactosidase), phoH-like protein (phosphate starvation-inducible protein),
ftsZ (cell division protein) and groEL (chaperonin). As 19F, the serotype most associated
with carriage duration, is predominantly the β -lactam resistant PMEN14 lineage the pbp
association may be driven through strong LD between with this serotype. Figure A.9
shows the analysis of SNPs which may be driving significant lineage associations – this
also suggested dnaB (DNA replication) may be associated with altered carriage duration.
Associated k-mers were also found in phtD (host cell surface adhesion), mraY (cell wall
biosynthesis), tlyA (rRNA methylase), zinT (zinc recruitment), adcA (zinc recruitment)
and recJ (DNA repair). Additionally I found k-mers in the bacteriocin blpZ and immunity
protein pncM (Bogaardt et al., 2015) to be associated with variability in carriage duration.
This could be evidence that intra-strain competition occurs within host via this mechanism,
consistent with previous in vitro mouse models (Dawid et al., 2007).
It is not possible to determine whether variation in these genes is associated with
a change in carriage duration or if the variation is present in longer carried, generally
more prevalent lineages. For example, β -lactam resistance may appear associated as the
long carried lineages 19F (dominated by PMEN14, as noted above) and 23F are more
frequently resistant, or it may genuinely provide an advantage in the nasopharynx that
extends carriage duration independent of other factors. Future studies of carriage duration,
or further experimental evidence will be needed to determine which is the case for these
regions.
Antigenic variation in known regions (of pspA, pspC, zmpA or zmpB) may be expected
to cause a change in carriage duration (Lipsitch & O’Hagan, 2007), however I did not find
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any of these to be associated with a change in carriage duration. This was likely due to
stratification of variation in these regions with lineage, but may also be caused by a larger
diversity of k-mers in the region reducing power to detect an association.
3.6 Child age independently affects variance in carriage
duration
Finally, I wished to determine the importance of two environmental factors which are
known to contribute to variance in this phenotype: child age and whether the carriage
episode is the first the child has been exposed to (Abdullahi et al., 2012a, 2012b; P. Turner
et al., 2012). These have been applied throughout the analysis as covariates, both in the


























Figure 3.8: Predicted mean carriage duration as a function of child age. Fit is an exponential decay over the
first two years of life, using the decay rate inferred from a linear regression of log(carriage duration).
I applied linear regression to these factors while using the first 30 PCs to correct for
the effect of the bacterial genome, which showed they were both significantly associated
with carriage duration as expected (age p = 3.9×10−7; previous carriage p = 2.5×10−8).
Using the linear mixed model to control for bacterial genotype both factors were again
significant (LRT = 26.4; p = 1.8×10−6). Together, they explained 0.046 of variation in
carriage duration. As found previously, increasing child age contributes to a decrease in
the duration of carriage episodes. From a mean of 68 days long, I calculated a drop of 19
days after a year, and 32 days after two years. Extrapolating, this causes carriage episodes
longer than two days to cease by age 11 (fig. 3.8). Previous carriage of any serotype was
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estimated to cause an increase in the duration of future carriage episodes, though previous
studies have found no overall effect (Weinberger et al., 2008). It has previously been
shown that prior exposure to non-typables in this cohort make colonisation by another
non-typable occur later, and for a shorter time (P. Turner et al., 2012). The positive effect
observed in this analysis is therefore likely to be an artefact due to subsequent carriage
episodes being more likely to be due to typable pneumococci.
Additional environmental factors that explain some of the remainder of the variance
may include the variation of the host immune response and interaction with other infections
or co-colonisation. In particular, co-infection with influenza A was not recorded but
is known to affect population dynamics within the nasopharynx (Kono et al., 2016).
Fundamentally, imprecise inference of the carriage duration will limit the ability to fully
explain its variance here.
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3.7 Conclusions
Other than serotype, the genetic determinants of pneumococcal carriage duration were
previously unknown. By developing models for longitudinal swab data and combining
the results with whole genome sequence data I have quantified and mapped the genetic
contribution to the carriage duration of S. pneumoniae. I found that despite a range of other
factors such as host age which are known to cause carriage duration to differ, sequence
variation of the pneumococcal genome explains most of this variability (63%). Common
serotypes and resistance to erythromycin caused some of this effect (19% total), as does the
presence or absence of particular prophage sequence in the genome. Table 3.5 summarises
the sources I found to be significantly associated with variation in carriage duration.
Source of which is Total variance explained Proportion of total
heritability explained
Total heritability (H2) 0.634 (CPP) 1.00
Common SNP heritability (h2SNP) 0.438 (LMM) 0.691
Serotype and resistance 0.190 (R2) 0.300 (R2)
0.253 (LMM) 0.399 (LMM)
Serotype only 0.178 (R2) 0.281 (R2)
0.135 (LMM) 0.213 (LMM)
Resistance only 0.092 (R2) 0.145 (R2)
0.113 (LMM) 0.178 (LMM)
Phage k-mers 0.067 (LMM) 0.106
Intact comYC 0.127 (LMM) 0.201
Measured environmental Age and previous carriage 0.046 (R2) -
effects
Table 3.5: Summary of variance of carriage duration explained by genetic and environmental factors. H2
encompasses all rows, other than the measured environmental effects. For each variant component the
method used to estimate it is reported: CPP - closest phylogenetic pairs; LMM - variance component using a
linear mixed model with pathogen genotype as random effects; R2 - linear regression using lasso to select
predictors.
I have provided a quantitative estimate of how closely transmission pairs share their
carriage duration, and show evidence for differences both between and within serotypes.
The implication of phage as having a significant effect on carriage duration has interesting
corollaries on pneumococcal genome diversification through frequent infection and loss of
prophage, even during carriage episodes in this dataset.
Investigating a mechanism for the prophage association, I found that having an intact
comYC gene, which is frequently interrupted by prophage causing loss of function of
the competence system, was associated with increased carriage duration. While the
competence system is observed to remain intact over the evolutionary history of the
species, these disruptive mutations spread irreversibly through the population as competent
bacteria can acquire the mutation, and non-competent bacteria can no longer reverse it
through recombination (Croucher, Hanage et al., 2014). Selection must therefore maintain
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the function at this locus over short timescales, and an increased carriage duration may
be evidence of this. I therefore hypothesise that the associated prophage sequences may
haved affected carriage duration through disruption of the competence system.
The results presented here have important implications for the modelling of pneumo-
coccal transmission and their response to perturbation of the population by vaccine. Im-
portantly, the analysis of heritability shows that variants other than serotype affect carriage
duration, consistent with recent theoretical work (Lehtinen et al., 2017). Here I have shown
that these alleles do exist in a natural population, and also identified candidates for the loci
which fulfil this role. Together these studies suggest that variants exist in the pneumococcal
genome which alter carriage duration, which in turn is linked to antibiotic resistance.
I was not able to fully explain the basis for heritability of carriage duration for a
number of reasons. The close association of the phenotype with lineage limited our power
to fine-map lineage associated variants other than capsule type which may affect carriage
duration. Meta-analysis with more large studies with higher resolution may help to resolve
these issues. Additional environmental factors that explain some of the remainder of the
variance may include the variation of the host immune response and interaction with other
infections or co-colonisation. In particular, co-infection with influenza A was not recorded
but is known to affect population dynamics within the nasopharynx (Kono et al., 2016).
This is a phenotype which would have been difficult to assay by traditional methods
such as in an animal model due to the cohort size needed and the length of time experiments
would need to be run for. By using GWAS I have been able to quantitatively investigate a
complex phenotype in a natural population. This chapter has also advanced the application
of GWAS methods applied to bacteria started in chapter 2 by application to a more
difficult to define phenotype, introducing heritability and genomic partitioning, and testing
specifically for locus effects. I have also implicitly compared fixed effect and random effect
models to control for population structure. In the next chapter I will continue using these
approaches to identify pneumococcal genetic variation associated with bacterial meningitis,
while developing a more thorough catalogue of variation within the pneumococcal genome.
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4.1 Introduction
This chapter deals with the contribution of variation in the pathogen genome to bacterial
meningitis. Using a GWAS framework, I first wished to test whether any variation in
the pneumococcal genome is associated with susceptibility to meningitis or with a poor
outcome of the infection. To study this, I used isolates collected as part of the MeninGene
study (section 1.1.4). This part of the study consists of 3 089 pathogen isolates from the
culture-proven cases of bacterial meningitis from the Netherlands. DNA was extracted
from CSF and blood cultures and sequenced with 100bp paired end reads on the Illumina
HiSeq platform. Of these sequences, 1 984 were S. pneumoniae. 751 carriage genomes
from Dutch adults and children were also sequenced to use as controls for susceptibility
analysis.
I first catalogued all forms of variation to use as the loci to test in a GWAS (section 4.3).
While k-mers cover most of this variation, I also included tests of SNPs and genes due to
their more straightforward interpretation. Some forms of variation such as inverting repeats,
CNVs, recombinogenic antigens cannot be captured by these methods, so I developed new
techniques to call variants at these loci. While this covered all forms of common variation
detectable by short reads in the pneumococcal genome, rare variants may also play a role
in disease pathogenesis. I annotated the predicted effect of rare coding variants to choose
which to use in burden tests.
Using the SNP variation to tag other forms of variation in the genome, I was able to
estimate the heritability of each of these traits (the proportion of variance in the phenotype
is explained by variation within the genome). Finding evidence for pneumococcal genetic
variants contributing to invasiveness other than serotype, I then used the methods presented
in chapters 2 and 3 to test whether any of the specific variants that I called were associated
with susceptibility to or severity of meningitis.
Section 4.5 concerns pathogen variation that occurs over the course of a single infection.
Croucher, Mitchell et al. (2013) have previously shown that in a single patient bacteria
appeared to adapt to the distinct conditions of blood and CSF. These are very different
niches from that of nasopharyngeal carriage where this variation is well documented
(Cremers et al., 2014), not least because the bacteria are exposed to different immune
pressures (Habets et al., 2012) and have less time over which to accumulate mutations.
It is possible that bacteria inhabiting the nasopharynx are already well adapted for CSF
invasion. However, genetic variants that enable invasion of the CSF are not expected to
be under positive selection, since invasion is an evolutionary dead end for the bacterium.
Studies of carriage alone will therefore be unable to detect selection during invasion.
Current knowledge on within-host variation during invasive disease is mostly focused at
the serotype and MLST level, and lacks the resolution and sample size to be able to address
this question (Brueggemann et al., 2003; del Amo et al., 2015; D. A. Robinson et al., 2001).
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Though the only whole genome based study suggests there is no difference between blood
and CSF populations (at the gene level) in S. pneumoniae (Kulohoma et al., 2015), larger
sample sizes are needed to better answer this question.
I therefore wished to expand the analysis of Croucher, Mitchell et al. (2013) by
including more cases of disease, and used 938 pairs of genomes from the blood and the
CSF of the same patient, and 54 pairs from the nasopharynx and CSF of the same patient
sequenced as part of the MeninGene study described above. This sample set included both
N. meningitidis isolates and S. pneumoniae isolates, each of which was analysed separately.
As isolate pairs are matched they are closely related; the issue of population structure
affecting bacterial GWAS is no longer a problem. Variants between pairs can be grouped
by functional effect and tested for association with a niche straightforwardly.
4.2 Quality control and processing
In this section I discuss initial QC of isolates in the collection, and evaluations of both
assembly and variant calling software to be used throughout the chapter.
Using a single S. pneumoniae isolate, I compared the quality of three assembly methods
that have previously been shown to perform well on bacterial genomes (Magoc et al., 2013):
Velvet (Zerbino & Birney, 2008), SPAdes (Bankevich et al., 2012) and SOAPdenovo2 &
MaSuRCA (Zimin et al., 2013). Statistics from this comparison are shown in table 4.1.
I decided that the SPAdes pipeline provided good quality assemblies while being easy
to run, so assembled all isolates in the collection with v3.5 of the software using default
settings. Additionally I ran velvet on all samples, which when k-mer length is optimised
and scaffolds are improved, gave similar results to SPAdes. I corrected the resulting velvet
assemblies with SSpace and GapFiller (Page et al., 2016). The assembly result used for
each purpose will be stated throughout the rest of the thesis.
Velvet SPAdes SOAPdenovo2 & MaSuRCA
# contigs 48 7 7
Total length 2 096 048 2 205 585 2 139 022
N50 77 648 429 779 481 453
# genes 2 073 2 208 2 166
CPU time 6 h 7.2 h 5.5 h
Maximum memory 3.7 GB 7.0 GB 4.3 GB
Disk space 0.1 GB 0.6 GB 4.2 GB
Table 4.1: Assembly and annotation of S. pneumoniae isolate 11822 8 30. N50 is the median contig length.
For each performance metric the best scoring method is in bold.
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I then analysed the quality of the SPAdes assemblies using quast (Gurevich et al.,
2013) and kraken (Wood & Salzberg, 2014). I performed this analysis at the sample level,
rather than at the contig level. As the primary aim is a GWAS I desired complete and
comparable assemblies, so the number of included samples at each variant is the same. I
found two assemblies which were predominantly another species, and discarded them. I
also discarded five sequence runs with low yield, 17 with total lengths over 2.5Mb, two
with total lengths under 1.8Mb and one with a GC content of 31.4%. This left 1 144 CSF
isolates and 674 pairs of blood and CSF isolates for downstream analysis. For the carriage
samples I removed 29 isolates contaminated with another species (determined by kraken,
and the position on a preliminary core gene alignment phylogeny), and 8 isolates which
showed evidence of being mixed samples (number of heterozygous SNPs in preliminary
mapping was greater than two standard deviations above the mean). This left 693 carriage
isolates for downstream analysis.
To compare variant calling methods I produced a set of true variant calls for 30 samples.
I did this by simulating evolution of S. pneumoniae genomes along the branch of the tree
between S. pneumoniae R6 (Hoskins et al., 2001) and the common ancestor with S. mitis
B6 (Denapaite et al., 2010). The rates in the GTR matrix and insertion/deletion frequency
distributions were estimated as in section 2.3.1. I created an average of 10 000 mutations
with these rates, and Illumina paired end read data at 200x coverage simulated using pIRS
(Hu et al., 2012).
Method True positives False negatives False positives
bcftools 24922 900 244
freebayes 22253 3569 1465
GATK 25024 798 191
Table 4.2: Performance of variant calling algorithms on simulated data. True positives are SNPs or INDELs
correctly called; false negatives are variant sites which were missed by the caller; false positives are sites
without variation but called as a variant.
I mapped the reads with bwa-mem (H. Li, 2013), followed by samtools fixmate, sort
and markdup. I then called variants using bcftools, freebayes (Garrison & Marth, 2012)
and GATK (Van der Auwera et al., 2002). The results are shown in table 4.2. freebayes
performed poorly due to its use on multiple nucleotide polymorphism (MNP)s, which were
difficult to compare to the simulations. GATK performed the best on all measures, and
in particular achieved much better power at calling indels. I used it for calling SNPs and
indels throughout, unless otherwise stated.
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4.3 Catalogue of all pneumococcal variation
In this section I detail how I catalogued population level variation in the pneumococcal
genome. These variants are then used throughout the rest of this chapter as the predictor
variable in GWAS with various phenotypes of interest, analysis of within-host variation and
in chapter 5 as the phenotype in a genome to genome analysis. As discussed in section 2.2,
variation in bacterial genomes is not well represented by short changes compared to a
linear reference due to extensive variation of the accessory genome (Donati et al., 2010;
McInerney et al., 2017), mosaic alleles created by recombination (Hanage et al., 2009),
structural variation (Croucher, Coupland et al., 2014; Manso et al., 2014) and copy number
variation (Howden et al., 2015). I used different techniques to determine the variation
present in each sample from each of these sources to ensure maximum discovery power of
the GWAS performed.
While short variants (i.e. SNPs and small indels) with respect to a single linear
reference only partially covers the variation present in the pneumococcal population, it
is still a useful dataset to produce. A genome alignment produced this way can be used
to generate the phylogenetic relationship between all samples from the population and
create discrete related clusters. Both of these are useful for QC, heritability analysis
and evaluating population structure. Additionally, the effect of these variants on protein
function can be straightforwardly predicted, making conclusions drawn from them more
easily interpreted and also of use in indirect tests of association section 4.4.2.
I produced a whole genome alignment in two ways. Firstly I mapped reads to the
ATCC 700669 reference using bwa mem with default settings
bwa mem r e f e r e n c e . f a f o r w a r d r e a d s . f a s t q r e v e r s e r e a d s .
f a s t q | s a m t o o l s f i x m a t e −O bam − > o u t p u t . bam
and finally marked duplicate reads in these binary sequence alignment/map (BAM) files
using Picard. I then called variants from each of these BAM files separately using samtools
mpileup and bcftools call, and as a population using GATK HaplotypeCaller. I then applied
hard quality filters to each of these call sets to create initial calls. To select variants based
on a correctly scaled sensitivity and specificity I used GATK VariantRecalibrator to scale
the variant quality scores. This tool requires known true positive calls as a prior – I used the
intersection of hard filtered variants from GATK and bcftools with 90% confidence (Q10),
and filtered variants from the Maela and Massachusetts studies with 68% confidence (Q5)
as recommended. After recalibration, I applied 99.9% power as the cut-off for variants to
maximise sensitivity at this stage. Finally, I annotated the predicted consequence of all
passing variants with variant effect predictor (VEP) (McLaren et al., 2010).
I also produced a core-genome alignment using roary (Page et al., 2015) with a 95%
blast ID cut-off. Roary efficiently performs all by all alignment using every annotated
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protein in the dataset. Those matches with over 95% ID are assumed to be orthologs
and are clustered and undergo multiple sequence alignment. Using a single cut-off will
mean that some genes with orthologous function but without sequence homology (for
example different alleles of a gene) will not be clustered together, and that some genes
without orthologous function but with sequence homology will be incorrectly clustered.
We chose the cut-off of 95% based on having the best balanced accuracy of these two error
classes when using reciprocal best BLAST hits to define true orthologs (Ward & Moreno-
Hagelsieb, 2014). As well as core genes (present in at least 99% of samples) roary also
clusters accessory genes into COGs, which I later used as a variant in association. In this
case the annotated function helped determine whether the cluster is showing presence or
absence of gene or groups of different alleles of a gene that is being tested for association.
I counted k-mers using fsm-lite (section 2.2), which required 75Gb RAM and 14hrs
CPU time to count all informative k-mers with a minor allele count (MAC) of ten or more.
In this sample set there were 11.7M informative k-mers with 2.6M unique patterns. I
called CNVs from the BAM files produced above using cn.mops (Klambauer et al., 2012)
which fitted the coverage of mapped reads in 1kb windows with a mixture of Poisson
distributions, and determined the most likely integer coverage value for each sample in
each window. I extracted the inferred copy number from those windows which had support
for a CNV from more than one sample.
4.3.1 Allelic variation of three pneumococcal antigens
I wished to determine whether sequence variation of pneumococcal antigens is associated
with virulence and disease outcome. As well as being plausible GWAS hits, these antigens
vary rapidly (Croucher, Vernikos et al., 2011), meaning sequence variation is not popula-
tion stratified, which increases discovery power. Conversely, while the k-mer approach
(section 2.2) either directly assays or indirectly tags most variation in the population,
variation of these antigens may not be captured by this method. For example, pspC can
be difficult to assemble due to repeats and copy number variation (Iannelli et al., 2002),
and therefore k-mers from the gene sequence will not appear in the assembly, and not be
counted or tested. In pspA and zmpA, mapping of k-mers may not be specific to the allele
sequence due to sequence homology with orthologous and paralogous genes (Hollingshead
et al., 2000; Bek-Thomsen et al., 2012).
Here I consider pspC/cbpA, pspA and zmpA, which have all been shown to have
interactions with the host immune system (Croucher et al., 2017), but have variability
that may not be assessed by the methods discussed above. I needed to develop a way
first to classify possible alleles, then determine the allele of each sample from short read
sequence data. For the latter issue, de novo assembly (followed by a BLAST with a set
of reference alleles) is unreliable for completely reconstructing the gene sequences, but
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usually contained some information about the allele present. Alternatively mapping the
sequence reads to a set of reference alleles is less affected by repeat sequences and may be
more accurately used to find the allele of genes (Inouye et al., 2014), but determining the
closest match is non-trivial. I decided to use a method which combines summary statistics
from both of these techniques to determine the allele type. This has previously shown to
be advantageous for antibiotic resistance typing from genomic data; Hunt et al. (2017)
designed a method using combination of assembly and mapping which had improved type
I and type II error rate over either technique alone.
I defer discussion of the variability and construction of a reference panel specific to
each of these alleles until the sections below, and first discuss the typing method I applied
to determine the allele of all three antigens given such a reference panel. I first generated
statistics from the assemblies of all samples by running blastp between the annotated genes
in both the velvet and SPAdes assemblies and the reference panel. From this, I extracted
the % ID, number of mismatches, number of gaps, E-value and bitscore between the two
assemblies of sample and every possible reference. For mapping I used srst2 (Inouye et al.,
2014) in a mode which maps reads to all reference sequences, and reports information
about coverage over every possible allele. I used the coverage, number of SNP mismatches,
number of indel mismatches and number of truncated bases.
This led to a data frame with 16 predictors for every reference sequence, per sample
(for example pspC had 48 references, so there were 768 predictors). When a match was
not reported by blastp or srst2 I filled in value with the minimum reported value of the
predictor (or maximum for the number of mismatch fields), and removed predictors without
variation.
To produce labelled training data I performed the same process on the reference panel
itself, for each sequence using blastp against all the reference sequences and srst2 with
simulated reads (these were error-free 100bp reads with 200x coverage and 350bp insert
size with 80bp standard deviation (s.d.)). In all cases, on the test data simple variance
analysis showed these statistics could be used to predict classification of alleles successfully
(fig. A.13). I fitted a classifier to this training data (see section 4.3.1 for details), then finally
used the trained model to predict the allele for all samples. The results are shown in fig. 4.1.
As expected, all the antigens show some, but not total, concordance with background
genotype. I used the above process for typing all antigens; I now discuss the specifics of
constructing the reference panel for each antigen.
pspC/cbpA allele
The pspC gene, also known as cbpA, hic, spsA or pbcA, is paralogous to pspA and is known
to have a number of immunogenic functions. These include binding host proteins C3, CFH
and IgA, all of which are involved in the immune response to pneumococcal colonisation
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Figure 4.1: The inferred allele of pneumococcal antigens zmpA, pspA and pspC. Left: phylogenetic tree of
CSF isolates. Right: tips coloured by the inferred allele for three antigens, and key. The first two columns
are alleles 1–6 and 7–11 of pspC, which may have two copies present (Iannelli et al., 2002).
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Figure 4.2: Pictographic alignment of the two forms of PspC, as in Iannelli et al. (2002). The top shows
cbpA-5; all alleles cbpA 1-6 have a choline anchor, and otherwise vary in their α helix content. The bottom
shows pspC-7; all alleles pspC 7-11 have an LPXTG anchor instead of a choline anchor.
(Brooks-Walter et al., 1999). The locus encoding PspC varies extensively, and two main
forms exist (fig. 4.2) which are distinguished by having a choline anchor (alleles 1-6) or
a LPXTG anchor (alleles 7-11) (Iannelli et al., 2002). Each genome may encode neither,
one or both of these forms and they are normally found in tandem.
I used the existing classification of 11 alleles described by Iannelli et al. (2002), and the
48 sequences reported by these authors (fig. A.10). To allow for the fact that each of the two
forms may be present or absent I trained two classifiers. The first, referred to as the cbpA
allele, used alleles 1–6 and treated 7–11 as missing. The second, referred to as the pspC
allele, used alleles 7–11 and treated 1–6 as missing. Though there was correlation between
the two allele types (for example 4 and 10 were more likely to co-occur) I trained the
two classifiers independently. I first checked whether the reference data could distinguish
between the labels using PCA, and then predicted two different alleles for each sample.
I tried four different ‘out of the box’ classifiers: support vector machine (SVM) with a
linear kernel, weighted k-nearest neighbours, random forests and DAPC (Jombart et al.,
2010). I inspected the statistics and annotations to manually assign the allele pair for 25
genomes from across the tree, then using these truth values and compared the classification
accuracy of each method. Table 4.3 shows that the SVM performed best; I used it for all
four classifiers. Inspection of the feature importance showed the blastp bitscore, E-value,
and number of mismatches as well as the srst2 number of truncated bases and number of






Table 4.3: Comparison of classifiers of antigen alleles. The balanced accuracy is given by the average of
1
2 (sensitivity+ specificity) for all alleles.
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pspA and zmpA alleles
PspA is a well studied pneumococcal antigen (Crain et al., 1990) which binds C3 (Tu et al.,
1999) and lactoferrin (Shaper et al., 2004). Its locus is involved in both ancestral and recent
recombination events which has created variation at the locus (Hollingshead et al., 2000;
Croucher, Harris, Fraser et al., 2011). ZmpA, also known as Iga, is a zinc metalloprotease
which cleaves IgA molecules (Wani et al., 1996). Similarly to pspA, the sequence is
variable within the population and is under diversifying selection (Bek-Thomsen et al.,
2012).
Croucher et al. (2017) have manually created clusters of sequences for both of these
antigens using 616 carriage genomes (Croucher, Finkelstein et al., 2013). Sequences were
combined into the same allele if their translated sequence was identical, giving 39 possible
sequences for pspA and 18 possible sequences for zmpA. I used these sequences as the
reference panel for each allele.
Unlike pspC where sequences had been further clustered based on functional domains
by Iannelli et al. (2002), this reference panel contained very similar sequences with different
allele labels. Using this directly for GWAS would lead to low power as the number of
sequences with each allele would be very small, and the classification would also likely
be poor due to the relative paucity of reference data for each allele. To avoid this I used
the phylogentic relationship between sequences to clustered similar sequences into allele
groups before training each classifier.
For both antigens I aligned the reference panel of amino acid sequences using MUSCLE
(Edgar, 2004), and built a phylogeny with RAxML with a CAT+GAMMA model. To test
the robustness of these phylogenies I ran 100 maximum-likelihood bootstrap replicates,
and 106 mrbayes Markov-chain Monte Carlo (MCMC) iterations (discarding the first 25%
as burn-in, sampling every 103 steps) to generate a sample of 750 trees from the posterior
distribution. I compared the topology of these trees using treescape (Kendall & Colijn,
2015), and found the placement of ancestral branches of the topology were poorly resolved,
though placement of sequences in main clades was well supported. I therefore took a cut
through the deep branches of the two phylogenies, defining four alleles for pspA (fig. A.11)
and three alleles for zmpA (fig. A.12). This phylogeny and classification is similar to three
families previously defined for pspA, and three families previously seen for zmpA. Using
these alleles I then fitted classifiers to the reference panels as in section 4.3.1, and predicted
the allele for all samples in the study.
4.3.2 Phase variable type I R-M system allele (ivr)
Croucher, Coupland et al. (2014), J. Li et al. (2016), Manso et al. (2014) have highlighted
a potential role in virulence for the ivr locus, a type I restriction-modification system with
a phase-variable specificity gene allele of hsdS in the host specificity domain (fig. 4.3).
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Figure 4.3: The structure of the ivr type I restriction-modification locus. The restriction (hsdR) and
methylation (hsdM) subunits, and the 5’ end of the specificity subunit (hsdS) are generally conserved.
Inverted repeats IR1 (85bp) and IR2 (333bp) facilitate switching of downstream incomplete hsdS elements
into the transcribed region. Top: The green read pair has the expected insert size, and suggests allele A
(1.1, 2.1) is present. The red read pair is in the wrong orientation and has an anomalously large insert size.
Bottom: The red read pair is consistent with the displayed inversion, suggesting allele D (1.2, 2.1) is present.
There are six possible different alleles A-F for hsdS, each corresponding to a different level
of capsule expression. Some of these alleles are more successful in a murine model of
invasion, whereas others are more successful in carriage.
Due to the high variation rate and structural rearrangement mediating the change the
allele cannot reliably be determined using assembly and/or standard mapping of short read
data. Instead, I extracted mates of reads mapping to the reverse strand of the conserved
5’ region for each sample, and mapped with BLAT (Kent, 2002) to the possible alleles in
position 1. This forms a vector ri of length two for each sample i, with the number of reads
mapped to 1.1 and 1.2. Similarly, to determine the 3’ allele (position 2), I extracted pairs
of reads mapping to each of the reverse strand of allele 1.1 and the forward strand of allele
1.2 and mapped to the three possible alleles in position 2. This forms a vector qi of length
six for each sample i, with the number of reads mapped to each allele A-F.
I performed this on all samples in the collection and found 677 of 693 carriage samples
and 1 052 of 1 144 invasive CSF samples had at least one read mapping to an allele of the
ivr locus hsdS gene. In the invasive samples, this corresponded to 621 CSF blood sample
pairs. Those without any reads mapping had either a deletion of one component of the
locus, or a large insertion mediated by the ivr recombinase.
4.4 GWAS of bacterial variants associated with meningitis
While it is well known that pneumococcal serotype contributes to invasive propensity
(Hausdorff et al., 2000; Brueggemann et al., 2003), it is of great interest in the field of
pneumococcal biology whether variation in other regions of the genome can independently
affect invasiveness. Many virulence factors are known to be involved in and essential
for pneumococcal colonisation and disease (Kadioglu et al., 2008), but whether natural
variation in these regions affects clinical cases of disease has yet to be assessed. Indeed,
the overall role of pneumococcal variation in invasive disease is as yet unknown, and
therefore the proportion of variation in invasiveness which can be ascribed to the capsule
and the proportion due to other factors cannot be determined. Additionally, the lack of
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large cohorts combining detailed clinical metadata with bacterial data means that little is
known about about the effect of pneumococcal variation on disease outcome. Previous
studies with small sample sizes have suggested a role for platelet binding (Tunjungputri
et al., 2017) and arginine synthesis (Piet et al., 2014), with additional evidence from in
vitro observations.
I first performed a heritability analysis to quantify the amount of variation due to the
pneumococcal genome for each phenotype. As well as using the methods described in
section 3.3 I also applied a phylogenetic mixed model assuming an Ornstein-Uhlenbeck
(OU) process of trait evolution as implemented in the patherit package (Mitov & Stadler,
2016), which has previously been shown to be less biased than other techniques for
estimating the heritability of pathogen traits (Blanquart et al., 2017). I performed 200 000
MCMC iterations, discarding the first half as burn-in and thinning the chain to every
hundredth value. LDAK performs heritability estimation of this binary trait on the liability
scale (Lynch & Walsh, 1998). I peformed this analysis within genomes collected from
meningitis, stratified using GOS to define clinical outcome, and between genomes from
carriage and genomes from meningitis (referred to as ‘invasiveness’).
Trait Method
LDAK OU closest phylogenetic-pairs (CPP)
Invasiveness 0.983±0.003 0.9936 (0.9928-0.9943) 0.995 (0.991-0.998)
Unfavourable outcome 0.006* did not converge 0.05 (-0.04-0.16)
Death 0.0001* 0.02 (-0.07-0.11) 0.07 (-0.03-0.17)
Table 4.4: Estimated heritability of pneumococcal invasiveness and outcome due to variation of the pathogen
genome. Values shown in brackets are the 95% CIs, where provided by the method, for LDAK the standard
error is shown, unless the LRT p-value was > 0.05 so there is no support for a non-zero heritability (shown
by an asterisk).
Table 4.4 shows the predicted heritability from each method. There is evidence that
invasive propensity is highly heritable, but that disease outcome is not determined by
natural variation of pathogen genetics. The latter is not surprising as invasive disease as
an evolutionary dead end for the pathogen, adaptations affecting virulence over the short
course of infection are unlikely to be selected for. The dependence on invasiveness is well
known to depend on pneumococcal genetics, but not the degree. The high heritability
estimated here, supported by three different techniques, suggests that in this population
some bacteria are able to invade while others are not, with almost certainty depending on
the genetic background. This is consistent with some serotypes not being found in invasive
disease (Hausdorff et al., 2000), and their wide genetic separation from invasive serotypes.
The complete heritability is likely an overestimate due to the binary nature of the trait,
but does show that pathogen genetics are important in invasiveness and not likely to be
important in severity.
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I then wished to quantify the amount of this heritability which was due to serotype,
which is the current focus of pneumococcal vaccination and the most well known invas-
iveness determinant, versus other factors. As in section 3.4.1 I used leave-one-out cross
validation with lasso logistic regression to select the 36 serotypes (of 63 observed) which
were informative of invasiveness. I then assessed the variance in invasiveness explained
by these serotypes using Nagelkerke’s pseudo R2 from logistic regression (International
Schizophrenia Consortium et al., 2009; Hosmer et al., 2013), which was 0.45. Caution
should be used in directly interpreting this R2 as variance explained, but it does show the
model fit from serotype alone is not as good as using the pneumococcal kinships, suggest-
ing there are factors other than serotype which affect invasiveness. I also checked whether
invasiveness is well predicted by capsule charge, as has been previously suggested by Y. Li,
Weinberger et al. (2013). Using the previously measured zeta potentials, and using the
serogroup average when a serotype charge was not available, I performed the same logistic
regression using charge as the predictor rather than serotype. Charge significantly affected
invasiveness but was not as informative as the specific serotype (p < 10−10; Nagelkerke’s
R2 = 0.08), suggesting a role for finer structure of the capsule structure (Bentley et al.,
2006).
In the rest of this section, using the variation defined for all samples as in section 4.3
and the GWAS methods developed in chapters 2 and 3, I tried to find the pneumococcal
variants other than serotype which affect invasivness. Even though there is no evidence
from the above heritability analysis that variation in the pneumococcal genome contributes
to disease outcome I ran the same analysis on these phenotypes anyway – it may be that
the common/core variation used to produce these estimates fails to tag variation in the
accessory genome or phase variable regions which may contribute to outcome. In this
case a lack of association will also provide further support for zero heritability due to the
bacterial genome.
In the first section I consider association of common variants in the pan-genome (all of
those described in section 4.3) with the phenotypes predominantly using the techniques
already described. I then go on to asses the role of rare variation firstly using tests
of selection, and more directly using an association combining variants with the same
predicted effects. Finally I developed a model to test whether any particular ivr allele, or
the amount of variation of the allele is associated with any of the phenotypes.
4.4.1 Role of common variation
Using the variants catalogued above, with previously described filtering thresholds, I
performed a GWAS between the isolates from invasive disease and asymptomatic carriage,
as well as unfavourable outcomes and/or death within the invasive isolates. I used SEER
with the first ten MDS components to correct for population structure, as well as FaST-
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LMM (Lippert et al., 2011) using the kinship matrix estimated from SNPs and INDELs as
random effects.
Figure 4.4 shows the Q-Q plots of the resulting p-values from these methods on SNPs
and k-mers with invasive versus carriage isolates. In both cases the test statistic from SEER
is clearly highly overinflated for this population and phenotype, meaning a high significance
threshold would be needed to remove population structure confounded associations. I
have shown that invasiveness is highly heritable, so population structure being highly
confounding is unsurprising. Increasing the number of fixed effect population structure
covariates may help alleviate this issue, but as the LMM test statistic is better controlled,
and as it was a successful method in chapter 3, I have used it for all associations of common
variants with the three phenotypes. For significance thresholds I used the unique number
of patterns as the number of tests in a Bonferroni correction, giving p < 8.2×10−7 for
SNPs and p < 1.9×10−8 for k-mers. However, inspection of the Q-Q plots shows that for
k-mers the LMM is still overinflated, so I have instead taken p < 1×10−16 to describe the
top hits.
From all three of SNPs, COGs and k-mers by far the most highly associated variants are
transposons. These mobile elements of DNA can insert into different places in the bacterial
host genome through inverted repeat sequences, and coevolve with the bacterial population
(Kleckner, 1981; Levin & Moran, 2011). In some cases transposons can carry cargo genes,
such as antibiotic resistance conferring mechanisms, which increase host fitness (Croucher,
Harris, Fraser et al., 2011). However, the transposons here appear to be simple elements
lacking such cargo, and are therefore unlikely to explain a difference between carriage
and invasive isolates directly. Most likely these transposons are present in some genetic
backgrounds and not others, and are therefore a population structure confounded result.
Their variability in position in the genome and specific sequence may mean they are less
well controlled for against genetic background. Due to the lack of plausible functional link
with the phenotype I do not consider them further here.
Other hits are shown in table 4.5, ordered by the variant type discovered. In some
cases COGs were incorrectly clustered and actually represent two alleles of the a gene
orthologs. For three of these alleles I found a positive association with invasive isolates
from one allele, and a negative association from the alternative allele. To annotate the
genes here I used the best blastp match to the core and accessory genome defined by
Croucher, Finkelstein et al. (2013), and if not annotated already I used blastp with the
nt/nr database to find annotated orthologs, and hmmscan and cd-hit to find functional
domains to inform the annotation.
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Figure 4.4: Quantile-Quantile plots for invasive S. pneumoniae GWAS methods. Red line is for observations
following the null-hypothesis of no association, plotted points are observed p-values from each method. Top
row: p-values from SNPs and INDELs from mapping; bottom row: p-values from k-mers. Left column:
SEER run with the first ten population structure components. Right column: FaST-LMM run on the same
input.
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Gene ID Annotation Core Method p-value
FM211187.6011 tlyC; Membrane protein
(upstream)
Yes Mapped variants 7.7×10−31
FM211187.977 pbpX; penicillin binding
protein
Yes Mapped variants 3.6×10−18
FM211187.313 hypothetical protein (up-
stream)
Yes Mapped variants 2×10−16
FM211187.1802 yhfE; Aminopeptidase
(upstream)
Yes Mapped variants 1.0×10−9
FM211187.1019 wzh; capsule synthesis No Mapped variants 3.6×10−9
FM211187.150 comA; bacteriocin/com-
petence (upstream)
Yes Mapped variants 9.9×10−9
FM211187.3083 pbl3e/pldT; bacteroicin No COG absent 4.0×10−10
N/A transcriptional regulator
(pseudogene)
No COG absent 1.4×10−8




No COG alleles 4.7×10−9
FM211187.6189 C4-dicarboxylate (cit-
rate) ABC transporter
Yes COG alleles 1.4×10−7
FM211187.5843 23S rRNA (uracil-5-
)-methyltransferase
RumA2







FM211187.4259 Peptidase U32 Yes K-mers 1.7×10−59
FM211187.4090 aroK; Shikimate kinase Yes K-mers 1.7×10−59
FM211187.1923 yehU; Sensor kinase Yes K-mers 3.1×10−59










FM211187.213 Galactose uptake PTS
transporter, IIB subunit
Yes K-mers 2.5×10−42




FM211187.6594 ulaA; Pentose PTS
transporter IIA
Yes K-mers 3.7×10−25
Table 4.5: Common variation associated with invasiveness using FaST-LMM. I have annotated the gene the
significant locus overlaps, and intergenic variants are annotated with the nearest downstream genes as noted.
Gene ID is the name in the ATCC 700669 reference if present; ‘core’ refers to whether this gene was in the
core genome defined by Croucher, Finkelstein et al. (2013); method describes the type of variant that was
found to be associated.
The wzh gene is involved in capsule synthesis and is part of the gene cassette which
determines serotype (Bentley et al., 2006). As shown above and in previous studies,
serotype has a large effect on invasiveness and hence this association serves as a positive
control. The association of variants in pbpX is likely due to mosaic alleles which confer
resistance to β -lactams being common in invasive serotypes, similar to what I found in
section 3.5.2. The bacteriocins mediate intraspecies competition and determine strain
fitness (Dawid et al., 2007), but a specific association with invasiveness independent of
strain background has not previously been reported. comA, a core gene essential for
competence, affects the expression of these bacteriocins so may represent an effect through
the same pathway (Kjos et al., 2016).
The adhesin yhfE has previously been associated with virulence of S. pneumoniae
(M. W. Robinson et al., 2013). This adhesin functions as a peptidase, hence the other
peptidase may found to be associated also have similar role. Other genes found here
previously associated with virulence in animal models include: ulaA which utilises ascorbic
acid has been found to be upregulated in invasion (Afzal et al., 2015; Mahdi et al., 2015);
pyrB is involved in cell wall biosynthesis and can affect virulence (Mohedano et al., 2005);
aroK is involved in biofilm formation (Domenech et al., 2012); both comA and tauA were
found to be essential for growth during meningitis using a genome-wide screen (Molzen,
Burghout, Bootsma, Brandt, van der Gaast-de Jongh et al., 2011). For the other identified
regions I couldn’t find reference to a previous report relating them to a role in invasiveness
or virulence of S. pneumoniae.
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For unfavourable outcome and death, none of the above classes of variant reached
genome-wide significance. This is consistent with the low heritability estimated for these
phenotypes. No alleles of pspC, pspA or zmpA or any CNVs reached genome-wide
significance for any of the phenotypes.
4.4.2 Role of rare variation
The availability of whole genome sequence data for these samples allows the identification
of rare variants, here defined as those present in the population with MAF < 1%, which
are also plausible as having an effect on the phenotypes of interest. The amount of rare
variation compared to common variation present in a population is informative of recent
selection and population size changes (Ziheng Yang, 2006). An overall difference may
therefore be informative of different selection on regions of the genome depending on
the niche. In fig. 4.5a I have plotted the SFS by niche and predicted consequence to
look for an overall difference. Across the range of common MAFs in both niches the
proportion of synonymous/nonsynonymous/intergenic/LoF mutations is roughly constant
and as expected (Ziheng Yang, 2006; Thorpe et al., 2017), though at low frequencies, there
is an excess of potentially damaging variants.
Interestingly, there is a clear excess of rare variants in invasive samples compared to
carriage samples. To quantify this difference and identify which regions of the genome are
responsible for the excess of rare alleles I calculated Tajima’s D for each coding sequence in
the genome, and looked for differing signs of selection between cases and controls. Tajima
(1989) developed the summary statistic D to look for differences between an observed
population and an idealised population of a stable size evolving under neutral selection,
where mutation frequency is dominated by drift rather than selection. By comparing
the number of segregating sites with the average number of differences between pairs of
sequences, a statistic D can be calculated. Deviations with D< 0 are indicative of selective
sweeps and/or recent population expansion, whereas D > 0 is indicative of balancing
selection and/or recent population contraction. In terms of differences between SFS, a
negative D manifests as an excess of rare variants whereas a positive D manifests as a
uniform distribution (Bamshad & Wooding, 2003).
For speed, I implemented code in C++ (https://github.com/johnlees/tajima-D) which
uses the same optimised strain-wise distance calculation as SEER (section 2.3.2) to
calculate the average number of pairwise strain differences kˆ. Unknown or gap sites
are ignored in the calculation, and the codes produces the same value of D on standard test
data. The code uses a variant call format (VCF) file as input, so is readily generalisable to
other applications. Using this code, I calculated D for all coding sequences in the ATCC
700669 reference separately for carriage and invasive isolates, and the difference in D
between niches.
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Figure 4.5: Differing burden and frequency of rare variation between invasive and carriage isolates, based
on short variation called from mapping against the ATCC 700669 reference genome. LoF are frameshift
or nonsense mutations. a) The SFS stratified by niche and by predicted consequence. Frequency has
been normalised with respect to the number of samples in each population. b) Histogram of Tajima’s D
for all coding sequences in the genome, stratified by niche. c) Boxplot of number of rare variants per
sample, stratified by niche and predicted consequence. Damaging mutations are LoF mutations and missense
mutations predicted damaging by SIFT.
Comparison between D values to test for different selection between niches will only
work within the same population, otherwise changing population size may cause an overall
difference in D. The assumption that invasive and carriage populations are the same
is potentially reasonable, as all invasive isolates must first have been carriage isolates,
however the biased selection of case isolates used for GWAS and potential adaptation
and population growth after invasion (described futher in section 4.5) may violate this
assumption. In GWAS terms, although the calculation of Tajima’s D uses rare variation,
which is less prone to population structure confounding, common variation is also used
which is affected by population structure.
To test for an overall difference I compared the distributions of D by gene in each
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phenotype shown in fig. 4.5b. Genes in invasive isolates had a lower average D (difference
in medians -0.34; W = 1 996 100, p< 10−10) and a more positively skewed D (difference in
skewness 0.30; 95% bootstrapped CI 0.17-0.44). This difference in D may be representative
of a difference in population dynamics or population structure between niches, or may
show genuine differences in selection. To find individual genes which show a difference
in selection between niches I then ran 44 000 permutations per gene with randomised
phenotype labels to calculate a p-value on the difference in D between niches, to which I
applied a Bonferroni correction to adjust for testing of all genes (Winantea et al., 2006).
156 genes had a significantly different D between niches; in table 4.6 I report 18 of these
coding sequences which were outside of the 95% central mass of the D distribution for
one niche but not the other. Due to potential population structure effects results should
therefore be seen as suggestive, and potential for follow-up work.
Gene ID Annotation Invasive D Carriage D Direction
FM211187.1040 wzx; capsule synthesis -2.53094 -1.79867 Negative in
invasive
FM211187.5843 23S rRNA (uracil-5-
)-methyltransferase
RumA2
-2.4028 -1.63478 Negative in
invasive
FM211187.2360 ezrA; septation ring
formation regulator
-1.1051 -2.17726 Negative in
carriage
FM211187.4024 replication initiator pro-
tein (on ICE)





-1.61993 -2.21525 Negative in
carriage
FM211187.357 bacteriocin 4.19212 1.30796 Positive in
invasive
FM211187.420 tsaB; tRNA threonylcar-
bamoyladenosine bio-
synthesis protein
3.49345 1.39805 Positive in
invasive
FM211187.769 aceytltransferase 2.9055 1.80787 Positive in
invasive
FM211187.1019 wzh; capsule synthesis 2.76882 1.63677 Positive in
invasive
FM211187.1802 yhfE; Aminopeptidase 2.28654 1.19784 Positive in
invasive
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2.23028 0.722447 Positive in
invasive
FM211187.5184 dnaI; primosomal pro-
tein
2.32212 0.197632 Positive in
invasive




FM211187.3804 nanB; neuraminidase 1.6805 3.19937 Positive in
carriage
FM211187.5053 membrane protein 0.311619 2.46774 Positive in
carriage
FM211187.5358 secY; accessory secre-
tion system translocase
0.471641 2.36541 Positive in
carriage
Table 4.6: Coding sequences with extreme values of Tajima’s D, with a difference between carriage and
invasive isolates as determined by permutation testing.
A positive D statistic implies common variants are being maintained in the population
more than expected, suggesting that multiple alleles of the gene are common. The positive
estimates of D in bacteriocins are consistent with their function, where having a different
allele to competing strains is advantageous and increases fitness (Bogaardt et al., 2015;
Miller et al., 2017). nanB is similarly involved in competition and in virulence (Shakh-
novich et al., 2002; Brittan et al., 2012); the difference in D I found suggests that this
selection may be more important in carriage where more common alleles appear to be
maintained. A negative D suggests purifying selection acting on a gene. For example,
ezrA is essential for growth in carriage (van Opijnen et al., 2009; Cleverley et al., 2014),
so a negative D suggests that changes to the protein are not tolerated in this niche. As
wzx, wzh, yhfE, RumA2 and bacteriocins were found to be associated with invasiveness
above, this suggests that the difference in D I observed is less likely to be due to population
stratification and more likely a real sign of selection. Genes found through these approach
which may affect cell growth such as ezrA, secY, dnaI and tarI may make the population
more or less immune stimulating, depending on their direction of effect.
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Burden testing of coding sequences
I then wished to consider whether rare variants were associated with any of the three
phenotypes. These variants will have occurred on terminal (or close to terminal) branches
and therefore population structure is less of an issue than for common variants. Power to
detect associations is proportional to MAF and OR, so and at low MAF, there is only power
to detect those variants with a large effect size (Liu & Anderson, 2014). However, for rare
alleles the statistical tests described so far lack the power to test for an association even
for an infinite OR. In human genetics combining sets of variants with the same predicted
effect on a more complex biological function (yet simpler than the whole phenotype), for
example grouping rare LoF variants in the same gene, then testing the group for association
with the phenotype of interest has been the most common approach (B. Li & Leal, 2008;
Morris & Zeggini, 2010). This is known as a burden test – in bacterial genomes this
technique has successfully found LoF variants associated with antibiotic resistance in
M. tuberculosis (Desjardins et al., 2016).
In each test I used only variants with MAF < 1% from the variant calls derived from
mapping. Using the annotations from VEP, I defined frameshift and stop gained mutations
as LoF – 6 825 variants in total. I also analysed the effect of all predicted missense variants
using Provean (Ng & Henikoff, 2003; Choi et al., 2012), and used the default threshold
of -2.5 to select variants with a predicted effect on protein function – 26 206 of 50 383
missense variants passed this threshold. I combined these variants with LoF variants to
define a damaging class. Figure 4.5c shows the overall burden of damaging rare variants
between carriage and invasive samples; in both classes there was higher burden in carriage
isolates (median LoF: invasive 7, carriage 11, W = 297 440, p < 10−10; median damaging:
invasive 22, carriage 26, W = 345 370, p = 8× 10−4), so results showing a burden in
carriage should be interpreted with caution.
I then used plink/seq to perform a burden test on all coding regions in the ATCC
700669 reference genome, which looked for an excess of rare damaging alleles in genes,
and Bonferroni corrected all resulting p-values. I tested all six possible phenotypes:
invasiveness, carriage, favourable outcome, unfavourable outcome, survival, death. For the
latter four phenotypes based on clinical outcome no genes showed a significant burden of
LoF or damaging variants. Table 4.7 shows the results for carriage and invasive isolates.
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Gene ID Annotation p-value Class Direction
FM211187.1036 wchV; capsule synthesis 0.0022 LoF Carriage
FM211187.1143 membrane protein 0.0022 LoF Carriage
FM211187.1634 bglG; transcription anti-
terminator
0.0022 LoF Carriage







FM211187.4679 platelet binding phage
protein
0.0022 LoF Carriage
FM211187.4714 prophage protein 0.0022 LoF Carriage
FM211187.4939 membrane protein 0.0022 LoF Carriage










FM211187.1025 wze; capsule synthesis 0.0067 LoF Carriage
FM211187.4017 hypothetical protein (on
ICE)
0.0067 LoF Carriage
FM211187.1040 wzx; capsule synthesis 0.0089 LoF Carriage




FM211187.6861 comFC; competence 0.011 LoF Carriage
FM211187.6608 pcpA; choline binding
protein
0.016 LoF Carriage
FM211187.4717 prophage protein 0.018 LoF Carriage




FM211187.1804 bacteriocin 0.039 LoF Carriage
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FM211187.2661 bceA; ABC exporter AT-
Pase
0.0045 Damaging Invasive
FM211187.3585 smc; Chromosome par-
tition protein
0.0045 Damaging Invasive
FM211187.5524 trpD; anthranilate phos-
phoribosyltransferase
0.0045 Damaging Invasive
FM211187.2550 fruA; Fructose PTS
ABC transporter
0.027 Damaging Invasive
FM211187.3460 ispA; Farnesyl diphos-
phate synthase
0.038 Damaging Invasive
FM211187.2615 pfkA; ATP-dependent 6-
phosphofructokinase
0.042 Damaging Invasive
Table 4.7: Burden testing of rare LoF and damaging variants in coding sequences associated with invasive
or carriage isolates. P-values are Bonferroni corrected using the total number of genes.
Those regions found with a larger number of LoF variants in carriage than disease
represent genes which are advantageous in invasion, and hence include a number of well-
known virulence factors. Specifically, capsule related genes, zmpD and nanA have all been
previously described as increasing virulence in animal models (Brueggemann et al., 2003;
Bek-Thomsen et al., 2012; Brittan et al., 2012) and have some overlap with associations
found through common variant association. The large effect size caused by these LoF
mutations is similar to the gene knock-outs used in these experiments.
As well as these well-described virulence factors, I found four more genes which were
more likely to be functional in invasive isolates which had been previously described as
virulence related in a single or small number of studies. PsrP is an adhesin which has been
shown to increase virulence in mice (Obert et al., 2006; Shivshankar et al., 2009), and
found here were two genes which affect the protein’s function. pcpA (Glover et al., 2008;
Sa´nchez-Beato et al., 1998) and pclA (Paterson et al., 2008) are choline binding and surface
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anchored proteins respectively, both previously associated with virulence. Tunjungputri
et al. (2017) have reported association with presence of the phage-derived platelet binding
protein PblB with 30-day mortality of meningitis in humans – the platelet binding protein
found here may have a similar role in invasiveness (though I did not find it to be associated
with severity or mortality).
I could not find previous reports of association with virulence or invasive potential of
the other hits in this category. Also, few of the genes found to be essential in a mouse
model of meningitis (Molzen, Burghout, Bootsma, Brandt, van der Gaast-de Jongh et al.,
2011) were found here, suggesting either that the induced variants do not occur in natural
populations, that the mouse does not perfectly model human meningitis or that the sample
size here was too low to discover these effects.
Only one gene was found to lose function more frequently in invasive disease, though
as it is a pseudogene in the reference this is unlikely to be a real functional effect. For
missense variants affecting protein function the direction of effect is less clear, as the
variants may be fitness increasing or decreasing. This inconsistent direction may also make
the burden test less powerful, and a test which does not rely on this assumption such as
the SKAT test may be preferred (Wu et al., 2011; S. Lee et al., 2012). In carriage isolates,
including missense variants also found ybaB and a multidrug transporter to be significantly
altered in carriage but not in invasion. In invasive isolates a few more possible hits were
found. smc is involved in cell division and growth, but also has epistatic links to much of the
rest of the chromosome (Skwark et al., 2017). LoF in trpD has previously been associated
with attenuated virulence (Hava & Camilli, 2002), and fruA as being associated with
the switch in virulence between nasopharyngeal colonisation and bloodstream invasion
(Trappetti et al., 2017).
4.4.3 Hierarchical Bayesian model for ivr allele prevalence
Manso et al. (2014), J. Li et al. (2016) have reported an association with ivr allele and
invasive propensity in a murine model; this dataset offers the opportunity to test whether
such as an association exists in clinical samples. As the ivr varies rapidly and independently
from population structure (Croucher, Coupland et al., 2014) a simple association test can
be performed for each allele. I first used the mapping approached described in section 4.3.2
to determine the ivr allele for each sample. However, as even a single colony contains
heterogeneity at this locus, simply taking the allele with the most reads mapping to it in
each sample gives a poor estimate of the overall presence of each allele in the invasive
and carriage niches. To take into account the mix of alleles present in each sample, and to
calculate confidence intervals, I developed a hierarchical Bayesian model for the allele in
each niche (fig. 4.6). This simultaneously estimates the proportion of each colony pick
with alleles A-F for both individual isolates (pi), and summed over all the samples in each
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niche (µ). The model is applied this over i samples and c niches (in this case c can be
blood, CSF or carriage).
I first modelled the state of the 5’ allele (TRD1.j) only. For the two possible alleles 1.1
and 1.2, the number of reads mapping to each allele (a 2-vector ri) was used as the number
of successes in multinomial distribution zc (c – index for niche). From these I inferred the
proportion of each allele in each individual sample pii, and in each niche overall µc. This
was done by defining Dirichlet priors expressing the expected proportion of an allele in a
given sample pii to be drawn from a Dirichlet hyperprior representing the proportion of the
allele that is found in each niche as a whole µc. The κ parameter sets the variance of all
the individual sample allele distributions piic about the tissue average µc, with a higher κ
corresponding to a smaller variance.
The hyperparameter Aµ , which encodes the total proportion of each allele we expected
to see over all samples, was set to the average amount of the allele observed from the long
range polymerase chain reaction (PCR) in a subset of 53 paired samples, as described in
section 4.5.4.
The observed number of reads mapping to each allele, prior distributions defined above,
and structure of the model in fig. 4.6 defines a likelihood which can be used to infer the
most likely values of the parameters of interest pi and µ . I used Rjags to perform MCMC
sampling to simulate the posterior distribution of these parameters. I used 3 different
starting points (i.e. three chains), and took and discarded 30 000 burn in steps, followed by
45 000 sampling steps. Noticeable auto-correlation was seen between consecutive samples,
so only every third step in the chain was kept when sampling from the posterior. I manually
inspected plots of each hyperparameter value and mean at each point in the chain, as
well as the Gelman and Rubin convergence diagnostic, which showed that the chains had
converged over the sampling interval.
To model both the 5’ end (TRD 1.1 and 1.2) and the 3’ end (TRD 2.1, 2.2 and 2.3)
together, so each isolate i is represented by an allele A-F, for each isolate the total number
of reads mapping ni was drawn from the distribution in equation eq. (4.1)
ni ∼∑
j
pii j · ri j (4.1)
where j is the index of the TRD region, ri j is the number of reads in sample i that had a
mate pair downstream from TRD1. j mapping to any TRD2 region, and pii is the posterior
for allele frequency in the sample.
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Figure 4.6: Hierarchical model for ivr allele. Solid double arrows denote a deterministic relationship; wavy
arrows represent a value drawn from a distribution. z is a vector of the number of reads mapping to each
allele from a total of N reads mapping to the variable region; i is the sample number; c is an index for tissue
type. µc, κ are hyperparameters for mean allele prevalence and how closely a sample is representative of a
tissue type respectively. Aµ , Bµ are priors for allele prevalence in invasive disease. Sκ , Rκ are the shape and
rate parameters for a gamma distribution, which were used to set a broad prior on κ .
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The distribution for the number of reads mapping to each allele j, zi j was then defined
as in equation eq. (4.2)
zi, j ∼

ni · qi, j‖~qi‖ ·pii,1.1, if j ∈ A, B, E
ni · qi, j‖~qi‖ ·pii,1.2, if j ∈ C, D, F
(4.2)
where qi is a vector of length six which contains the number of reads mapped to each allele
A-F as described above, and pi , i and n are as previously. A single sample for z was taken
for each isolate i. This 6-vector zi j is then used as the observed data in the same model as
above to infer pii, and µc for the whole locus allele (A-F) rather than just the 5’ end.
For the 5’ allele (TRD1. j) a model using a single κ parameter rather than a κ indexed
by tissue c was preferred (change in deviance information criterion ∆DIC = −0.523
(Spiegelhalter et al., 2002)). For the 3’ allele (TRD2. j), a model with a single κ parameter
did not converge. A model with κ indexed by allele was used instead.
This simultaneously estimated the proportion of each colony pick with alleles A-F for
both each individual isolate (pi), and summed over all the samples in each niche (µ). I
applied this over i samples and c niches (in this case c can be carriage/nasopharynx or
CSF). The difference in mean of µ (corresponding to the mean allele frequency over all
sample pairs for each allele) shows whether alleles are selected for in carriage or invasive
disease, however as the confidence intervals overlapped for alleles, no particular allele
was associated with invasive disease or carriage isolates. I also checked the diversity of
alleles present in each sample by calculating the Shannon diversity index for each sample
using the pi vector. The median diversities were not significantly different (carriage 0.94;
invasive 1.00).
The finding that ivr allele does not associate with invasive disease is at odds with the
interpretation of Manso et al. (2014) that the capsule expression changes caused by each
allele (through genome-wide methylation profile changes) are central to colonisation and
disease. I found that, in clinical cases of meningitis, the allele of the ivr locus continues to
be phase variable regardless of the niche the bacteria are in. Its purpose is likely to defend
against phage (Croucher, Coupland et al., 2014), with little effect on disease course in
natural human infection.
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4.5 Genetic adaptation over the course of single infections
This section concerns whether the invasive pneumococcal population accumulates muta-
tions as it moves from carriage, through blood to the CSF, and if it does whether this
mutation represents adaptation to either of these niches. By sampling the same population
longitudinally the issue of population structure is not an issue as for the convenience
samples of cases and controls collected for GWAS, which will not be from the same
population of bacteria. I called variation between pairs of samples (table 4.8), and looked
for convergent evolution between different cases and/or signals of adaptation to a specific
niche.
Organism Number of pairs sequenced Mean coverage
blood/CSF nasopharynx/CSF
S. pneumoniae 674 6 91.7x
N. meningitidis 195 48 96.6x
Table 4.8: The number of paired samples analysed from the MeninGene study, and the average sequencing
coverage.
I made assumptions about the evolution of bacteria within the host, under which I
discuss the power of pairwise comparisons between single colonies taken from each niche
to capture repeated evolution occurring post-invasion:
1. There is a bottleneck of a single bacterium upon invasion into the first sterile niche
(usually blood), which then founds the post-invasion population (Gerlini et al., 2014;
Moxon & Murphy, 1978).
2. A large invasive population is quickly established, as the population size approaches
the carrying capacity of the blood/CSF. The population size is large enough for
selection to operate efficiently.
3. As infection occurs in a mass transport system, populations are well mixed without
any substructure. Therefore, the effective population size equals the census popula-
tion size.
4. The bacterial growth rate within blood and CSF is similar.
Initially the population size is small, so selection is inefficient and the population-wide
mutation rate is low. However, the eventual carrying capacity (the maximum number of
cells) of the blood and CSF are large enough (> 1.5×105 colony forming units (CFUs))
(Brown et al., 2004; La Scolea & Dryja, 1984) for beneficial mutations to fix rapidly.
Due to the short generation time of around an hour (Allegrucci et al., 2006), this carrying
capacity is reached early in the course of the disease (after 1-2 days) (Gang et al., 2015).
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Crucially, population sizes where selection acts efficiently (Patwa & Wahl, 2008) are
reached even earlier than this – a few hours after invasion. Therefore, mutations with a
selective advantage occurring after the first stages of infection will eventually become
fixed in the niche’s population. So, sequence comparison between colony picks from each
niche is likely to find adaptation that has occurred post invasion.
Similarity of the bacterial growth rate within blood and CSF is an important assumption
because in 45% of the pneumococcal cases there was evidence that CSF invasion happened
before blood invasion (patients had a documented prior CSF leak, otitis media or sinusitis
(Brouwer, Heckenberg et al., 2010; Heckenberg et al., 2012)). This allowed me to search
for post-adaptation invasion that happens in either direction in this species. I investigated
the validity of this assumption using analysis of data on the ivr locus (section 4.5.4).
In carriage samples, although the population size is small (Y. Li, Thompson et al.,
2013) carriage episodes can persist over many months (chapter 3), therefore allowing the
potential for mutations conferring an advantage in an invasive niche to arise. Additionally,
during carriage there is known to be population wide diversity (Cremers et al., 2014) and in
some cases competition between strains (Cobey & Lipsitch, 2012). I only had access to the
sequence of a single strain sampled from this diverse pool, which means I had less power
to detect mutations either side of the bottleneck. Combined with the small sample size,
this means only adaptive mutations with large selective advantages could be discovered in
this part of the study.
Finally, I considered whether the culturing process will bias the results. In S. pneu-
moniae I found that two additional passages of the previous sample pair resulted in one
additional insertion. In N. meningitidis a low rate of variation and no selection on phase-
variable regions and no variation of other regions have been observed during the culture
steps (Fransen et al., 2009; van der Ende et al., 1995; van der Ende et al., 2000). I therefore
concluded that there will be minimal bias introduced during culturing, and that which is in-
troduced will increase the frequency of mutations between pairs without bias towards either
blood or CSF. Due to the higher power to detect variation between the blood and CSF, I
present those results first in section 4.5.2, and the carriage/CSF results in section 4.5.5.
4.5.1 Reference free variant calling
As the amount of variation beween blood and CSF isolate pairs is very low, I needed to
ensure I had sufficient power to call variants and did not suffer from an elevated false
negative rate. I used the same simulation setup as in section 4.2, except generated an
average of only 200 mutations between 100 simulated sample pairs.
To avoid reference bias, and missing variants in regions not present in an arbitrarily
chosen reference genome, I then performed reference free variant calling between all
sequence pairs of isolates using two methods: the ‘hybrid’ method (Uricaru et al., 2014)
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and Cortex (Iqbal et al., 2012). The former uses de novo assembly of the CSF sequence
reads, mapping of reads from both the blood and CSF samples back to this sequence, then
calling variants based on this mapping. Cortex uses an assembly method that keeps track
of variation between samples as it traverses the de Bruijn graph.
In the hybrid method I used the SPAdes assembly of the CSF sample as the reference,
then mapped reads from both members of the sample pair to this sequence using SNAP
(Zaharia et al., 2011) followed by variant calling with bcftools v1.1 (H. Li, 2011) using the
command:
s a m t o o l s mpi leup −C 50 −m 2 −F 0 .0005 −d 1000 − t DP , SP −g −
p −L 1000 −f a s sembly . f a mapping . bam | b c f t o o l s c a l l −vm
−P 1e−3 samples . t x t
I filtered variants with QUAL< 50, MQ< 30, SP> 30, MSQB< 0.001, RPB< 0.001 or
DP < 4 out.
For Cortex I first error corrected sample reads using quake (Kelley et al., 2010) to
prevent false positive calls supported by very low coverage of reads. I then used the joint
workflow of cortex with each set of corrected reads in its own path in the de Bruijn graph,
and bubble calling was used to produce a second set of variants between samples. SNPs in
the error corrected reads were also called using the graph-diff mode of SGA (Simpson &
Durbin, 2012).
I then called variants between these sequences and a draft R6 assembly from simulated
read data using both of the above methods; comparison with the mutations known to be
introduced allowed power and false positive rate to be calculated – separately for SNPs
and INDELs.
In addition to in silico simulation, I cultured blood/CSF paired strains 4038 and 4039
(Croucher, Mitchell et al., 2013) and resequenced them using the same 100bp Illumina
paired end sequencing as the rest of the isolates in the study. The genomes of strains
4038 and 4039 have been exhaustively analysed using multiple sequencing technologies
(Illumina, 454 and capillary sequencing), so represent high quality positive control data to
assess the calling methods. I tested both methods on these data.
The highest power was achieved using hybrid mapping for SNPs and Cortex for
INDELs: median power for calling SNPs was 90% using hybrid mapping, and 74% for
INDELs using cortex (fig. 4.7a). SGA recovered few true variants. I therefore used this
combination of methods, mapping for SNPs and cortex for INDELs, across all samples.
When applied to the paired strains 4038/4039 the same mutations as originally reported
are recovered, plus a 37bp insertion in cysB which was found to be introduced during
culturing.
I used simulations to compare against a simple method of mapping against an arbitrary
reference, in this case TIGR4 (Tettelin et al., 2001). I found my reference free method has
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Figure 4.7: Performance of variant calling methods. SNPs (gold) and INDELs (blue) are shown separately.
a) Boxplot of power (recall) for each method of variant calling for 100 simulated samples. b) shows the
false discovery rate. c) Boxplot of power and false positive rate for reference based calling. Run on the same
100 simulated samples as a), calculated by number of false positives/number of true positives. d) Count of
annotated genes present in blood but not CSF (red) or vice-versa (turquoise) between the 673 S. pneumoniae
samples. The level of variation is inflated due to frequent misannotation of coding sequences (CDS)s.
greater power, especially for INDELs (fig. 4.7c), and a markedly reduced false positive
rate. I also tested an assembly method alone to compare gene presence and absence, but
this too suffered from a vastly elevated false positive rate (fig. 4.7d).
Variant direction and effect annotation
To be able to compare between samples using a consistent annotation, I mapped the called
variants to the ATCC 700669 reference (Croucher et al., 2009) for S. pneumoniae, and
MC58 reference (Tettelin et al., 2000) for N. meningitidis. This was done by taking a 300
base window around each variant and using blastn on these with the reference sequence.
‘Directionality’ was then relative to the reference used, and a binomial test with λ = 0.5
was used to test significance. I used VEP (McLaren et al., 2010) to annotate consequences
of each SNP as synonymous, non-synonymous, or stop-gained and INDELs as frameshift
or inframe.
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4.5.2 No repeated post-invasion adaptation in coding regions across
species
For each species I then counted the number of variants of any type between each blood/CSF
isolate pair taken from a patient (fig. 4.8). In S. pneumoniae 452 of 674 paired samples
(67%) were identical. The distribution of number of variants between isolate pairs is
roughly Poisson (mean = 0.547), excluding outliers. Variation between N. meningitidis
pairs also followed a roughly Poisson distribution (mean = 2.34), which when compared
to S. pneumoniae showed a higher number of variants between blood and CSF isolates
(Wilcoxon rank-sum test, W = 25 790, p < 10−10) such that most pairs have at least one
variant between the blood and CSF samples.
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Figure 4.8: Histograms binned by number of variants between a blood/CSF sample pair, for both pathogens.
Total pairs analysed in table 4.8. SNPs are from mapping, INDELs are from cortex. Three S. pneumoniae
and one N. meningitidis sample with over 10 variants are not shown.
To test whether certain genotypic backgrounds were associated with a higher number
of mutations that occurs post-invasion, I performed a linear fit of each MLST against
number of mutations between blood and CSF isolates. I Bonferroni corrected the p-values
of the slope for each MLST; at a significance level of 0.05 no MLST was associated with
an increased number of mutations.
In both species, the mutations that do exist, if they cause the same functional change,
could represent a signal of adaptation. To determine whether this is the case, the number of
mutations in each CDS annotation was counted. I then performed a single-tailed Poisson
test using the genome wide mutation rate per base pair multiplied by the gene length as the
expected number of mutations. The resulting p-values were corrected for multiple testing
using a Bonferroni correction with the total number of genes tested as the m tests; I have
reported results with p < 0.05 in table 4.9.
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Gene name Gene length (bp) Blood/CSF mutations p-value
pde1 (SPD 2032) 1973 19 < 10−10
dltD (SPD 2002) 1269 13 < 10−10
dltB (SPD 2004) 1245 12 < 10−10
dltA (SPD 2005) 1551 11 < 10−10
clpX (SPD 1399) 1233 7 1.3×10−8
wcaJ (SPD 1620) 693 6 3.4×10−8
cysB (SPD 0513) 909 5 1.6×10−5
cbpJ 1122 5 4.7×10−5
amiC (SPD 1670) 1332 4 6.0×10−3
marR 435 3 9.6×10−3
fhuC 519 3 1.6×10−2
Table 4.9: Genes containing significantly repeated mutations between blood and CSF isolate pairs in
S. pneumoniae. Ordered by increasing p-value; locus tags refer to the D39 genome, if present.
The dlt operon, responsible for D-alanylation in teichoic acids in the cell wall (Deininger
et al., 2007; Habets et al., 2012; Kova´cs et al., 2006), was the most frequently mutated
locus: 36 mutations in 31 sample pairs (Poisson test p < 10−10). This occurred in only 5%
of samples, so adaptation to a niche due to variation in genes is not common. To investigate
whether this represented adaptation to either blood or CSF, I annotated the effect of these
variants, and determined whether they were specific to a niche. I mapped them to the R6
S. pneumoniae strain, which has a functional dlt operon and was therefore assumed to be
the ancestral state. There was no directionality to the mutations: 19 occurred in the blood,
and 11 in the CSF (p = 0.2). Only seven of the patients infected by these strains showed
signs of blood invasion before CSF invasion (sinusitis or otitis); this also did not show
directionality. I have plotted the position and nature of the mutations in fig. 4.9. Most of
these mutations would be expected to cause LoF in the operon. Though this suggests this
locus has a deleterious effect in invasive disease generally, the lack of directionality to
the mutations means it does not show evidence of adaptation to either the blood or CSF
specifically.
The next most significantly mutated gene was pde1. The pde1 gene was first found to
be essential for growth in an experimental meningitis model (Molzen, Burghout, Bootsma,
Brandt, Der Gaast-De Jongh et al., 2011); further study by Cron et al. (2011) showed
that S. pneumoniae mutants with pde1 (SP2205 in TIGR4; SPD2032 in D39) and its
paralogue pde2 (SP1298 in TIGR4; SPD1153 in D39) knocked out exhibited reduced host
cell adherence and attenuated virulence in a mouse model of meningitis. Following work
confirmed that Pde1 acts as a phosphodiesterase, cleaving c-di-AMP into pApA (Bai et al.,
2013; Kuipers et al., 2016). These signalling molecules are known to have broad effects
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Figure 4.9: Mutations observed between all paired samples in the dlt operon. The operon consists of four
genes in the three reading frames of the reverse strand. Mutations, displayed by type, in the blood strains are
shown above the operon, and in the CSF strains below the operon.
on the cell (Tamayo et al., 2007) and were again shown to affect growth and virulence in a
mouse model of pneumonia. In both studies, the authors suggested that these proteins are
promising vaccine targets.
I therefore checked whether pde1 appeared to be under selection in the sampled
population. The ratio of nonsynonymous to synonymous mutations was neutral (dN/dS
= 0.89) and contained variants with a SFS similar to that of other genes (fig. 4.10a and
b; Tajima’s D = −1.44; p = 0.67). However, as all the within-host mutations were
nonsynonymous, this implied that selection may act on pde1 during the course of invasive
disease. I then computationally predicted the effect of the 19 mutations observed to occur
in pde1 using SnpEff and PROVEAN (Cingolani et al., 2012; Choi et al., 2012), and have
plotted these along with the predicted functional domains in fig. 4.10c. Of these mutations,
14 are predicted to change protein function, without causing LoF. The mutations are not
evenly distributed across the gene and are mostly clustered in the DHH family domain
or just before it. While this does not allow a singular interpretation of the effect of these
variants on gene function, this is consistent with selection acting on pde1 during meningitis.
This supports the conclusion of Cron et al. (2011) that pde1 is essential for virulence,
and lends credence to the idea it may be an effect component of a pneumococcal protein
vaccine.
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Figure 4.10: Evidence of selection on pde1 during meningitis. Panels a and b show the SFS of mutations in
just pde1 and in all CDS, respectively. Variants are coloured according to the predicted effect. Panel c shows
the positions and predicted effects of mutations observed in pde1 during cases of meningitis and predicted
pfam domains.
In all the other genes in table 4.9 the variants are non-synonymous SNPs distributed
evenly between blood and CSF, therefore also showing no adaptation specific to either
niche.
The most frequently mutated genes between pairs in N. meningitidis are shown in
table 4.10. Top ranked are those relating to the pilus: pilE (19), pilC (6) and pilQ (4). Pilus
genes are associated with immune interaction (Wo¨rmann et al., 2014), and are therefore
expected to be under diversifying selection; an excess of non-synonymous mutations
(dN/dS = 1.39; p = 0.024) was consistent with this. The other notable gene with more
mutations than expected in N. meningitidis was porA, encoding a variable protein which
is a major determinant of immune reaction (Russell et al., 2004), in which 12 samples
had frameshift mutations in one of two positions. Phase variation in the gene’s promoter
region, affecting its expression, is discussed in more detail below.
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Gene name Gene length (bp) Blood/CSF mutations p-value
pilE (NMB0018) 384 18 < 10−10
lgtC 189 16 < 10−10
hyaD 327 14 < 10−10
oatA 1869 19 < 10−10
hpuB (NMB1668) 2382 17 < 10−10
porA (NMB1429) 1178 12 < 10−10
lgtA (NMB1929) 1050 10 < 10−10
kfoC 360 7 < 10−10
cotSA 1134 7 9.2×10−9
ssa1 3252 6 3.9×10−4
Table 4.10: Genes containing significantly repeated mutations between blood and CSF isolate pairs in
N. meningitidis. Ordered by increasing p-value; locus tags refer to the MC58 genome, if present.
The mutations in table 4.10 showed no association with blood or CSF specifically, so
do not represent adaptation to either niche. Genetic variation in pilE, hpuA, wbpC, porA
and lgtB within host has been observed previously in a single patient with a hypermutating
N. meningitidis infection (Omer et al., 2011). These coding sequences overlap with those
in table 4.10, which also suggests an elevated background mutation rate in these sequences,
rather than strong selection between the blood and CSF niches.
Finally, I tested whether the increased mutation rate in the genes in tables 4.9 and 4.10
was associated with a particular genotype. I performed a logistic regression for each gene
with over ten mutations reaching significance in the Poisson test, coding samples as one
and zero based on whether they had a mutation in the gene being tested or not: no genes
being mutated post invasion were associated with an MLST.
Copy number variation
I called CNVs between samples by first mapping each species to a single reference genome
(ATCC 700669), then fitting the coverage of mapped reads with a mixture of Poisson
distributions (Klambauer et al., 2012) as in section 4.3. Using windows of 1kb, I ranked
regions by the number of sample pairs containing a discordant CNV call, as defined by the
integer copy number being different between blood and CSF samples. I then inspected the
top 5% of these regions.
In S. pneumoniae the most frequently varying region was due to poor quality mapping
of a prophage region. The only other region with p <0.05 was a change in copy number of
23S rRNA seen in a small number of sample pairs. In N. meningitidis mismapping in the
pilE/pilS region accounts for the only CNV change.
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4.5.3 No evidence for repeated adaptation in intergenic regions in S.
pneumoniae and N. meningitidis
The previous result suggesting adaptation from blood to CSF was an intergenic change
affecting the transcription of the patAB genes, encoding an efflux pump (Croucher, Mitchell
et al., 2013). In general it is known that in pathogenic bacteria a common form of adaptation
is mutation in intergenic regions, which may affect global transcription levels, causing
a virulent phenotype (Gripenland et al., 2010; Johansson et al., 2002), antimicrobial
resistance (Sreevatsan et al., 1997) and changing interaction with the host immune system
(Magnusson et al., 2007). Changes in these regions have previously been shown to display
signs of adaptation during single cases of bacterial disease (Marvig et al., 2014).
I therefore separately investigated the mutations in non-coding regions. Analysing the
positions of these mutations required a consistent co-ordinate system across all sample
pairs. To achieve this, I remapped the co-ordinates of each variant discovered in an
intergenic region to the co-ordinates of the ATCC 700669 reference genome. I used the
population matched carriage isolates as the ancestral state to determine whether these
mutations occur in the blood or CSF isolate.
Figure 4.11 shows all mutations plotted genome-wide in S. pneumoniae. The peaks
correspond to mutations in genes described in table 4.9. In the remaining 121 mutations
in non-coding regions I observed no clustering by position. Over all pairs of samples,
intergenic mutations were spread between blood and CSF isolates when compared to a
carriage reference. This suggests none of the intergenic mutations are providing a selective
advantage in either invasive niche.
The mutations in N. meningitidis are plotted in fig. 4.12, 110 of which were in non-
coding regions. I observed enrichment (> 1 mutation), but no niche specificity, in the
upstream region of six genes. These mutations are listed in table 4.11. Some of the
mutations upstream of porA and opc are in phase variable homopolymeric tracts, which
are discussed more fully in section 4.5.4. The other mutations are upstream of the ad-
hesins hsf /NMB0992 and NMB1994, which are involved in colonisation (Hung & Chris-
todoulides, 2013) and immune interaction during invasion (Griffiths et al., 2011), and
frpB/NMB1988 which is a surface antigen involved in iron uptake (Delany et al., 2006).
Differential expression of these genes may be an important factor affecting invasion, but
the mutations I observed that may affect this do not appear to be specific to blood or CSF.
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Figure 4.11: Mutations observed between all S. pneumoniae pairs, overlaid onto the Spn23F reference.
Each blue point on the lower row corresponds to a SNP or INDEL variant observed between at least one
sample pair. The blocks in the upper row represent CDSs, lying above or below the central line depending on
whether they are on the forward or reverse strand respectively. The panels show a) whole genome (stacked,
grouped by 1 000 bp windows); b) dlt operon (four genes in the centre, from 2 152 238 to 2 156 543 base
pairs); c) pde1 (gene in the centre from 2 185 398 to 2 187 371 base pairs).
Coordinates Downstream gene Blood/CSF mutations
1468329–1468331 porA (NMB1429) 7
1072215–1072328 opc (NMB1429) 7
1008872–1008985 hsf (NMB0992) 6
1315621–1315672 NMB1299 6
2092257–2092552 frpB (NMB1988) 5
2100124–2100258 NMB1994 4
Table 4.11: Intergenic regions containing significantly repeated mutations between CSF and blood isolate
pairs in N. meningitidis. Ordered by increasing number of mutations; coordinates refer to the MC58 genome.
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Figure 4.12: As fig. 4.11. a) whole genome. b) pilus encoding genes. Mapping to the MC58 reference places
these incorrectly in the unexpressed pilS cassette; compared to the reference the isolates have recombined
between pilS and the expressed pilE. c) oatA.
4.5.4 No evidence for repeated adaptation in phase variable regions
in S. pneumoniae and N. meningitidis
Phase variable regions, which may also be intergenic, can mutate rapidly and are known
to be a significant source of variation in pathogenic bacteria (Bucci et al., 1999). This
mutation is an important mechanism of adaptation (Moxon et al., 1994), and meningococcal
genomes in particular contain many of these elements (Snyder et al., 2001).
In N. meningitidis I observed six samples with single base changes in length of the
phase-variable homopolymeric tract in the porA gene’s promoter sequence, and five
samples with the single base length changes in the analogous promoter sequence of opc.
While changes in the length of these tracts will affect expression of the corresponding
genes, both of which are major determinants of immune response (Sarkari et al., 1994;
van der Ende et al., 2000), the tract length does not correlate with blood or CSF specifically.
Consistent with this, porA expression has previously been found to be independent of
whether isolates were taken from CSF, blood or throat (van der Ende et al., 2000).
In S. pneumoniae I was interested in whether the allele of the phase variable ivr locus
discussed in section 4.3.2 was associated with either the blood or CSF niche specifically,
as this could be a sign of adaptation. As the locus inversion is rapid and occurs within host,
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we first ensured that cultured samples are representative of the original clinical samples
using PCR quantification of each allele. We therefore extracted DNA from a subset of 53
of 674 paired clinical CSF samples and the respective bacterial isolates.
Allele prevalence was quantified using a combined nested PCR protocol based on
PCR amplification of the ivr locus (Manso et al., 2014). Allele prevalence was identical
between the original clinical sample and cultured bacteria in 50 out of the 53 samples. The
predictive power of the in vitro detected ivr allele prevalence in a pneumococcal culture
for the original allele prevalence within the clinical sample was therefore sufficient to draw
conclusions about adaptation from.
I then used the mapping method described in section 4.3.2 to determine the allele for all
the paired samples from the read data. 621 sample pairs had reads mapping to hsdS from
which an allele can be called. However, as even a single colony contains heterogeneity
at this locus, simply taking the allele with the most reads mapping to it in each sample
gave a poor estimate of the overall presence of each allele in the blood and CSF niches. To
take into account the mix of alleles present in each sample, and to calculate confidence
intervals, I used the same hierarchical Bayesian model for the ivr allele used for GWAS
in section 4.4.3. This simultaneously estimated the proportion of each colony pick with
alleles A-F for both each individual isolate (pi), and summed over all the samples in each
niche (µ). I applied this over i samples and c niches (in this case c can be blood or CSF).
For each pair of blood and CSF samples the difference in allele prevalence piCSF−piblood
was calculated. All S. pneumoniae samples had a difference in mean of at least one allele
(as the highest posterior density (HPD) overlaps zero), highlighting the speed at which this
locus inverts. While this means that between a single CSF and blood pair the allele at this
locus usually changes, it is the mean of µc (corresponding to the mean allele frequency in
each niche over all sample pairs) which tells us whether selection of an allele occurs in
either the blood or CSF more generally. This is plotted in fig. 4.13. As the HPD overlap,
no particular allele is associated with either blood or CSF S. pneumoniae isolates.
Manso et al. (2014) showed in a murine invasion model that an increase in proportion
of alleles A and B occurs over the course of infection. I did not observe the same effect in
these clinical samples, though the large confidence intervals from the mathematical model
suggest that genomic data with a small insert size relative to the size of repeats in the locus
is limited in resolving changes in this allele. A small selective effect of ivr allele between
these niches would therefore not be detected, but strong selection for a particular allele
(odds ratio > 2) can be ruled out.
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Figure 4.13: Mean and 95% HPD for µc. This shows the proportion of each allele present in each of blood
(red) and CSF (turquoise) tissues pooling across all samples.
Diversity of ivr allele within samples
As the speed of inversion is rapid, I used the subsequent polymorphism of this locus to
evaluate the assumptions about diversity of the bacterial population within each niche. I
calculated the Shannon index of each sample’s vectors µCSF and µblood to measure diversity
of the sample in each niche. The mean Shannon index across CSF samples was 1.01 (95%
HPD 0.39-1.51) and 0.98 (95% HPD 0.35-1.55) in the blood (fig. A.14). Looking at each
sample pair individually, the difference between diversity in each niche appeared normally
distributed with a mean of zero. Together, these observations suggested a similar rate
of diversity generation in each niche. This is in line with the assumption that the two
populations have similar mutation rates, and a similar number of generations between
being founded and being sampled.
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4.5.5 Carriage and invasive disease sample pairs show some evidence
of repeated adaptation
Using the same methods, I also analysed pairs of genomes from 54 patients that were
collected from the nasopharynx and CSF. Six of these were S. pneumoniae. In these
samples, I detected only one sample with any variation (fig. 4.14), which was a two
base insertion upstream of the gph gene. This is similar to the amount of mutation
observed between the blood and CSF isolates, which is expected given the similar sampling
timeframes. While I found that a functional dlt operon appears to have a deleterious effect
in invasive disease, I did not observe mutation between the carriage and disease samples.
However, this was expected given the small number of carriage samples relative to the
effect size detected for this operon.
Between the remaining 48 N. meningitidis carriage and CSF isolate pairs small numbers
of mutations were common. I went on to search for regions enriched for mutation, however
in 8 samples I observed large numbers of mutations clustered close together (fig. 4.14).
These represented single recombination events, so when analysing genes enriched for
mutation I counted each recombination as a single event (Croucher, Page et al., 2015;
Maiden et al., 1998).
Table 4.12 shows the results of this analysis. Similar genes are mutated as in the
blood/CSF pairs, again with no specificity to either niche. In phase variable intergenic
regions, I observed four sample pairs with an insertion or deletion in the porA promoter
tract with no niche specificity. Otherwise, none of the regions above showed enrichment
for mutation in either niche. These observations support the theory that these genes mutate
at a higher rate but do not confer a selective advantage in any of the three niches studied.
Gene name Gene length (bp) Carriage/CSF mutations p-value
lgtA (NMB1929) 1050 6 5.0×10−7
oatA 1869 6 1.5×10−5
hyaD 327 4 2.6×10−5
pilE (NMB0018) 384 4 3.8×10−3
pilT (NMB0052) 1131 4 3.5×10−3
dca (NMB0415) 444 3 1.1×10−2
Table 4.12: Genes containing significantly repeated mutations between nasopharyngeal and CSF isolate
pairs in N. meningitidis. Ordered by increasing p-value; locus tags refer to the MC58 genome, if present.
A notable exception to this is the dca gene, a phase variable gene involved in compet-
ence in Neisseria gonorrhoea but of unknown function in N. meningitidis (Snyder et al.,
2001; Snyder et al., 2003), in which all mutations are protein truncating variants in the
invasive isolate. Similarly, though not reaching significance (due to the long length of the
genes) were the ggt (NMB1057) and czcD (NMB1732) genes in which three recombina-
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Figure 4.14: Histograms binned by number of variants between a carriage/CSF sample pair, for each
bacterial species. a) As fig. 4.8. In N. meningitidis eleven samples with over ten variants between them due
to recombination events are grouped. b) The number of recombination and SNP/INDEL events in samples in
the group with over ten detected variants.
tions occurred, all of which were in the invasive isolate of the pair.
The mutations in these three genes therefore may confer a selective advantage in
the invasive niche; the sequence at these loci in the invasive strains are the same as the
MC58 reference, an invasive isolate itself. ggt has previously shown to be essential for
N. meningitidis growth in CSF in rats (Takahashi et al., 2004), and metal exporters such as
czcD have been shown to increase virulence in a mouse sepsis model (Veyrier et al., 2011).
More such paired carriage and invasion samples would be needed to confirm if this is the
case in human invasive disease.
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4.6 Conclusions
In this chapter I have used a population of S. pneumoniae genomes to determine the
contribution of naturally occurring bacterial variation to the progression of meningitis from
asymptomatic carriage through blood invasion to CSF invasion. I first used a variety of
bioinformatic methods to catalogue as wide a variety of variants as possible, particularly
those which have previously been associated with virulence.
Using these variants and a matched collection of carriage and invasive isolates I found
that the bacterial genome is crucial in determining invasive potential, with serotype likely
to be the main factor. However, I did not find any evidence that the bacterial genome
contributes to severity or outcome of disease. Using GWAS of both common and rare
variants I found many regions and genes to be associated with invasive disease, independent
of genetic background. Some of these have been previously described, whereas this is
the first time others have been associated with invasive human disease. Genes involved
in capsule synthesis, yhfE, RumA2, bacteriocins, nanA and nanB were associated with
invasiveness using both common and rare variants, as well as analysis of selection.
The rare variant burden test found some well known virulence factors, showing that
large effect size LoF mutations generated in lab mutants exist in the natural population,
and further can affect disease in human infection. Common variants with smaller effect
sizes may be the most interesting result of this approach in future, as the smaller effect
sizes are harder to discover with bottom-up approaches, and their higher frequency in the
population may make them more appealing vaccine targets.
I did not find evidence for association with invasiveness for some previously described
variants. I did not find that the ivr allele was associated with invasive disease, suggesting
that its function is to defend against highly variable prophage and that the variable capsule
expression it can produce are not selected for in natural disease. The three antigen alleles
were not associated with invasiveness, suggesting the allelic variants are a general form
of diversifying selection without specific forms having a differing fitness in carriage or
invasion.
These hits, as they rely on a single study population, are susceptible to batch effects
specific to the Dutch setting or due to sampling bias of the collection. The association of
positive controls such as capsule is reassuring, but replication in an independent population
is necessary before further interpretation. The hits I have reported here will be useful for
meta-analysis when further sampling and GWAS is performed.
As well as large scale population differences, previous studies have shown that substan-
tial levels of genomic DNA sequence variation occur in bacteria colonising or infecting
human hosts (Eyre et al., 2013; Kennemann et al., 2011; Morelli et al., 2010) and suggest
that some of this variation may be due to selective adaptation (Croucher, Mitchell et al.,
2013; Jorth et al., 2015; Marvig et al., 2014; L. Yang et al., 2011; Young et al., 2012). Such
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adaptations during invasive bacterial disease could lead to new insights into the processes
of pathogenesis with the potential to inform therapies (Sudip Das et al., 2016; Didelot et al.,
2016), which would be difficult to assess with GWAS due to the rapid disease progression.
I have searched for variation in S. pneumoniae and N. meningitidis, by comparing the
pan-genomes from bacteria isolated from both blood and CSF from the same individuals
in 869 bacterial meningitis cases. The genetic background within-host is the same, so this
comparison could be performed without population structure correction.
I found overall that blood and CSF isolates have very similar genetic sequences. The
mutations observed are not randomly distributed throughout the genome, but are instead
randomly distributed between blood and CSF isolates. These mutations are therefore
an observation of a higher mutation rate in these regions during invasion (for example
the pilus in N. meningitidis, which is known to be under diversifying selection) but not
repeated adaptation to either niche. This study indicates that the previous observation
of variation between blood and CSF isolates from a single case of meningitis (Croucher,
Mitchell et al., 2013) was a rare event most likely driven by antibiotic selection pressure
during treatment. The large sample size means that this eliminates the need to search for
bacterial diversity between invaded host niches (blood and CSF) when trying to explain
pathogenesis of meningitis, which is a tempting analysis for reference labs with both sets
of samples available. However, my comparison between the genomes of carriage and
invasive isolates did show some weak signals of adaptation. I found that dlt appeared to be
deleterious in invasion, and that selection appeared to be acting on pde1 during invasion.
These genes were not associated with invasiveness in the GWAS, which may be due to
insufficient power or population stratification.
I went on to analyse 54 samples comparing carriage and invasive isolates from the
same patient. Though the sample size was lower, and fully sampled diversity within
the nasopharynx was not available, I was able to get an insight into potential genetic
differences between bacteria in these niches. I saw some of the same genes that mutate
rapidly between blood and CSF isolates also do this between carriage and invasion. This
supports the conclusion that these genes have a higher mutation rate, rather than giving
a selective advantage to a niche. However the power in these comparisons was limited
by sample size and single colony sequencing, so comparison with GWAS results is not
possible.
In the next chapter I will perform a similar analysis on the effect of host genetics on
bacterial meningitis, starting with the proportion of variability attributable to common host
genetic variation for invasiveness and disease severity. Together, this will give an overall
picture of host and pathogen genetics affecting pneumococcal meningitis.
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5.1 Introduction
The previous chapter has considered variation present within the pneumococcal genome
that is associated with colonisation and invasive disease, while mostly treating the infected
hosts as identical, with the exception of section 3.6 where I showed infant age and previous
colonisation were both associated with carriage duration. However, the hosts are in reality
heterogeneous: as epidemiological parameters such as contact network (Dagan et al., 2002;
P. C. Hill et al., 2010), vaccination status (Klugman, 2001), co-infections (McCullers,
2006; Siegel et al., 2014; Cohen et al., 2013) host age and immune response (Cobey &
Lipsitch, 2012) have all been shown to affect invasive pneumococcal disease.
However, as well as varying in these ways, humans differ in the sequence content of
their genomes. The contribution of human genetics to adult pneumococcal meningitis is
presently unknown – both whether it affects the disease at all, and if so which specific
regions of the genome contribute to the effect. Twin studies (Jepson, 1998; Burgner
et al., 2006), linkage studies (Abel & Dessein, 1997) and then GWAS studies have all
suggested a role for human variation for many bacterial diseases (Chapman & Hill, 2012).
Association of HLA allele as well as other regions have been found. Despite likely being
selected against over human history, variants pre-disposing to bacterial diseases as stable
and enduring as tuberculosis have been found (Curtis et al., 2015; Sveinbjornsson et al.,
2016).
I start this chapter by using genotype data from the MeninGene (section 1.1.4) cohort
to calculate the heritability of susceptibility to and severity of meningitis (section 5.2).
After I found that human genetics is expected to explain the variation in these traits, I
performed a GWAS for each trait to find specific regions of the genome associated with
bacterial meningitis and its progression. To obtain more evidence for the associations, and
increase power, I then performed the same analysis in two additional cohorts, and finally
meta-analysed the results of all of the studies with a further two previous cohorts for which
we obtained summary statistics.
In section 5.3 I bring host and pathogen genetics together by performing a genome to
genome analysis, using cases of pneumococcal meningitis from the MeninGene cohort
where both the pathogen genome and corresponding host genotype was available. Rather
than looking for human variants which affect meningitis susceptibility and severity regard-
less of the bacterial variation, this section attempts to find specific bacterial variation which
correlates with specific host variation to contribute to disease. This can be considered an
interaction, between the genomes. As interactions between host and pathogen proteins
are known to be important in pathogenesis (Lambris et al., 2008; Serruto et al., 2010),
this is a plausible avenue to explore and may further determine the genetic architecture
contributing to infection in clinical cases of disease.
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5.2 GWAS of human variation associated with meningitis
The MeninGene collection was built up in three batches over the course of this work: the
final numbers along with each phenotype are shown in table 5.1. As the collection includes
all consenting adults with culture-proven meningitis, all causative pathogen species are
included in the collection. My analysis so far has mostly been restricted to pneumococcal
meningitis, as being the most common cause of meningitis in adults it is the most well
powered. However in this chapter I will also consider meningitis as a whole, which also
includes cases caused by N. meningitidis, L. monocytogenes and H. influenzae. As well
as microbiological data, clinical information has been collected for most cases, allowing
an association of disease severity as in section 4.4. For the association I used genotype
data from the ALS (van Es et al., 2009) and B-PROOF (van Wijngaarden et al., 2011) as
population matched controls, all of whom were adults.
Cohort Country Age Data Samples Phenotype
MeninGene Netherlands Adults Illumina Omni array 1 149 Meningitis
732 Pneumococcal meningitis
277 Unfavourable outcome
ALS & BPROOF Netherlands Adults Illumina Omni array 4 836 Controls
Benfield Denmark Children Illumina Omni array 353 Pneumococcal meningitis
873 Pneumococcal bacteremia
473 Controls
GOYA Denmark Young adults Illumina quad array 2 805 Controls
23andme European All Summary statistics 842 Bacterial meningitis
82 778 Controls
GenOSept European Adults Summary statistics 220 Pneumococcal bacteremia
WTCCC UK Adults Summary statistics 2 244 Controls
Table 5.1: Summary of cohorts with available human genotype data. The first section shows cohorts with
full genotype data where I performed a GWAS; the second section is cohorts with the summary statistics
from an existing GWAS used in meta-analysis only. Sample numbers are after the QC in section 5.2.1.
I also used data from Danish children with invasive pneumococcal disease (referred to
here as the Benfield cohort). Using archived blood spots in the Danish national biobank, we
extracted DNA for genotyping from cases of children with pneumococcal meningitis and
bacteremia, as well as 473 population controls. As additional population matched controls
I obtained the genotypes of controls from the GOYA study, which randomly sampled 2 805
healthy Danish young adults (Paternoster et al., 2011).
Finally, summary statistics were available from two existing studies. The first, per-
formed by 23andme, gave participants a questionnaire on infectious diseases. Those
responding yes to the question ‘Have you ever had bacterial meningitis?’ were classified
as cases, and those responding no as controls (‘I’m not sure’ was also an option, and
these responders were excluded from further analysis). The analysts performed a logistic
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regression at all imputed SNPs using age, sex and the first four principal components
as covariates (Tian et al., 2016). The second is the unpublished GenOSept study which
included 220 adults with sepsis, who suffered shock in intensive care unit (ICU) and were
either blood culture positive from pneumococcus, or were positive from pneumococcal
antigen in their urine. The analysts used controls from WTCCC (Burton et al., 2007) and
performed a regression at all imputed sites using a linear mixed model as implemented in
gemma (Zhou & Stephens, 2012).
5.2.1 Genetic data processing
In this section I describe the set of steps I took to prepare genotyping intensity data for
GWAS analysis. From the Dutch cohort there were initially 905 cases available from the
collection since the Meningene study began, with a second batch of 94 new cases covering
a subsequent winter, and a final third batch of 178 new cases covering a subsequent two
winters. As controls, 1 981 samples from the ALS study, and 2 898 from the B-PROOF
study were available from the start. From the Danish collections, 373 meningitis cases and
475 controls were available as called genotypes, and we genotyped 904 additional samples
with pneumococcal bacteremia. I also applied for access to 2 817 samples from the GOYA
study, which I received as quality controlled genotype calls.
The following analysis was completely repeated four times to arrive at the final SNP
calls used in the association study. The processing steps and cut-offs used were the mostly
same for all of these genotyping runs, however I do point out where steps differed based
on cohort or run, and where cohorts or runs have been merged. Throughout, I have used a
combination of plink v1.9 (Purcell et al., 2007; Chang et al., 2015) and my own perl scripts
(https://github.com/johnlees/bioinformatics) to convert between different data formats.
Genotype calling
Genotyping arrays have hundreds of thousands of SNP probes, allowing for a relatively
cheap assay of all common (> 5% MAF) positions in the human genome. For each variant,
there is a red florescently tagged probe which binds to the A allele, and a green probe
which binds to the B allele. By comparing the relative intensities of these two colours
across a large number of samples a genotype probability can be assigned to each sample in
the run.
We processed raw genotyping data using Illumina’s Beeline software to produce
normalised intensity files. In these files, for each sample an x and y intensity is recorded at
every SNP typed by the array, proportional to the amount of the A and B allele present. In
the ideal case a sample homozygous for A would have high x and low to no y intensity,
whereas a sample homozygous for B would have the opposite. Heterozygous samples
would have half of each intensity. In practice the intensities are distributions (fig. 5.2),
156
Chapter 5. Human genetics contributing to invasive pneumococcal disease
and the best way to produce genotype calls is to plot x against y for many samples, and
find three discrete clusters. As a final complication, at any given site some samples will
act anomalously and either fail to produce an intensity, or worse produce an extra cluster
which confounds the identification of the real genotype clusters. Such samples should be
assigned a missing genotype at these sites.
As high quality genotyping is important for downstream imputation and any eventual
fine-mapping (Spain & Barrett, 2015), I used optiCall (Shah et al., 2012) to deal with these
issues and produce genotype calls for all the samples with genotype intensity data. This
method has been shown to throw away fewer correctly typed variants than other methods,
and produce more accurate calls overall. The algorithm first samples random intensities
from across the genotyping run to generate priors of where the three genotype clusters are
centred, then for each variant uses an EM algorithm to adjust class membership based on
these priors and the observed data.
I ran optiCall using default settings on a per chromosome basis separately for each
genotyping run, using the sample sex as a covariate. In the second and third rounds of
Dutch case samples, each batch contained fewer than 200 samples. So at the rarer end of
the SFS, less than one sample is expected to be in the homozygous rare category. While
optiCall is robust to missing classes in rare variation, it needs reliable prior information to
do so. To ensure high quality calling of these runs I therefore:
1. Combined the meningitis samples with intensity data from a run of 41 samples from
a European population on the same platform, used by another study.
2. Treated the run ID as a covariate in optiCall.
3. Used chromosome 1 to generate priors for all other chromosomes, as it contains the
most number of variants.
After calling, I discarded the samples from the other study. I will cover direct assessment
of genotype call quality in section 5.2.1.
Quality control of genotype data
When performing QC of the called genotype data I followed the advice of C. A. Anderson
et al. (2010), though using more modern and faster algorithms where appropriate. I first
merged the first two runs of Dutch cases and controls, giving five sample sets to QC (Dutch
combined, Dutch case batch three, Danish meningitis combined, Danish bacteremia and
Danish controls).
For all these datasets, I performed the following basic QC steps using plink:
1. Predict sample sex using genotypic data (heterozygosity rate on X chromosome).
Where discordant with recorded phenotypic sex, or the phenotypic sex was missing,
I replaced it with the predicted value.
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2. Remove samples with an overall heterozygosity rate above three standard deviations
from the mean.
3. Remove samples with > 3% of genotypes missing.
4. Remove markers with > 5% of genotypes missing.
5. Remove markers with a significantly different call rate between cases and controls
(p < 10−5).
6. Remove markers with MAF < 1%.
7. Remove markers out of Hardy-Weinberg equilibrium (HWE) (p < 10−5).
Failing samples were removed before failing markers, to maximise the number of markers
retained. Steps 2–5 remove those samples and markers which have not been genotyped
well on the array, whereas step 6 removes those markers with insufficient power to inform
imputation or association. Step 7 is useful in discarding genotype failures as almost all
markers are close to being in HWE, so the number of samples in each genotype group
can be related to the MAF. Departures from HWE are mainly due to genotyping failures,
where clusters have been incorrectly merged or labelled. However, while a good first step,
this step is not sufficient to remove all genotyping failures.
I then estimated sample ancestry and relatedness within each collection. To estimate
degree of relatedness between samples I used KING with default settings (Manichaikul
et al., 2010). For ancestry, I first removed palindromic SNPs (A/T or C/G) to minimise
strand issues, and merged with the genotype data with 270 individuals from four different
ancestries released as phase II of the HapMap project (International HapMap Consortium,
2005; International HapMap Consortium et al., 2007). I then used eigenstrat to perform
PCA on the merge of samples and hapmap to identify and control for ancestry (A. L. Price
et al., 2006).
I did not immediately discard these samples as they can still be included in a linear
mixed model to increase discovery power (Lippert et al., 2011; Zhou & Stephens, 2012).
Instead, I only removed identical samples, and recorded those which were related as
third-degree or closer, and samples of non-European ancestry (PC1 < 0.07 in the hapmap
projection; fig. 5.1). These were only removed in downstream analyses requiring unrelated
samples from the same population.
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Figure 5.1: Projection of samples onto first two principal components of case (green crosses) and control
(blue stars) samples from a) the Netherlands and b) Denmark with HapMap phase I populations. HapMap
populations are 3 (red crosses) – CEU, European; 4 (pink squares) – CHB, Han Chinese; 5 (turquoise
squares) – JPT, Japanese; 6 (yellow squares) – YRI, Yoruba Nigerians.
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Using this first pass of QC, I performed an initial association test at all passing sites
using a logistic regression. I removed all population divergent and third-degree or closer







at every marker, where y is the vector of binary phenotypes, X is the additive model matrix
of genotypes (0 for homozygous common; 1 for heterozygous; 2 for homozygous rare)
and β is the fitted slope. Using the Wald test p-values I found 226 sites suggestively
associated with the susceptible phenotype p < 10−4, and manually inspected the genotype
cluster plots using Evoker (https://sourceforge.net/projects/evoker/files/). Many of these
plots were miscalled in one or more cohorts, though in such a way that the HWE p-value
managed to pass the filter set earlier. Some examples of faulty calling are shown in fig. 5.2
– all such identified variants were removed prior to downstream analysis and imputation. In
addition, I performed an association within the control group, using the ALS study as cases
and the B-PROOF study as controls. As there should be no overall phenotypic difference
between these cohorts any significant results are likely artefacts from genotyping batch or
incorrect calling (Burton et al., 2007). I therefore removed all markers with p < 5×10−8.
Figure 5.2: Examples of manual quality control of genotype cluster plots. All were removed rather
than recalled. a) Evoker view of rs9516252. In cases missing genotypes have been mistakenly called as
homozygous rare, whereas in cases-ext they were correct (red circles). b) A common mode of failure when
cluster centres are not near the average. Left: incorrect identification of only two clusters at rs2717808.
Right: corrected identification of three clusters. c) A common mode of failure when there are only two
clusters at low MAF. Left: incorrect split into three clusters at rs17876189. Right: corrected identification of
two clusters.
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Imputation of untyped variants
To increase the power of GWAS it is common practice to impute the allele of untyped
common variants in LD with those directly typed by the array, using haplotype information
from whole genome sequenced population cohorts (Stranger et al., 2011). By finding
overlap between genotyped alleles and haplotypes drawn from the population at these
positions while taking into account population level LD it is possible to assign a probability
of each genotype at all known variable positions. This increases the number of locations at
which association can be tested for, mitigating the loss of low quality markers, and giving
more information around signals of association. During genotype imputation all sites in
the reference panel are assigned a most likely allele. At many common sites imputation
accuracy is good (R2 =∼ 0.9), and accuracy can be assessed through the INFO score which
assesses how much information has been added at each position over the worst case of
assigning the population MAF.
Humans are diploid organisms: they inherit one copy of a chromosome from their
mother and the other from their father. However, as imputation works with haplotypes,
a linear sequence along a single inherited chromosome, input genotypes must first be
‘phased’ into haplotypes. Phased data ensures that heterozygous SNPs are assigned to the
chromosome they came from: for example if two alleles A/B were called as heterozygous
and were next to each other possible haplotypes would be AA + BB or AB + BA (fig. 5.3).
Data can be directly phased by barcoding which DNA molecules are being sequenced
(Borgstro¨m et al., 2015), or by sequencing the sample’s ancestors (mother and father).
With genotype arrays used for GWAS direct phasing is not possible, but phased population
reference panel data can be used to statistically estimate the most likely haplotypes of the





Figure 5.3: Demonstration of the effect of phasing. The subject is heterozygous for an A/B allele at two
positions. The left panel shows one possibility, where the maternally inherited haplotype (red chromosome)
is AA and the paternally inherited haplotype (green chromosome) is BB. The right panel shows the other
possibility, of AB and BA haplotypes. Though there are another two possibilities gained from switching the
parents, phasing does not distinguish these.
I performed phasing and imputation of variants using two methods. The first method,
which I performed with the first batch of Dutch cases and controls, used the software
shapeit2 (Delaneau et al., 2013; O’Connell et al., 2014) and impute2 (B. N. Howie
et al., 2009; B. Howie et al., 2011) directly. I first merged the data, working with a file per
chromosome across all case and control samples, then performed phasing with shapeit2.
It is common to use the 1000 Genomes Project as the reference panel, as it contains a large
collection of diverse haplotypes (1000 Genomes Project Consortium et al., 2015). It has
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been shown that using a population specific reference panel can further increase imputation
accuracy due to better matching, longer haplotypes being present between the reference
panel and genotyped subjects (The Genome of the Netherlands Consortium, 2014). I
therefore used impute2 in reference panel merging mode, using both 1000 Genomes phase
3 (5 008 haplotypes) and The Genome of the Netherlands (GoNL) (998 haplotypes) as
references to try and attain the best possible imputation accuracy for Dutch samples. I
wrote a pipeline to automatically perform the imputation over a cluster system using this
method by working in parallel on chunks of 2.5Mb at a time with a 250kb buffer to avoid
loss of accuracy at the ends of each chunk, and automatically resubmitting failed jobs with
more memory or wall-time as appropriate.
As more data became available later through the project, more efficient methods and
sophisticated interfaces to phasing and imputation became available. Faster phasing became
possible with eagle2 (Loh et al., 2016) and faster imputation with PBWT (Durbin, 2014).
This allowed the collection and use of the much larger and more diverse reference panel
the haplotype reference consortium (HRC) (McCarthy et al., 2016). Though imputation
accuracy is slightly lower than impute2, the efficient data structure and matching algorithm
within PBWT allows rapid imputation even with the 63 000 haplotypes in release 1.1 of
the HRC. The larger reference panel size overall gives good imputation accuracy, and
includes both reference panels used in my previous imputation iteration. I therefore re-ran
the phasing and imputation using this procedure, through the Sanger imputation server
(https://imputation.sanger.ac.uk). Sex chromosomes were not included in this release, so
all downstream analysis is of autosomes only.
To homogenise samples before imputation I used the HRC strand checking tool (http:
//www.well.ox.ac.uk/∼wrayner/tools/#Checking). For each sample cohort, this checked
whether alleles, strand of genotyping (which should all be on the positive strand, rather than
the Illumina TOP strand), reference allele and MAF match with the reference panel. SNPs
with MAF > 0.2 different from the reference panel are removed, which may assist with
missed strand flips. I merged all samples with the same array version together (table 5.1)
and then performed phasing and imputation.
Using the imputed data, I performed a final QC check on all the markers from the
reference panel to remove low confidence sites. I re-applied the filters of MAF > 1% and
HWE p < 10−5, as well as removing any sites with an INFO score < 0.7 (suggesting poor
imputation accuracy). After this step, 6.8M good quality SNPs were left for association.
For phenotypes with lower numbers of cases (unfavourable outcome, genome to genome
analysis) I applied a stricter MAF filter of > 2%.
An initial association using eq. (5.1) revealed two quality issues not identified by
the filters described. In both cases the issue was manifested by many highly significant
p-values of markers, and non-significant values of those nearby and in LD with the lead
variant. The first was a failure to match the strand between cases and controls, and in some
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cases the imputation reference panel, at palindromic SNPs. At non-palindromic SNPs the
reference strand is unambiguous and was correctly assigned by the strand checking tool,
but at 1 722 (around 0.3% of genotyped positions) A/T or C/G SNPs with MAF > 30%
neither allele or frequency mismatch could be used to disambiguate the genotype value. I
used the Illumina genotype manifests data to ensure all genotypes were with respect to the
positive reference strand rather than the Illumina TOP strand, and re-ran the imputation
and subsequent QC on all affected cohorts.
The second issue was due to a mismatch of array design between cases and controls
for the Danish bacteremia samples and GOYA controls. Despite performing separate QC
and imputation of these cohorts to arrive at the same set of genotyped markers, a simple
merge led to spurious association results. Although the imputation model in theory should
allow for imputed sites to be merged when produced from different sets of calls, in practise
subtle differences in genotyping quality and marker density for a large number of samples
can easily lead to systematic differences between cases and controls. To match these two
cohorts without introducing technical differences between them, I took the intersection
of SNPs between the two panels and merged the genotype calls, then performed identical
QC steps on the dataset as a whole. As this left only 291 830 markers (∼ 50% of that on a
single array) I used minimac3 via the Michigan imputation server (Sayantan Das et al.,
2016) to perform imputation to the HRC, as this algorithm coped with the relative sparsity
of markers better than PBWT.
Finally, as the CFH region was of particular interest given its previously reported
association with meningococcal meningitis, we reimputed it for all the Dutch samples
using impute2. In this mode we allowed impute2 to infer the phasing during its MCMC
which is far slower, but more accurate over this small region. This imputed data was
used for meningococcal meningitis associations not reported here, and for the specific
association with antigens in section 5.3.3.
5.2.2 Association results
Using the quality controlled genotype data I was able to perform three analyses on each
cohort. The first was an estimation of heritability of each trait of interest, which represents
the proportion of phenotypic variance explained by genetic variation. As in sections 3.3
and 4.4 I performed this calculation using different methods, as various technical limitations
of each can bias estimates (Evans et al., 2017; Speed et al., 2017). All methods assume
unrelated individuals with shared ancestry, so I filtered out these samples before performing
heritability calculations.
I used the GCTA-GREML model, as implemented in bolt-lmm (Loh et al., 2015),
which assumes normally distributed effect sizes with a variance equal to the genetic
component of heritability σ2g (J. Yang et al., 2010; J. Yang, Lee et al., 2011). Under this
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assumption, restricted maximum likelihood optimisation of a LMM can be used to estimate
h2SNP. This model does not adjust for LD, which in some cases may lead to underestimation
of h2SNP (Speed et al., 2012). I therefore used LD-pruned SNPs as the input, and performed
an additional heritability estimate with LDAK, which adjusts the weights of SNPs by their
LD when calculating the kinship matrix used as the random effects in the linear mixed
model.
After confirming that it is expected that a genetic contribution to the phenotype exists,
I then ran an association scan. This performs a regression between variant and phenotype
at every marker, though the use of an LMM allows ancestry and relatedness of samples to
be included as random effects in the regression model. This means ancestrally divergent
and related samples do not have to be completely removed, increasing the power to find
associations without increasing type I error (A. L. Price, Zaitlen et al., 2010). It has
previously been computationally prohibitive to fit this model to every imputed marker, but
recent efficiency advances have allowed this technique to become commonplace (Lippert
et al., 2011; Zhou & Stephens, 2012). I used bolt-lmm to perform the association (Loh
et al., 2015), using LD-pruned genotyped markers to estimate the kinship matrix and
random effects, and performing association at all genotyped and imputed sites. Where
appropriate, I have included covariates such as immunocompromised status as fixed effects
in the model.
The final question I wished to test using this data was whether there was evidence
for difference of the genetic basis between similar sub-phenotypes of invasive disease.
For example, is the association with CFH specific to meningococcal meningitis, or is it
also shared by pneumococcal meningitis too? Overall, is there a difference in genetic
susceptibility to different pathogens, or different manifestations of invasive disease? As
the case numbers are low, these studies were underpowered to detect a difference through
direct association of different sets of markers, or to calculate co-heritability. However, in
such cases, performing an association between all cases and controls, and then between
sub-phenotypes of cases may help test for an overall difference. Liley et al. (2017) have
developed the subtest method which fits a mixture of Gaussians to the Z-scores from these
two association tests, which compares the null model fit assuming no difference between
subphenotypes and the alternative model when there is a difference. It can extract a p-value
from the LRT which expresses the probability that the genetic basis for the subphenotypes
are distinct. When running subtest I used the weights from LDAK to account for LD
between associations, and performed 1 500 subsamples of 400 samples to generate the
null-distributions of the test statistic.
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Dutch cohort results
In the Meningene cohort I considered three different phenotypes: the susceptibility of
adults to bacterial meningitis (using all cases), pneumococcal meningitis only, and severe
(unfavourable clinical outcome) meningitis. In all of these associations I used immuno-
compromised status as a covariate (10% of cases) assuming that no controls were immuno-
compromised, as population prevalence is around 1% (van Veen et al., 2011; Harpaz et al.,
2016).
The heritability analysis (table 5.2) showed that human genetic variation was expected
to contribute to all of the phenotypes of interest. The size of the contribution varied, but
was relatively high in comparison to other complex traits (Ge et al., 2017). In general
LDAK estimated a higher heritability than GCTA-GREML, as expected from the structure
of the models (Evans et al., 2017). Analysis using subtest as described above did not
provide any evidence that pneumococcal meningitis was distinct from other bacterial
meningitis (PLR = 0.25; p = 0.75) or that unfavourable outcome was distinct from overall
meningitis susceptibility (PLR = 0.14; p = 1.00). However this may rely on relatively
highly associated SNPs, which were not found with this few samples. Susceptibility to any
meningitis has a significantly higher heritability than its sub-phenotypes, which also have
heritability above zero. This is more consistent with some difference in genetic architecture
between the phenotypes.
Phenotype Method Heritability Error Fit p-value
All meningitis GCTA 0.418 0.064 2.4×10−6
LDAK 0.556 0.088 3.9×10−11
Pneumococcal meningitis GCTA 0.353 0.068 2.4×10−6
LDAK 0.416 0.096 3.9×10−6
Unfavourable outcome GCTA 0.192 0.067 2.8×10−5
LDAK 0.325 0.090 1.4×10−4
Table 5.2: Human SNP heritability (h2SNP) of three meningitis phenotypes in Dutch adult cohort. Pneumo-
coccal meningitis and unfavourable outcome are subsets from the ‘all meningitis’ phenotype. For each
phenotype I estimated heritability using both GCTA-GREML and LDAK models, in every case there was
evidence for heritability significantly above zero.
The Manhattan plots of the association results are shown in figs. 5.5 to 5.7. Across
the three traits only one locus reached genome-wide significance: position 64680775
on chromosome 1, an intronic variant in UBE2U, was associated with unfavourable
outcome (MAF = 0.43; OR = 1.62; p = 2.0× 10−8). UBE2U is part of the ubiquitin
pathway (responsible for degrading proteins in the cell) (Gregory et al., 2006), but has not
previously been associated with any other disease or trait. The signal also spanned ROR1
(fig. 5.4), a protein of unknown function (Bainbridge et al., 2014) which has previously
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been associated with cancers (Reddy et al., 1996) and pulmonary function (Lutz et al.,
2015). Signals suggestive of significance for each trait are reported in table 5.3. Despite the
lack of association from meningitis susceptibility, the heritability estimates above suggest
that meta-analysis with more samples should be able to find associations with lower OR
and MAF. I otherwise delay a detailed interpretation of results until they are replicated in
an independent study and reach genome-wide significance in section 5.2.3.
Phenotype Position Effect allele MAF OR p-value Annotation
All meningitis chr6:153582990 T 0.42 1.27 7.2×10−8 Upstream of RGS17
Pneumococcal meningitis chr6:117624549 G 0.46 0.77 8.8×10−7 ROS1 intron
chr18:48403560 T 0.43 0.65 7.6×10−8 ME2/ELAC1/SMAD4
chr22:47506160 G 0.33 0.74 5.5×10−7 TBC1D22A intron
Unfavourable meningitis chr1:64680775 A 0.43 1.62 2.0×10−8 UBE2U/ROR1
chr4:182823804 A 0.33 1.58 4.1×10−7 AC108142.1 intron
chr9:37382231 A 0.07 2.36 6.7×10−7 ZCCHC7/GRHPR
Table 5.3: Signals of association in the Dutch cohort. I report the lead SNP at each associated locus with
MAF > 5% and p < 1×10−6, and nearby annotated genes. The suggestive signal in all meningitis cases
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Figure 5.4: Locuszoom plot (Pruim et al., 2010) of association on chromosome 1 with unfavourable outcome,
which is a zoom of the Manhattan plot on the locus. The lead SNP is a purple diamond, other markers are
circles coloured by their r2 with the lead SNP to show LD. The bottom panel shows annotated genes in the
region, with exons as boxes and introns as lines. Recombination rate in cM/Mb is plotted as a pale blue line.
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Danish cohort results
Once again analysis of all invasive pneumococcal disease, pneumococcal meningitis and
pneumococcal bacteremia suggested a heritable component to each of these phenotypes
(table 5.4), with estimates consistent with the Dutch study (although with wider confidence
intervals, due to the smaller number of samples). Subtype did not provide any evidence
that bacteremia and meningitis are genetically distinct phenotypes (PLR = 311; p = 0.60),
as associations between the phenotypes followed a similar profile. No genome-wide
significant associations were found for either pneumococcal meningitis or pneumococcal
bacteremia (figs. 5.8 and 5.9). The only suggestive association (MAF > 5% and p <
1× 10−6) was found on chromosome 14 at 67181537 (MAF = 0.14; OR = 0.45; p =
2.2×10−7) in an intron of GPHN.
Phenotype Method Heritability Error Fit p-value
Invasive pneumococcal disease GCTA 0.259 0.081 1.3×10−5
LDAK 0.285 0.092 8.5×10−4
Pneumococcal meningitis GCTA 0.727 0.451 5.1×10−7
LDAK 0.849 0.569 7.3×10−2
Pneumococcal bacteremia GCTA 0.371 0.098 1.4×10−5
LDAK 0.575 0.113 2.1×10−7
Table 5.4: Human SNP heritability (h2SNP) of three pneumococcal phenotypes in Danish children cohort, as
in table 5.2. Pneumococcal meningitis and bacteremia are subsets of the overall category of invasive disease.
5.2.3 Meta-analysis of four studies
An important step in GWAS is to confirm the results using an independent study population.
As well as avoiding possible batch effects from a single cohort, this also increases sample
size and power at true associations with an OR/MAF too low to find in the initial study.
Here I did this analysis for meningitis susceptibility, which had the most total samples
available. I used the summary statistics (p-value and β ) that I generated from the Dutch
and Danish cohorts, as well as summary statistics I received from 23andme and GenOSept
(table 5.1).
I performed the meta-analysis between these studies using METAL (Willer et al., 2010).
At each site the beta values (effect sizes and direction) and p-values from each study are
converted into z-scores, which are then combined as a weighted sum with the weights given
by the number of samples N in each study. This combined z-score gives the meta-analysis
p-value. Before doing this I made sure all marker positions and alleles were given with
respect to the same reference, as the direction of effect is crucial. For the association
170










































































































































































Chapter 5. Human genetics contributing to invasive pneumococcal disease
studies I performed using bolt-lmm I adjusted the beta values using the formula










rather than the total number of samples, as some of the studies were highly biased to a
larger number of controls (for example 23andme used 842 samples and 82 778 controls). I
only included markers that had summary statistics from all studies in the meta-analysis (M
= 5 627 710), to avoid effects of sample size heterogeneity in the final p-values.
Figure 5.10 shows the results of the meta-analysis genome-wide. No sites were
significant in this analysis, and the additional data did not support the genome-wide
significant hit in an intron of CA10 reported by 23andme (Tian et al., 2016). A possible
reason for these observations is due to heterogeneity of phenotype between the cohorts in
the meta-analysis. The simple method used here assumes that sites must have the same
direction of effect, and are independent observations of significance, and are on the same
phenotype with no measurement error. However, the Dutch and Danish cohorts differ in
that they analyse adult and childhood meningitis respectively, which differ in their immune
system competence and their vaccination status (Imo¨hl et al., 2010; Rodrigo et al., 2014).
GenOSept includes bacteremia cases, which may be different from meningitis specifically.
Finally, 23andme uses self-reported status of bacterial meningitis. While self-reported data
has generally been shown to be as good as hospital diagnoses for phenotype association,
especially given the increased number of cases available, for difficult to diagnose infectious
diseases such as lupus this has been shown not to be the case (Tian et al., 2016; Cortes
et al., 2017). For bacterial meningitis cases have not been culture-proven, and may well be
viral meningitis or not meningitis at all. If they are meningitis, most likely a wider range
of pathogens compared to the other cohorts have been included.
A future analysis will include association statistics calculated from the UK biobank,
which has a large collection of genotyped samples (N = 500 000) and hospital diagnoses
for bacterial and pneumococcal meningitis. This may help to provide extra samples with
a well-defined phenotype. Alternatively, modelling the heterogeneity in phenotype may
help, though sample size is still likely to be a limiting factor.
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5.3 Genome-to-genome analysis of host and pathogen
variation
In this final section I aim to bring together data from chapter 4 and section 5.2 to search
for genome-to-genome associations between the host and pathogen in cases of bacterial
meningitis. By linking the datasets from the human and pathogen arm of the Meningene
study and performing an association study between pairs of variants drawn from each
genome over all these samples, I tested the hypothesis that certain bacteria are more likely
to cause invasive disease in specific host genotypic backgrounds. This dataset is unique,
and to the best of my knowledge the first time both host and pathogen have been sequenced
for a bacterial infection. The present analysis does not require a phenotype, an advantage
of such epistasis analyses (Skwark et al., 2017).
In viral infections, two previous analyses have been published attempting this analysis.
Bartha et al. (2013) used host genotype and the infecting viral genome from 1 071 HIV
patients to perform a logistic regression between every human SNP (of which there were
∼ 7 million) and every viral amino acid (of which there were 3 000) while using the first two
principal components to correct for viral population structure. The authors recapitulated
the well known association with viral load and HLA allele, but were unable to find any
new genome-to-genome links. They estimated having 80% power to detect a variant with
MAF of 10% with an OR of 4.2 given their sample size and the number of tests being
performed.
Azim Ansari et al. (2017) performed a similar analysis on 542 cases of hepatitis C
infection. Again using imputed human genotypes and viral amino acids they performed a
logistic regression between variants, using the first three principal components to control
for human population structure, and the first ten to control for viral population structure. As
well as finding expected associations with the HLA, they found a region of the viral genome
associated with variability in IFNL4, though not quite reaching significance. However, the
same human SNPs were found to be associated with viral load, for which the authors were
able to conclude a link between the strength of selection acting on the viral population due
to the IFNL4 response, and the resulting fitness of circulating virions.
I wished to first remain agnostic to annotation or previous knowledge of host-pathogen
interactions to attempt to uncover previously unknown genome to genome links in clinical
cases of bacterial meningitis, following a similar design to the two viral studies. To do
this, in section 5.3.1 I performed an association test between every genotyped human
SNP and every bacterial mapped SNP/INDEL. However, given the small sample size
and the large amount of variation between the two genomes, the power to overcome the
multiple testing was very low for even moderate effect sizes. I therefore used unsupervised
clustering techniques which use the correlation structure present in the bacterial population
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to produce a lower dimensional representation of the bacterial genomic variation, lowering
the multiple testing burden (section 5.3.2).
Finally I wished to test whether variation in host and pathogen protein which are well
known to interact with each other is correlated in cases of disease (section 5.3.3). I used
the detailed antigen calling already performed in section 4.3.1 as the bacterial variants,
and tested for correlation with human variation. As these bacterial proteins are known to
be broadly antigenic (Croucher et al., 2017), I tested not only the specific human gene
involved in the interactions, but every imputed human variant to try and identify potential
new interaction partners.
In the tests below I used the 460 samples which passed the QC filters from both
sections 4.2 and 5.2.1. When performing associations on a sub-phenotype, as in splitting
these samples into two based on cluster or antigen membership and testing human SNPs
against this, I only tested those sub-phenotypes which contained at least 5% of samples.
This avoided spurious results from testing rare (and underpowered) variants resulting from
partitioning lower frequency variants into yet lower frequency phenotypes.
5.3.1 All by all variant association
To perform a correlation analysis between 7×106 imputed human variants and 1×105
requires around 1012 association tests, which even given the availability of a large number
of CPU cores and the embarrassingly parallel nature of the problem is computationally
challenging.
To approach this problem, I modified the SEER C++ code from chapter 2 to perform
the association tests, as I had already optimised it for speed. I converted the VCF files with
the human and pathogen variant calls to comma separated values (CSV) files, coding the
human calls as 0, 1 or 2 based on the number of copies of the minor allele the genotype
contained (the additive model). These CSV files then only contained the genotypes, and
I stored site and sample level metadata in separate files – this separation allows much
quicker processing of genotype data, especially when accessing specific chunks (Ganna et
al., 2016). I extended the χ2 test to a 3x2 table, and added efficient code for a 3x2 Fisher’s
exact test (https://github.com/chrchang/stats) which I applied when the assumptions of
the χ2 test were violated (by small expected values in the table counts, when MAF in
either genome was low). I used a filter of p < 5×10−11 for this uncorrected test, which is
equivalent to a Bonferroni correction with a significance level of α = 1. I then tested the
pairs of variants which passed this filter with a logistic regression, using the human SNP
and the first three components of the bacterial MDS projection as the design matrix X and
the bacterial variant as the response vector y.
To parallelise the code I used 300 independent jobs. Each job first read in all the
bacterial variants from the CSV file, and parsed these into a matrix stored in main memory.
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The null log-likelihood for the logistic regression was calculated for each at this point,
to avoid having to make this calculation multiple times when the same bacterial variant
was tested against every human SNP. The chunk of human SNPs assigned to the job were
then read in, and each one passing filtering was tested for association with every bacterial
variant.
As the number of imputed human SNPs was still prohibitively large, I tested the
genotyped human variants only. This is similar to testing an LD pruned subset of sites
with the advantage that their genotype calls could be further investigated if they proved
significant. Using this approach I tested 623 649 human SNPs for correlation with 113 059
associated bacterial variants (SNPs and INDELs from section 4.3). 1.8×1010 variant pairs
passed filters of MAF > 5% in both human and bacterial population with < 5% of calls
missing. Using 300 jobs the total computation time was 268 hrs, using 600Mb memory
per job. 2 433 variant pairs passed the initial p-value filter for p < 1 when adjusting for
multiple testing, but none of these were significantly associated at p < 0.05 when tested
adjusting for bacterial population structure.
Due to the high multiple testing burden from the large number of variant pairs being
tested, this number of samples would only detect strong correlations between genomic
variants. This is plotted in fig. 5.11: assuming a MAF of 25% in each population, the
sample size of 460 has 80% power to detect an epistatic effect with an odds ratio of 4.
While bacterial population structure is less likely to be an issue for this analysis, it may
still reduce the power to fine-map specific interactions. To find whether interactions exist
at lower coupling strengths it would help to have more samples, as at sample sizes double
this study the discovery power increases sharply. The number of samples is also currently
too small to do a heritability analysis of the interaction effect.
While sample size fundamentally limits this analysis, there are some further steps to be
taken. Firstly, the use of Direct Coupling Analysis has been shown to have greater power
at detecting epistatic interactions in the S. pneumoniae genome than the simple χ2 tests
I have used (Skwark et al., 2017). However, an implementation of this which will scale
to the size of the present problem does not exist. Instead, in subsequent sections I use
a representation of the pathogen genome in a lower number of dimensions to attempt to
reduce the multiple testing burden.
5.3.2 Reduced representation of pathogen genome
Given the difficulties encountered when testing every human variant against every bacterial
variant, I wished to find a way to reduce the dimensionality of the problem. This problem is
well known in eQTL studies, where both transcriptomic and genomic variation is measured,
and an association is performed between the genetic variation and altered gene expression
(Breitling et al., 2008; L. Franke & Jansen, 2009). One approach is to model the per-gene
177














Figure 5.11: Power for detecting genome-to-genome interactions. Assuming no population structure effect,
the power of detecting an correlation between genome positions at 25 % MAF at a range of ORs. The 460
samples I was able to use in this study is marked as a vertical dashed line.
levels of transcript variation as a smaller number of latent variables, each of which affect a
number of transcripts. The simplest way to do this would be by PCA which would use the
linear combinations of transcripts explaining most of the variation as the latent variables,
though more sophisticated methods exist (Marttinen et al., 2013; Gillberg et al., 2016). In
the present analogy, transcript variation corresponds to bacterial sequence variation, and
the latent variables may combine these into features such as sequence type, serotype or
antibiogram type.
A method which has been successfully used for this purpose is probabilistic estima-
tion of expression residuals (PEER), which estimates latent factors and their per sample
weighting from high dimensional input (Stegle et al., 2012). PEER’s advantages over PCA
are that: the latent factors estimated from the data do not have to be orthogonal, which
may not always be biologically realistic; covariates can be included in the model fit such
as batch effects or case/control status; the factors can be controlled to not be parallel with
other known influences, for example serotype or sequence type.
I therefore ran PEER, learning 40 unobserved factors (though this is an unimportant
setting, as automatic relevance determination is used to determine this from the data). The
results are shown in fig. 5.12 – the first few factors can be seen to represent the large scale
population structure, and some later factors represent finer scale population structure. I
performed an association with all imputed variants against all the inferred factors, which
gave uninflated results for the first twelve factors. Further factors gave spurious results at
lower frequency variants.
While the PEER factors can be interpreted by the looking at the weights assigned to each
input variants for the associated factor, I found this difficult to link directly to a biological
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Host and pathogen genetics associated with pneumococcal meningitis
interpretation. Noting that the first components were describing population structure,
I instead opted to instead test discrete population clusters for correlation with human
variation as the interpretation of the bacterial variants was much more straightforward.
This is essentially testing for lineage effects correlated with human variation, as the power
to find locus effects is limited (as calculated above). I therefore created a core-genome
alignment of these strains using roary as in section 4.3, and ran BAPS on this to generate
population clusters. I found that the PEER components generally represented the same
population structure as the BAPS clusters (fig. A.15).
Cluster Serotype Samples Tested
1 4 17 -
2 - 145
3 8/11A/33F 49
4 10A/35F 22 -
5 23A/B/F 32





Table 5.5: Number of samples in each population cluster. Cluster two is a polyphyletic ‘bin’ cluster. The
dominant serotypes for each cluster, where they account for > 50% of the isolates, are listed.
Table 5.5 lists the ten clusters found in the data, and the dominant serotypes for each
cluster. I ran an association with the BAPS clusters with at least 10% of samples in the
subphenotype. The only result reaching genome-wide significance was an association
between cluster eight (serotypes 9N/15B/19A) and variants on chromosome 10 (fig. 5.13).
The lead variant is at position 134046136 on chromosome 10 (MAF = 0.27; OR = 4.28; p
= 1.2×10−8) located in an intron of STK32C, a serine/threonine kinase highly expressed
in the brain. The high effect size estimated for the interaction is consistent with the power
predicted in fig. 5.11.
5.3.3 Association of antigens
This section considers known interactions between host and pathogen proteins, and whether
variation in the coding sequence or surrounding regions of each gene is correlated in cases
of bacterial meningitis. S. pneumoniae has many virulence factors, some of which are
known to interact with specific human proteins (Kadioglu et al., 2008). However, I was
mostly interested in the interactions where the pneumococcal protein contains sequence
variation, ideally somewhat independent of population structure. These regions have
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Figure 5.13: Locuszoom plot of association on chromosome 10 with sequence cluster 8, as in fig. 5.4.
higher power to be detected in an association analysis, and the higher rate of variation
is potentially a sign of diversifying selection, which may mean the variation is more
likely to be associated with specific interactions with the human immune system. Using a
combined mapping and assembly approach, followed by a supervised machine learning,
in section 4.3.1 I have classified the pspA, pspC and zmpA allele of every sample in the
Meningene collection.
pspA is known to bind to C3b, preventing decomposition on the pneumococcal surface
and blocking the complement pathway response to infection (Tu et al., 1999). The LTF
gene encodes lactoferrin, an iron-binding protein found in the granules of neutrophils. This
protein is bacteriocidal, and forms part of the innate immune response against pneumococci.
It has been found that pspA binds lactoferrin to the surface of the pneumococcus, thus
reducing their killing by this protein (Shaper et al., 2004).
Like pspA, pspC has been shown to bind C3 and prevent opsonic decomposition on
the pneumococcal surface (Q. Cheng et al., 2000). In addition, some forms of pspC have
been shown to bind factor H (Janulczyk et al., 2000; Dave et al., 2001). Factor H inhibits
complement activation by preventing C3b degrading and activating the next step in the
complement pathway. By binding this protein to the surface, the pneumococcus further
prevents activation of C3. This locus in the human genome is also known to be involved in
susceptibility to invasive meningococcal disease (Davila et al., 2010).
Finally I tested allelic variation of zmpA, which is a protease known to bind IgA
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(Wani et al., 1996). This is the most abundant antibody in the nasopharynx, and is an
important part of the immune response to pneumococcal infection (Cerutti & Rescigno,
2008). However, it is not produced by simple translation from a single gene and instead
involves a pathway covering the HLA along with other regions of the genome (Fagarasan
& Honjo, 2003; Ferreira et al., 2010).
For all of the antigen alleles with enough observations (fig. 5.14) I performed an
association against all imputed human variants as in section 5.2.2. I used a more accurate
imputation of the CFH region due to its potential relevance in these interactions. For
each test I produced a genome-wide Manhattan plot, and a locuszoom plot for the known
interaction partner.


















zmpA 1 26 -
2 236
3 185
Figure 5.14: Antigen classification of pspA, pspC and zmpA. The total number of samples in the genome-to-
genome analysis with each allele is shown, and those where an association test performed are noted.
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None of the bacterial antigen alleles were significantly correlated with variants in
their human interacting counterparts at the suggestive level (p < 10−5). However, there
were two associations of pspC allele reaching genome-wide significance elsewhere in the
genome. Figure 5.15 shows a locuszoom plot of each of these associations. The first is
between pspC-8 and position 148788006 on chromosome 6 (MAF = 0.08; OR = 9.20; p =
4.1×10−9). This is in SASH1, which has previously been found to have decreased expres-
sion during meningococcal meningitis (https://www.ebi.ac.uk/arrayexpress/experiments/
E-GEOD-11755/) . The second is between pspC-9 and position 98891272 on chromosome
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(b) pspC allele 9, and chromosome 13 (FARP1)
Figure 5.15: Locuszoom plot of association between pspC allele and imputed human SNPs, as in fig. 5.4.
5.4 Conclusions
This chapter has considered the effect of host variation on susceptibility to and severity of
pneumococcal meningitis. By using two relatively large well-phenotyped cohorts from the
Netherlands and Denmark, I have estimated h2SNP to be around 30-40% for susceptibility,
and around 25% for severity. This suggests that human genetics plays a role in determining
how likely invasive disease is, given that a bacteria which is capable of invasion has
colonised the individual (chapter 4). Additionally, I have shown that host genetics explains
some of the variability in disease outcome after invasion has happened, which may occur
by variation in immune response.
I then attempted to use GWAS to find specific variants which contribute to these traits,
and while I found signals reaching significance in the Dutch population, none of them have
replicated when meta-analysed with summary statistics from other similar studies. No data
from other studies is currently available associating human variation with disease outcome,
so any planned future confirmation of the association with UBE2U may have to use an in
vivo model of pneumococcal meningitis.
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It is difficult to collect bacterial meningitis cases due to: 1) their rarity, and 2) the
difficulty to confirm the causative organism by culture. It is even more difficult to determine
which of those cases resulted in a poor clinical outcome, as this requires a study design
with patient follow-up potentially months after discharge from hospital. The number of
cases collected by the collaborators for this analysis is impressive, and this has allowed
the first heritability estimates of these traits to be made. These estimates suggest that
continuation of the Meningene cohort is warranted, as is the meta-analysis with other
well phenotyped studies. With enough cases, specific associations replicating in multiple
cohorts will be found. The attempt at meta-analysis I performed here did not find any hits,
perhaps due to heterogeneity of phenotype between cohorts. Additionally, a previously
reported association in an intron of CA10 could not be confirmed.
The only previously known genetic association with meningitis is the CFH region,
which the minor allele is protective for susceptibility to invasive meningococcal disease in
children (Davila et al., 2010). I did not find this association with pneumococcal meningitis,
though when I restricted analysis to adult meningococcal cases, meta-analysis with the
Dutch cohort did not refute its existence. This may suggest a difference in the host response
based on invading pathogen, with CFH binding being less important for pneumococcal
infection.
In the genome-to-genome analysis I was able to put a limit on the strength of inter-
actions that could be detected. Despite being underpowered given the large combined
complexity of the host and pathogen populations, I was able to find possible correlations
between lineage and host variants. Additionally, some antigen alleles showed possible
correlation with variants in the host, though not in regions they are known to interact with.
The lack of association may point at the variability of antigen binding of host-proteins
being uninvolved in disease course, or may just be limited by a combination of small
sample size and high antigenic diversity. The other possible hits from this single study will
need replication before biological meaning can confidently be inferred, but the method
here shows how such analysis might be done for a bacterial infection, and the results can




6.1 Summary of findings
S. pneumoniae is a human commensal, which in rare cases can invade a usually sterile
niche. If the blood or CSF is invaded this usually leads to serious disease, called bacteremia
and meningitis respectively. While virulence factors of the pathogen necessary for invasive
disease have been identified from bottom-up lab based approaches (often relying on
a mouse model of infection), the role of naturally occurring sequence variation in the
pathogen genome in invasive disease is generally unknown.
I have used a large cohort of S. pneumoniae genomes isolated from invasive disease
and asymptomatic carriage to determine the importance of sequence variation in disease
susceptibility and severity, and to find the specific regions of the genome which contribute
to these variations in phenotype. My main approach was to use GWAS, which is a
hypothesis-free way of testing all genomic variants for association with a given phenotype.
This approach does not require prior assumptions about which genes may affect the
phenotype and does not rely on large-effect size gene knock-outs or animal models of
disease.
In the context of bacterial populations, GWAS faces difficulties caused by strong
population structure and highly plastic genomes. I developed a piece of software to help
overcome these issues by finding an appropriate adjustment for population stratification,
and using sequence elements (k-mers) to test for variation of the pan-genome. After
testing this method using antibiotic resistance as a positive control, I then applied it to the
phenotype of pneumococcal carriage duration, where I also developed a model to estimate
carriage duration from longitudinal swab data. By adapting methods derived from human
genetics, I was able to calculate the heritability caused by the pathogen genome, and
identify which variants explained variation in this important epidemiological parameter.
Using a range of bioinformatic approaches I catalogued variation of the population
of pneumococcal genomes sampled from the Netherlands, from both carriage and dis-
185
Host and pathogen genetics associated with pneumococcal meningitis
ease. I then performed associations between all of these variants and three phenotypes:
invasive disease potential, severity and mortality. This analysis showed the importance of
pneumococcal variation beyond serotype for invasive potential, but not in disease outcome,
and identified many putative genes and regions associated with increased or decreased
invasiveness. I also performed an analysis of within-host variation between blood and CSF
isolates, and while I didn’t find adaptation specific to either niche I did find evidence of
selection on genes post-invasion.
Finally I performed a GWAS of host variation with susceptibility and severity of
meningitis. I found these traits to be heritable, but despite attempts at meta-analysis with
other studies the relatively low sample size and possible prototypic heterogeneity hasn’t
yet led to a confirmed association in either case. I also attempted a genome-to-genome
analysis using both host and pathogen variation. I calculated the limit of detection given
the small sample size, and using dimensionality reduction and biological hypotheses found
possible interaction effects.
In summary, I have made the following advances. I have developed one of the first
methods to overcome the challenges of bacterial GWAS, and showed that it works better
than existing approaches. Using this technique, and others, I have quantified the effect of
pneumococcal variation on variation in carriage duration beyond the resolution of serotype,
and found some of the specific variants which affect it. I also used this top-down approach
of assessing the genetics of pneumococcal meningitis, both in host and pathogen. This
was not based around known required virulence factors, and used variation occurring
in the natural population. Analysis of within-host diversity during meningitis found
selection acting on additional genes. I calculated the heritability of host susceptibility to
pneumococcal meningitis, and performed an association study using human genetic data. I
also attempted the first genome-to-genome analysis with bacterial genomes and human
genotypes.
6.1.1 Bacterial genome-wide association studies
Bacterial GWAS approaches have faced three main difficulties: lack of large sample
collections, strong population structure confounding results and extensive pan-genomic
variation. With the first restriction starting to be lifted, there is a need for scalable GWAS
methods directly applicable to large populations of bacterial genomes. Such methods must
account for population structure, and ideally assay variation in both the core and accessory
genome without relying on a reference alignment.
The use of k-mers to assess pan-genomic variation had previously proven successful,
so I wished to implement an approach which could efficiently perform associations using
these as sequence variants. As the application of phylogeny based approaches are restricted
due to their heavy computational burden and the need for an accurate recombination-
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free tree, I opted to adapt regression-based methods used in human genetics to apply to
bacterial GWAS. I wrote code to maximise the likelihoods of these regressions in C++,
using efficient optimisation techniques as a first try, and more robust methods as a second
pass.
To work out how to deal with population structure I compared various approaches in
terms of accuracy and computational burden for phylogeny reconstruction. Knowing that I
would be using k-mers in the association, I found that a method using the Jaccard distance
between subsets of overall k-mers was sufficient to control for population structure in my
simulations, and for antibiotic resistance in S. pneumoniae. Since writing this code the
minHash distance has been adapted for distances between genetic sequences (Ondov et al.,
2016), and can now be used as a more efficient replacement for Jaccard distance. I used
the eigenvectors with the three largest eigenvalues calculated from this pairwise distance
matrices in a fixed effect logistic or linear regression, in analogy with the standard method
used in human genetics. To deal with possible very large effect sizes in these regressions I
used the LRT for significance, and Firth regression for when data was nearly separable (as
in trimethoprim resistance).
This approach proved to be broadly successful for antibiotic resistance in S. pneumo-
niae, worked with simulated data, and found a potential virulence factor in S. pyogenes.
However, in all of these cases the predicted effect size was very strong, and population
structure was generally not strongly associated with the phenotypes tested. I did not test
whether the population structure correction I applied here was more broadly applicable,
and would be sufficient in other species or phenotypes where these conditions no longer
hold. The use of more eigenvectors should improve the trade-off between false positive
rate and power, but it may be the case that including them as random-effects under a linear
mixed model may offer the best option. When used for carriage duration, I found that
a LMM had slightly higher power for detecting homoplasic low frequency effects when
compared to using fixed effects while controlling for false positive rate. However, it was
not as useful as the fixed effects model for including possible lineage associated variants
for follow-up elsewhere. For invasiveness of S. pneumoniae, the fixed effect model using
ten population structure components appeared to have a high false positive rate, where the
LMM offered better population structure control and was still powered to find associations.
I have therefore already observed situations in which different methods would be the
best to use. A comparison of these possible methods based on a range of population
structures, phenotype distribution, recombination rate/homoplasy, effect sizes, lineage and
locus associations would be useful, and is not something I attempted here. It is difficult to
simulate realistic bacterial phylogenies, and synthetic associations introduced as part of this
kind of simulation may be easier to find than associations in real populations. To perform
this comparison I would take observed sequence alignments from real populations, and
introduce synthetic associations using eq. (2.11) over the range of parameters of interest.
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A comparison of power and false positive rate of fixed and random effect regressions as
well as phylogeny based methods would be useful for future applications.
The population structure correction I used in SEER is a reasonable start, and works
well for strong effects such as antibiotic resistance. A comparison with other possibilities
with positive and negative controls (either simulated or known associations) will help
inform future development. I mostly tested methods on locus effects, and have ignored
or controlled for lineage effects in the output. In the future, a ranking of lineage effects
in the output would be useful in case lab-based follow-up of these sites is possible. Clear
assignment of sites as either lineage or locus effects would be helpful too, and ancestral
state reconstruction combined with a comparison between adjusted and unadjusted test
statistics may help classify variants into one of these two classes.
A difficulty in both cases is picking a significance threshold. In my first attempts I
reasoned that every possible site in the genome multiplied by all three possible mutations
should be used as the number of tests, and backed this up with permutation testing.
However, as samples are not independent and identically distributed due to their genetic
relatedness then permuting phenotype labels may not be appropriate, as it assumes any
switch of label has the same effect ignoring any covariance between samples. Permuting
labels within population clusters may be better, but likely too conservative. Monte Carlo
permutation using the a covariance structure calculated from the phylogeny is also possible,
though with the usual caveats of computational burden and reliance on a high-quality tree.
Inspection of Q-Q plots is useful and can visually allow for the identification of a breakpoint
between population structure effects and a significant signal, and how much the former is
affecting the association model overall. While this is not a consistent way of choosing a
threshold, it can help with ranking the top hits. For the LMM, where population structure
is well controlled at the lower end of the p-value spectrum, a conservative Bonferroni
correction based on number of patterns seems appropriate based on the Q-Q plots tested
here. For fixed effects models picking this threshold remains a challenge, though Q-Q
plots can help.
The use of k-mers worked well in the applications tested, and managed to find asso-
ciations SNPs would not. They enjoyed the expected advantages from not requiring an
alignment or clustering of orthologous genes. In cases where nearby SNPs independently
affect the phenotype, which occurs in some antibiotic resistance genes, k-mers may be split
up into lower frequency sequence units, lowering their power. In later chapters I therefore
assessed variation through k-mers, SNPs and COGs where possible. The interpretation
of k-mers has proved more challenging, due to the difficulty of mapping to the correct
place (particularly with smaller k-mers) in a well annotated genome. Ideally k-mers would
further be annotated by labelling SNPs and their predicted functional change in the k-mers,
using the ancestral state as reference. However, to map an associated region, especially




6.1.2 Epidemiological variation of S. pneumoniae
Duration of carriage of S. pneumoniae is an important measure of strain fitness in epidemi-
ological models, and its variation has been proposed as a mechanism by which antibiotic
sensitive and resistant strains can coexist. Previous analysis of the source of this variation
have been limited to serotype resolution, so using genome sequences from a longitudinal
study cohort offered the opportunity to refine the analysis of variance.
I first developed HMMs for longitudinal swabbing data per serotype, to allow carriage
acquisition and clearance rates and false negative swabbing rates to be estimated from the
whole data rather than from a set of assumptions. The only model that converged for the
most common serotypes was the simplest: two states for carrying and not-carrying. These
parameters could then be applied to individual carriage episodes to infer the most likely
durations based on the observed data. Using these durations as a continuous phenotype,
I used a LMM to investigate and quantify the variance components caused by serotype
and resistance, and GWAS to identify possible specific genetic variation which further
contributed to variation in carriage duration.
I found that bacterial genomic variation had a significant effect on carriage duration,
and that serotype was the largest lineage effect. However, only serotype 19F appeared
to have a contribution independent of the genetic background. I also identified prophage
k-mers which were associated with a lowered carriage duration, and evidence that this may
work through interruption of the competence mechanism (by inserting into the comYC
gene). These findings support the existence of duration and fitness modifying alleles in
the natural population, which can be used to explain coexistence of antibiotic resistant
and sensitive strains despite strong fitness differences depending on whether treatment is
currently being applied (Lehtinen et al., 2017). The increased precision of the carriage
estimates, per carriage episode rather than per serotype, along with provision of useful
covariates such as comYC status, host age and previous carriage will also be useful data
for models of coexistence and transmission.
However, one of the main limitations of this analysis was the monthly swabbing
resolution. While clearly a large and well-sampled collection, the design of swabs spaced
linearly in time to probe carriage durations which appear to be exponentially distributed
is suboptimal. A design that would be better for this purpose is exponentially distributed
sampling of cases that remain positive (Abdullahi et al., 2012a). Given the swabbing
design available here, the estimates of effect sizes of the explanatory variables on carriage
duration were therefore positively skewed.
As with all GWAS studies from a single population, results may be affected by batch
effects in this population. Therefore meta-analysis of the results from this section with
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another similar study would be useful before being generalised to the entire pneumococcal
species. However, as this amount of sequencing has previously been unfeasible and as
children need to be followed for two years, these studies are difficult to set up and long-
running from start to finish. There are no other studies currently combining carriage
duration estimates with genomic data, so this meta-analysis is not presently possible.
We are aware of a similar study starting collection in Cape Town, South Africa, so I
have released our results to facilitate comparison when this study’s sequencing has been
completed.
The function of altered carriage duration through comYC is an association only, and
does not prove causation through this mechanism. While it is possible to make evolutionary
arguments to support this interpretation, isogenic strains (controlling perfectly for genetic
background) in an in vivo model would be needed to bolster this claim.
6.1.3 Host and pathogen genetics of pneumococcal meningitis
In chapters 4 and 5 I have used genomic variation of infecting bacteria and human host
respectively to determine the impact of genetics on susceptibility to and severity of pneumo-
coccal meningitis. Heritability analysis showed that for susceptibility, host genetics played
a role and the genome sequence of the infecting strain is very important in whether invasive
disease can occur. For severity of disease a different picture emerged: pathogen variation
is unimportant, and host genetics is likely to play a small role. Though the estimation of
specific heritabilities with binary phenotypes can be problematic, the data and multiple
models support this overall conclusion.
I was unable to find and validate specific host associations through meta-analysis with
other studies given the current sample collection. This rules out the existence of common
variants with large effect sizes, the fitness defect of which would be unlikely to exist
evolutionarily. Whether the variation which contributes to this phenotype consists of low
effect size common variants, or rarer large effect size variants is a question that will need
to be answered by future studies with larger sample sizes and more sequencing covering
the entire variant frequency spectrum.
I did not include the sex chromosomes in the present analysis due to difficulties
with imputation, though I did perform an earlier analysis of the X chromosome when
using impute2 in the Dutch population that did not show any association with any of the
phenotypes. Tools are being developed to deal with the sex chromosomes in the same way
as the autosomes (Wise et al., 2013), and the imputation server and reference panel now
allows the X chromosome to be included. Future analyses should therefore not ignore this
variation.
Another issue was phenotype heterogeneity, as the cohorts differed in terms of par-
ticipant age and the exact disease presentation. While these differences have not been
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found to matter for many phenotypes, it is possible that differing effect sizes in the subtly
different phenotypes here are making associations impossible to find given the model used.
The sample size here may benefit from a specific model allowing for this heterogeneity
and expected correlations between effect sizes (as evidenced by the lack of signal from
subtest), though a simple first step would be to perform meta-analysis of only a subset of
the available studies to test for this possibility.
For the bacterial genetic contribution to meningitis, using GWAS I found many regions
of the genome to be associated with invasiveness. Reassuringly, positive controls such as
capsule (which I separately estimated to account for half of the variation in invasiveness)
and LoF mutations in virulence factors such as zmpD were found in this analysis. Some
other genes had previously been reported to affect virulence in invasive disease models, and
these results increase support for their importance in human disease too. The remaining
regions were associated with virulence for the first time here, and may suggest new
functions for these genes, or an impact on virulence through unknown interacting gene
networks.
I used a simple burden test when testing the effect of rare variants, which would not be
suitable if the variants included in the set had different directions of effect. While this is
probably correct for LoF variants, a different test may increase power for rare missense
variants affecting protein function. If there is still strong population structure at the tips of
the tree the method I have used has not explicitly accounted for it. It would be possible
to instead group variants manually, and perform the association using a LMM. A similar
caveat exists with the Tajima’s D analysis of differential selection, where permutation
testing may be insufficient to correct for population structure. In this case, the confounding
effect of different population histories or different effects of vaccine introduction may be
impossible to disentangle from signatures of selection.
These GWAS results are particularly susceptible to batch effects, due to the difficulty
of getting a perfectly matched sample of the population from carriage and invasive disease.
When analysing binary traits, if a covariate (such as serotype) is perfectly correlated with
the trait, then all the results will be confounded too. Therefore a crucial next step, before
further interpretation, is replication and meta-analysis with another population where both
carriage and disease have been sampled. Hits from both populations will then be much
better supported as the confounders may cancel out if in random directions, and power will
be raised for rarer and lower effect size variants. A project is underway in South Africa
which has taken such a sample, so we intend to perform this meta-analysis using those
sequences.
As mentioned in chapter 1 part of the power of GWAS over linkage studies comes from
the simple study design, where as many samples as possible are used without necessarily
worrying about matching for covariates or genetic background. These confounders can
then be adjusted for in the downstream analysis instead, which maximises discovery power.
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This is broadly true for bacterial genomes too, however the effect of population structure
is a much stronger confounder, and for some phenotypes which are tightly correlated
with genetic background (high heritability) this can make discovery of anything other
than homoplasic variants impossible. An alternative study design is to instead compare
variation from within the same bacterial population when it has divergent phenotypes. For
example, sampling the diversity of the bacterial population within-host in the carriage niche
and an invaded niche is not confounded by population structure (and also host covariates
such as age and immune response) as the genetic background is the same. Performing
a meta-analysis of the variation found to be associated with either niche across multiple
samples will then find those variants which occur during infection which have allowed
adaptation to the invaded niche.
I performed this analysis between blood and CSF isolates, as previous work on a single
case of pneumococcal meningitis had found convincing evidence for evolution occurring
during invasive disease. When I expanded to hundreds of cases, I found no evidence of
any variation causing adaptation to either the blood or CSF niche during disease. The
sample size was large enough to conclusively state that variation occurring after invasion is
rarely important for the progression of meningitis. However, when comparing the variation
present in populations from invasion to carriage reference sequences I did find signs that dlt
loses function in carriage more frequently than would be expected, and that pde1 is under
selection in invasion. To refine this analysis of variation occurring within-host between
carriage and disease I would need to use more samples than analysed here, and also deeper
sequencing of samples to assay the background of variation that exists within the founding




6.2.1 Bacterial GWAS methods
Since its release, I have received feedback about SEER which, if implemented, would
make it into a more broadly usable and applicable piece of software for microbiologists. In
terms of software development and installation, inclusion of SEER in a common ‘container’
would make installation automatic for those without C/C++ development experience, deal
with differences between platforms and ensure all users are working with the same version
of the code base.
I designed SEER with k-mers in mind, and therefore concentrated on making a scalable
piece of software with a single input source. As mentioned, k-mers may not be the ideal
variant when close SNPs are associated with a phenotype as the resulting k-mers will
be split up into words of smaller frequency, and therefore power. For some purposes it
may be useful to allow other forms of input such as VCF for short variants (SNPs and
INDELs) with respect to a reference, and a general presence/absence matrix for COGs and
aligned intergenic regions. The interpretation of k-mers can be challenging, both in finding
a suitable reference (even from the entire nr/nt) to map to and annotate them with, and
to determine whether they represent presence/absence of a region or variation within the
region. It has been recently argued that population variation is best represented by a pan-
genome graph, with shared haplotypes of any length being the natural variant (Marschall
et al., 2016; Paten et al., 2017). Though the counting of informative k-mers goes some
way toward testing longer variants, testing haplotypes may improve association power and
make interpretation easier. A method has been proposed using unitigs (high confidence
contigs not requiring repeat resolution), though this is not likely to scale beyond hundreds
of samples (Jaillard et al., 2017). Integrating a scalable approach such as vg (variant graph –
https://github.com/vgteam/vg) would be a promising way to include haplotype association.
Section 4.4.2 considered rare variation in GWAS assuming population structure was
not an issue, due to low frequency variants occurring at the tips of the phylogeny. Including
a way to input pathways of variants in SEER would relax this assumption, and also allow
both gene-based burden tests (in either direction) to be extended to operons and functional
pathways. Adding a model such as SKAT (Wu et al., 2011) would also improve power when
rare variants in a functional pathway do not all act in the same direction on the phenotype
of interest.
I picked a single method to adjust for population structure in SEER, but many others
could be used. For example, as shown in chapters 3 and 4, the fixed effect model of SEER is
in some cases a poor control for population structure. In the current implementation, BAPS
clusters could be used as a categorical covariate in the regression giving a similar test to the
CMH. A LMM has generally shown good control of population structure, likely thanks to
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using all SNPs in the population structure correction rather than a proportion through pick-
ing the top principal components. The LMM normally has complexity O(MN3), which is
infeasible for the GWAS problems considered here and as sample sizes grow in future. The
model of FaST-LMM rotates the design (X ) and relatedness (G) matrices so the regression
becomes linear along the eigenvectors of G (first using a singular value decomposition of
G), which with correct selection of G has complexity O(MN) (Lippert et al., 2011; Kadie
& Heckerman, 2017). In this case, G is a SNP-wise distance between samples. This is
similar to the O(MN2) phylogenetic regression method of Pagel (1997) which transforms
correlated error terms (due to relatedness between samples) into uncorrelated errors by
diagonalising the variance-covariance matrix G. In this case, G is the distance between
the root and MRCA of each pair of samples. These methods could be included as new
association models in SEER to allow for population structure correction when the current
fixed effect model is not appropriate.
The effect on GWAS power and false positive rate of these different population structure
corrections is unknown, and will likely be different depending on variant penetrance, level
of homoplasy and frequency. A simulation-based comparison between these methods
over a range of situations would therefore be useful. Based on the simulations used in
section 2.6.1, the best way to do this would be by adding in synthetic associations of
different penetrance at various points of the phylogeny of a real population using eq. (2.11),
which would allow varying homoplasy and frequency.
I used heritability and genomic partitioning to support the conclusions in chapters 3
and 4. While this is well-supported for continuous trait used in the former, the use of the
liability scale for bacterial traits in the latter has not been properly explored. Extension to
binary traits would be useful, and support of the applicability and robustness of the methods
used from simulated data will be important for having faith in quantitative estimates. If
this could be shown to work, the estimates of serotype importance may be better estimated
in a framework where genetic background is separately accounted for.
The use of SEER has been exclusively to single traits, but with the increasing availabil-
ity of high dimensional phenotypes as seen in genome-to-genome analysis (section 5.3),
pheWAS (Bush et al., 2016) and eQTL studies (L. Franke & Jansen, 2009; Wang et al.,
2009) the addition of a multitrait model could be considered. Transcriptomic data is now
being produced for bacteria (Bruchmann et al., 2015), so improved association power of
SEER for this purpose will be useful. Rather than associating every phenotype or transcript
separately, necessitating a harsh multiple testing correction, the correlation structure of
multiple traits can be exploited to find latent variables (biologically representing functional
pathways) to test for association with genetic variation improving power (Marttinen &
Corander, 2010; Marttinen et al., 2013; Marttinen et al., 2014). Recent implementations of
non-negative matrix factorisation are fast, and a promising way to find latent variables in




6.2.2 Genetics affecting pneumococcal meningitis
Further analysis using GWAS could further explain the biology of pneumococcal infection.
A simple additional analysis would be adult versus child colonisation using the Dutch
carriage population – I have already catalogued the variation, and host age is available for
all samples. Any results may be informative of the differences in immune system evasion
depending on host response, and could be important for vaccination which currently targets
children.
In the carriage stage, bacteria will only persist in the population if they can be transmit-
ted between hosts; ‘transmissibility’ of S. pneumoniae is therefore a measure of fitness.
Alleles which affect transmissibility may also be a promising vaccine candidate, as com-
pared to PCV they will reduce colonisation (and therefore disease) of all serotypes. Zafar
et al. (2017) have shown that ply is necessary for transmission, as the host cell damage
it causes increases shedding. A GWAS of S. pneumoniae transmissibility may be able to
detect more subtle effects of alleles which occur in the natural population.
Nebenzahl-Guimaraes et al. (2016) performed a GWAS on transmissibility of M. tuber-
culosis by selecting low transmission strains from at-risk hosts with rare genotypes and
high transmission strains from low-risk hosts with common genotypes. A similar way
to perform this analysis would be to use the carriage durations I estimated in chapter 3
and assume equilibrium transmission in an susceptible-infected-recovered (SIR) model
in the Maela population, which would then allow calculation of strain transmissibility
from carriage duration divided by strain prevalence. However, evidence from infant mouse
models suggests S. pneumoniae transmission may only occur shortly after colonisation,
when inflammation is highest promoting increased shedding (Kono et al., 2016; Zafar
et al., 2017). In this case a more complex transmission model using genetic similarity
and infection times may be more appropriate, and model comparison between different
functions of transmission intensity with respect to time would also be useful for inferring
the biology of real-life transmission. Numminen et al. (2013) proposed a more flexible
transmission model for the Maela population which was fitted with approximate Bayesian
computation. Due to many proposals of the transmission tree being inconsistent with
the observed infection times (and being assignedL = 0) the fitting was computationally
intensive; the use of the carriage durations estimated here rather than single time-points
may ameliorate this problem. Inference of alleles affecting transmissiblity could then
be jointly estimated in the process of inferring the transmission trees. Alternatively, if
the dimension of genetic variation is too high, they could be inferred separately by first
calculating strain-wise transmissibility from the transmission trees and then using these as
a phenotype in GWAS. An alternative approach would be to sample within-host diversity
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by deep sequencing of swabs, which allows finding the genotypes which make it through
the transmission bottleneck in each case through ancestral state reconstruction (where the
trait is the identity of the host). Averaged over many transmission chains, the variation
shared by these genotypes would represent transmissibility alleles.
In the analysis of host genetics affecting bacterial meningitis, a better model of the
shared architecture between the subtypes of meningitis analysed may help find associations
(Pickrell et al., 2016). Rather than using subtest with underpowered genotype data, it
may be better to use LD-score regression between summary statistics from all the studies
available, which would allow estimation of coheritabilities between the different sub-
phenotypes (Bulik-Sullivan et al., 2015). To aid in increasing power for detecting host
genetics we have applied to access the UK biobank (http://www.ukbiobank.ac.uk/), which
is about to release 500 000 genotypes of a richly phenotyped UK adult population. These
phenotypes include ICD-10 codes, which show hospital diagnoses for bacterial meningitis,
split up by causal species. Additionally, date of death is available, allowing inference of
clinical outcome. The large size and well-defined phenotype of these samples will allow
us to perform another GWAS, and meta-analyse the results with those of chapter 5 for both
susceptibility and severity increasing discovery power.
The genome-to-genome analysis was limited by the small sample size when testing
massive numbers of combinations of possible interactions. In future, the ~1 200 samples
from the Danish cohort will also have the causal S. pneumoniae sequenced, allowing this
analysis to be expanded. It may also be possible to model the effect of genome-to-genome
interactions on severity as well as bacterial and host factors, by analysing a combined
model of the form:
severity∼ Xbacteria+Xhost+Xinteraction
where the interaction term is Xbacteria×Xhost.
Finally, I would propose the following extensions to assessing with-host diversity
during bacterial meningitis. As I have shown that selection does not occur between blood
and CSF samples, but that it probably does occur between carriage and CSF, a greater
number of carriage and invasive samples from the same patient should be taken: greater
both in terms of the number of patients enrolled and in the depth of coverage of the
within-host diversity. This is a difficult study to set up: in the MeninGene cohort recent
attempts to swab bacteria from the nasopharynx of bacterial meningitis patients before
treatment started yielded no positive cultures, likely due to the small carriage population
(Wyllie et al., 2014; Wyllie et al., 2016). Alternative culture-free methods such as DNA
pull-down may be helpful, or alternative a study in an alternative population with high
rates of carriage may be able to achieve sufficient sample size.
The analysis of this data would benefit from an improved null model of mutation. In
section 4.5 I assumed a simple model of equal mutation rate per base and Poisson dispersion
196
Chapter 6. Conclusions
of number of mutations, which led to regions with higher mutation rates being found, and
may have suppressed the discovery of genes with lower mutation rates. Improving this
through a more refined model of mutation rates depending on sequence context and using
observed dispersion of the number of mutations would be a useful extension (Samocha
et al., 2014; Aggarwala & Voight, 2016). If more mutations were observed, using the
observed number of synonymous changes, which are assumed to be neutral, as a basis
for the null would also help (Ding et al., 2008). Finally, experimental evolution without
selection pressure may give the most accurate null model (Tenaillon et al., 2016), though
an experiment recreating the bottlenecks encountered in pneumococcal meningitis has not
yet been performed.
6.2.3 Future of statistical genetics in bacterial diseases
Statistical genetics, and specifically GWAS, of host and pathogen genetics contributing
bacterial diseases is still in its infancy. Looking at the boom in human genetics and given
the large sample sizes becoming available, it is reasonable to expect the field to continue to
expand. The near future is likely to consist of further methodological improvements and
analysis of new phenotypes, going on to functional validation and eventually integration
with host data. I hope that I have presented some reasonable early steps in this field in this
thesis, and that others find elements of what we’ve done useful for future research.
Thanks a lot for reading all the way to the end! (unless you skipped straight here)
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A.1 Data access and code availability
The following new data generated as part of this work is available publicly:
• S. pyogenes sequence reads from section 2.6.3 are available on the European Nuc-
leotide Archive under study accession IDs PRJEB2839 (isolates from Fiji) and
PRJEB3313 (isolates from Kilifi).
• From the paired blood and CSF isolates in section 4.5 read data, assembled and
annotated contigs were deposited in the European Nucleotide Archive (ENA): study
accession number ERP004245.
• Sample metadata used from these paired blood and CSF isolates has been deposited
in Figshare (DOI: 10.6084/m9.figshare.4329809).
Relevant code for each section can be found on github:
• Testing of tree inference methods, section 2.3.1: https://github.com/johnlees/which
tree
• SEER, section 2.5: https://github.com/johnlees/seer
• Carriage duration analysis and results, chapter 3: https://github.com/johnlees/carriage-duration
• Paired sample analysis, section 4.5: https://github.com/johnlees/paired-samples
• Calculation of Tajima’s D, section 4.4.2: https://github.com/johnlees/tajima-D
• Fix to subtest code, section 5.2.2: https://github.com/johnlees/subtest
• Code to perform all-by-all variant association in genome-to-genome analysis, sec-
tion 5.3.1: https://github.com/johnlees/epistasis-code
• Miscellaneous code and scripts, referred to throughout: https://github.com/johnlees/
bioinformatics
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A.2 Supplementary figures
Figure A.1: Monotonic warping function from warped-lmm. x-axis shows the centred and normalised input
phenotype; y-axis shows corresponding warped value.
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Figure A.2: Normal quantile-quantile plot of carriage length, and effect of monotonic transformation. Panel
a) the inferred carriage duration, b) after the natural logarithm is taken, and c) after the warping function is
applied.
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Figure A.3: Regression diagnostics and outlier removal. Panel a) shows prior to outlier removal, b) after
outlier removal as produced by plot.lm() in R. Points deviating from normal residuals (top right plot), and
at high leverage (bottom right plot) were removed. These observations appeared to be due to swabs not taken
at the prescribed monthly intervals.
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Figure A.4: Histogram of pairwise patristic distances on the inferred phylogeny. A cut-off for heritability
estimation was chosen at 0.04, under which a clear second maxima corresponds to closely related isolates on
the tree.
244
Appendix A. Supplementary information































































































66 66 66 66 66 65 65 59 55 47 39 30 15 9 5 4 3 2 0
a)
b)
Figure A.5: Lasso regression plots for lineage effects. Panel a) shows the value of each predictor on the
y-axis for different values of the `1 penalty λ on the x-axis, which increases from left to right. The labels
along the top are the number of predictors remaining in the model for each λ . Panel b) shows the results of
leave-one-out cross validation on the mean-squared error, along the same x-scale. The λ at minimum error is
shown by the left dashed line, and the λ within one standard error is shown by the right dashed line.
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Figure A.6: Identification of phage in assemblies by blastn hit length. Histogram of the length of top hits
against a database of phage sequence by blastn. Isolates with >5000bp hits were defined as having phage
present.




















Figure A.7: The lengths of those k-mers reaching significance in the LMM analysis, binned by frequency.
Lengths below 20 bases were filtered from downstream analysis, due to having low specificity.
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Figure A.8: Quantile-quantile plots of association p-values. For fast-lmm results on a) SNPs passing
quality filters and b) k-mers of all lengths passing quality filters.
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Figure A.10: Maximum likelihood tree of pspC protein alignment, with 100 bootstrap replicates (nodes are
labelled with bootstrap supports). Tips are coloured by allele group.
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Figure A.11: Maximum likelihood tree of pspA protein alignment, with 100 bootstrap replicates (nodes are


































Figure A.12: Maximum likelihood tree of zmpC protein alignment, with 100 bootstrap replicates (nodes are
labelled with bootstrap supports). Tips are coloured by allele group.
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Diversity difference count with Gaussian fit













Figure A.14: Distribution of difference in Shannon diversity index between the ivr locus model piblood and
piCSF. A Gaussian distribution was fitted to the data, which has a mean of roughly zero and little skew. The
maximum possible Shannon diversity index (for equal amounts of each allele A-F) is 1.8.
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Figure A.15: Plot of the samples in the genome-to-genome analysis. x-axis is the first PEER factor loading,
y-axis is the second PEER factor loading. Sample are coloured by the BAPS cluster they were assigned to.
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